DGE	Genes	Process~name	num_of_Genes	gene_group	percentage%	P-value	Benjamini and Hochberg (FDR)	 Hommel singlewise process	Bonferroni single-step process	Hommel singlewise process	Hochberg step-up process	Benjamini and Yekutieli
down	CCL21; FFAR3; TPST1; IL18RAP; LY86; C3; ORM1; ANXA1; KIT; CCL2; ITGB6; SDC1; HK1; IGFBP4; PTGS1; CRHBP; TACR1; EPHA2; CD40LG; BDKRB2; FCGR2B; CNR2; HRH1; BDKRB1; AIF1; NLRP6; ELF3; MS4A2; FUT7; NAIP; IL18; PRKD1; ECM1; IL34; AFAP1L2; IL27; IL17RE; BLNK; CD180; MGLL; IL1RL2; CYP4F11; PROK2; TLR9; STAB1; PLA2G2D; PF4; IL36A; PTGFR; CCL24; CCL17; CCL26; CCR5; IL1RN; FPR3; CX3CL1; CCR2; GGT5; XCL2; IL2RA; CCL20;	GO:0006954~inflammatory response	61	381	16.010498687664	0	0	0	0	0	0	0
down	IGKV2-28; IGKV2D-30; IGKV3D-20; IGKV1-12; IGLC7; IGKV2-29; C1R; C3; IGKV1-39; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV1D-12; IGKV2D-40; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV3-27; IGLV6-57; IGHV1-69; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-13; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHG2; IGHG3; C1QA; C1QC; C4BPA; IGLV7-43; IGKV1-16; IGKV1D-39; IGKV3-11; CFI; IGKV2-30; IGKV4-1; IGKV5-2; IGHV4-34; C1S; IGLC2; IGLC3; C7; IGHV1-2; IGLV3-21; SUSD4; IGHV1-18; IGHV4-4; IGHV1-45; IGHV3-21; IGHV5-51; IGHV3-20; IGHD; IGHV1-24; IGHV1-69-2; IGHV3-49; IGHV4-61; IGHV4-31; TRBC2; IGHV4-28; IGHV2-26; IGHV3-15; TRBC1; IGHV6-1; IGHV3-74; IGHV3-64; IGHV1-3; IGHV3-66; IGHV3-72; IGHA2; IGHV1-58; IGHV3-43; IGHV3-73;	GO:0006958~complement activation, classical pathway	91	161	56.5217391304348	0	0	0	0	0	0	0
down	CHL1; PODXL; PDZD2; EFS; EDIL3; NRP2; FARP2; VWF; ATP1B1; PTPRF; COL6A1; CCL2; CEACAM1; ITGB6; VCAM1; KITLG; CD9; CDH3; NME2; LAMA1; EPHA2; EPHA3; L1CAM; COL15A1; GP5; EFNB2; EMP2; MFAP4; BCAR1; RND3; CX3CL1; EFNB1; DST; TYRO3; DDR1; LGALS3BP; TROAP; CNTN1; MYBPH; SLAMF1; LSAMP; SEMA5A; TPBG; LAMC2; DSG2; ADGRE1; MYBPC2; HES1; DSC3; MYBPC3; COL19A1; POSTN; GRHL2; PPFIBP1; EGFL6; SPACA4; CNTNAP3B; MAGI1; BOC; STAB1; NTM; SIRPG; CD300A; CLEC4A; CLCA2; ROBO1; SIGLEC5; PCDH17; PCDH1; SIGLEC11; PCDHB13; SIGLEC6; PCDH7; PCDHB14; SIGLEC10; SIGLEC14; PARD3B; PCDHGC3; PCDHGA9; PCDH18; SPON1; SIGLEC7; ICAM3; PARD3; PCDHGB7; PCDHGB5;	GO:0007155~cell adhesion	86	454	18.942731277533	0	0	0	0	0	0	0
down	TNFRSF13B; LILRA1; TSPAN12; EGFR; HRAS; PRL; IFNG; IL2RA; ERBB2; MET; CD3G; CCL2; CD59; NPR1; EDN2; EPHA1; CXCR1; LAMA1; BDKRB2; LIFR; GLP1R; P2RY1; CCR5; ADGRE1; ADGRF1; GPR157; ADGRG6; ADGRA3; ADGRF5; ADGRF4; LILRB2; CLEC1A; ADGRV1; MAGI1; ADGRE3; ADGRL4; CLEC1B; CLEC4A; TRBV19; TRBV5-1; CD80; TRBV5-5; TRBV3-1; TRBV2; TRBV13; TRBV28; TRBV11-1; TRBV25-1; TRBV11-3; TRBV7-6; TRBV29-1; TRBV14; CTF1; TRBV20-1; TRBV7-4; TRBV12-5; TRBV6-5; TRBV12-4; TRBV5-6; TRBV23-1; ANXA1; TRBV18; TRBV7-9;	GO:0007166~cell surface receptor signaling pathway	63	268	23.5074626865672	0	0	0	0	0	0	0
down	WIPF3; UPK2; HMGB3; PI15; EDIL3; RECQL4; VENTX; HOXC6; CSF3; ERG; OSM; GATM; HMGA2; HUNK; ELF3; FGD1; TNFRSF17; C19orf57; CSRP2; HLF; CEP55; HHAT; ANO1; GGNBP1; RNF43; KCTD11; SPRED2; TXNRD3; SLC22A16; EGFL6; GPR65; NME8; VANGL1; EDARADD; CCL17; CCDC120; CADM1; SCUBE2; OLFML3; HELLS; PAQR5; EHF; ADAMTS9; EBF1; GTF2IRD1; TBX21; EPHA2; RARG; FGFR2; RARB; TYRO3; ROR1; ERBB2; DDR1; EPHA1; NTRK1; FLT4; FGFR3; CDH3; CDH13; EGFR; ERBB3; TIE1; EPHA3; LTK; FLT3; FSTL1; NTRK2; FGFR4; CDH26; CDH1; PPARG; MET; CDH24; EPHB3; KDR; KIT; SPINK5;	GO:0007275~multicellular organism development	78	513	15.2046783625731	0	0	0	0	0	0	0
down	DLL1; WNT10B; TBX3; BIRC5; PRC1; VEGFD; GREM1; LRP5; CLDN7; NTN1; EGFR; HRAS; IFNG; KRT6A; S100B; WNT1; CAPN1; ADRA2A; TGFB3; KIT; BMP4; RARG; OSM; VEGFA; EDN2; PTN; KITLG; EPHA1; FGFR2; FGFR4; FGFR3; ADRA1D; AVPR2; ALDH3A1; TTK; FLT4; KDR; FLT3; AVPR1A; CEACAM6; MATK; LIFR; PTGFR; SOX9; EFNB2; AKR1C2; CRIP2; EMP2; AIF1; RAB25; CX3CL1; PTK2; FOXM1; CDC20; TBX2; SLAMF1; LAMC2; KLF5; HES1; EZH2; CTF1; NTRK2; IL34; NCCRP1; SAPCD2; KLB; MYOCD; SFRP1; FAM98A; PROX1; TSLP; LGMN; S100A13; OSMR; MTA3; WWTR1; GAREM1; ARNT2; ESM1; SIRPG; HILPDA; ERBB2; ERBB3; PRL; BTC; CSF3; PROK2; RTKN2;	GO:0008284~positive regulation of cell population proliferation	88	490	17.9591836734694	0	0	0	0	0	0	0
down	FOXE1; PODXL; LAMA5; PLXNB1; CDK1; PTPRF; CEACAM1; JUP; HOXA5; EFNA1; FGFR4; CD24; EPHA2; EPHA3; L1CAM; BDKRB1; EPHB3; EMP2; BCAR1; SHROOM2; TNFAIP1; PTK6; DOCK1; HES1; SKAP1; WWC1; ASAP3; ELMO3; RHBDF1; FAM83D; CDC42BPB; LAMB3; TYRO3; KDR; SDC1; GPC1; LAMB2; ITGB6; LAMB4; PIK3C2G; NCKAP1L; RHOV; EFS; SDC4; NCKAP1; LAMC3; RHOD; ITGB5;	GO:0016477~cell migration	48	225	21.3333333333333	0	0	0	0	0	0	0
down	DAPL1; CFAP69; WIPF3; DLL1; TLL1; SOX15; KRT6A; MGP; MAL; MDK; COL15A1; NHLH2; HHEX; MECOM; SIM2; CBX2; COL19A1; ANGPT1; SHB; INA; CSRP2; ZNF750; GGNBP1; NXN; MYO7B; CXCL17; TXNRD3; SLC22A16; EGFL6; UNC45B; ARHGEF28; NME8; PSMA8; OSR1; EDARADD; ATOH8; MMP19; CHRDL1; CADM1; ZHX3; FGF22; DHCR7; MOSPD1; NDRG4; NDRG2; NR2C1; POU3F1; KIAA1522; NR2F2; POU2F3; FOXA1; NKX6-3; ETV5; EYA1; ETV4; HEYL; ID1; RARB; SPI1; HES1; EGFR; FOXQ1; EYA2; ELF5; ERG; PTK6; FSTL1; NHSL1; SOX2; SPIB; NR2F6; TNK1; FRK; SOX7; EHF; SLA; SOX21; SPINK5; BHLHE40; ELF3; RARG; PPARG; CAV2; FOXE1; YES1;	GO:0030154~cell differentiation	85	572	14.8601398601399	0	0	0	0	0	0	0
down	IL10; DEFB1; CCL20; IRF8; CEBPE; COLEC12; GBP6; S100A14; TLR9; STAB1; SLAMF8; ADAMTS5; IGHV3-48; IGHV6-1; IGHG2; IGLC3; IGHG3; IGHV1-46; IGHV3-53; IGHV3-13; IGHV1-24; TRBC1; IGHV3-73; IGHV1-2; TRBC2; IGHV3-30; IGHV1-45; IGHA2; IGLC2; IGHV3-72; IGHV2-5; IGHD; IGHV3-49; IGHV3-74; IGHV1-18; IGHV2-70; IGHV3-7; GSDMC; IGHV1-58; IGHV4-34; IGHV3-15; IGHV5-51; IGHV3-66; IGHV3-64; IGHV3-23; IGHV1-69; IGHV1-69-2; IGHV4-31; IGLC7; IGHV3-20; IGHV4-61; IGHV3-43; IGKC; IGHV4-39; IGHV4-28; IGHV2-26; IGHV4-4; IGHV3-21; IGHV3-11; IGHV4-59; IGHV1-3; IGHV3-33;	GO:0042742~defense response to bacterium	62	216	28.7037037037037	0	0	0	0	0	0	0
down	IGKV2-28; IGKV2D-30; TRAV19; IGKV3D-20; IGKV1-12; IGLC7; IGKV2-29; CD300LB; TYROBP; LILRA1; NCR1; C3; IGKV1-39; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV1D-12; IGKV2D-40; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV3-27; IGLV6-57; TRAV8-4; IGHV1-69; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-13; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; TRBC1; IGLV7-43; IGKV1-16; IGKV1D-39; IGKV3-11; TRBV7-9; CD1A; IGKV2-30; IGKV4-1; IGKV5-2; IGHV4-34; CD3G; IGLC2; IGLC3; CD8B; CD19; VCAM1; IGHV1-2; CD1B; CD1C; CD40LG; FCGR2B; ICAM3; KIR2DL1; KIR2DL3; CXADR; IGLV3-21; CD300E; COLEC12; TREML2; CD276; TREML4; CD300LD; LILRB2; LILRB1; RAET1E; CD300LF; NECTIN2; CD300A; SIGLEC7; BTNL8; BTNL3; BTN1A1; HHLA2;	GO:0050776~regulation of immune response	92	216	42.5925925925926	0	0	0	0	0	0	0
down	IGKV2-28; IGKV2D-30; IGKV3D-20; IGKV1-12; IGLC7; IGKV2-29; JCHAIN; IGKV1-39; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV1D-12; IGKV2D-40; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV3-27; IGLV6-57; IGHV1-69; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-13; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHA2; IGLV7-43; IGKV1-16; IGKV1D-39; IGKV3-11; ATP1B1; IGKV2-30; IGKV4-1; IGKV5-2; IGHV4-34; YES1; DBH; CD48; IGLC2; IGLC3; CEACAM1; SDC1; IGHV1-2; SDC4; L1CAM; GPC1; CEACAM3; CEACAM6; CXADR; IGLV3-21; GRB7; ANGPT1; FOXJ1; SIRPG; SLC7A8; CD84;	GO:0050900~leukocyte migration	73	193	37.8238341968912	0	0	0	0	0	0	0
down	ASPDH; PIR; SCD; PRODH; HR; UGDH; SC5D; CYP7B1; ALDH1L1; TM7SF2; CYP11A1; CYP2E1; DBH; TXN; CYP4B1; HPGD; VCAM1; MAOA; GPX3; FDXR; PTGS1; NOS1; ALDH3A1; RRM2; PYCR1; SPR; DCT; ADH7; ALDH3B2; ALDH9A1; ALDH7A1; ALDH3A2; AKR1C2; CYP4F2; BDH1; AKR1C1; SQLE; CRYM; PTGR1; DHCR24; NSDHL; MSMO1; GFOD2; CYP27C1; TP53I3; PHYHD1; RNLS; CYB5R2; NXN; CYP4F22; DEGS2; MOXD1; DHRS11; IDO2; LOXHD1; SDR16C5; CBR4; SDR42E1; DIO2; ERO1A; DHRS1; RDH12; VAT1; TXNDC17; BCO2; GSTO2; EGLN3; CYP4F11; DUOX1; STAB1; TECR; WWOX; DHCR7; STEAP1; PCYOX1; CYP2J2; CYP2A6; STEAP3; STEAP2;	GO:0055114~oxidation-reduction process	79	526	15.0190114068441	0	0	0	0	0	0	0
down	SPRY1; NGFR; GPC1; WNT5A; WNT4; SULF1; SPRY2;	GO:0040037~negative regulation of fibroblast growth factor receptor signaling pathway	7	16	43.75	0.00010126350080463	0.00331818792815198	0.540544567295158	0.557455571929533	0.39168722111234	0.540544567295158	0.0304965313032695
down	CIT; BUB1B; RECQL5; CCNO; NEK2; PLK1; CDH13; KIF18B; SKA3; CDCA5; PBK; PKMYT1; CDC6; CDT1; TTYH1; TPX2; TUBB4B; TUBB6; TUBB2A; PLK2;	GO:0000278~mitotic cell cycle	20	134	14.9253731343284	0.00010824652671215	0.00350527723264941	0.577603466536045	0.595897129550399	0.405428092155085	0.577603466536045	0.0322160164423437
down	UNC13B; GIPC1; PPFIA3; GJA1; BDNF; SLC1A3; SLC1A1; STXBP1; NTRK2;	GO:0014047~glutamate secretion	9	30	30	0.00011482198077128	0.00361683486542389	0.612575267414804	0.632095004145922	0.416030716349924	0.612575267414804	0.0332413112459206
down	FOXP2; LRP5; VEGFA; FGFR2; WNT5A; SOX9; PRRX1; SMO;	GO:0002053~positive regulation of mesenchymal cell proliferation	8	23	34.7826086956522	0.00011836339651116	0.00361683486542389	0.630995266801034	0.651590497793977	0.421731799523542	0.6306401766115	0.0332413112459206
down	TRPM2; VCAM1; KDR; PTGFR; GPR143; DEFB1; CCL20; HOMER2;	GO:0035584~calcium-mediated signaling using intracellular calcium source	8	23	34.7826086956522	0.00011836339651116	0.00361683486542389	0.630995266801034	0.651590497793977	0.421731799523542	0.6306401766115	0.0332413112459206
down	TP73; PTN; MDK; PPARG; ASPA; OLIG2; IL34; ZNF488;	GO:0048714~positive regulation of oligodendrocyte differentiation	8	23	34.7826086956522	0.00011836339651116	0.00361683486542389	0.630995266801034	0.651590497793977	0.421731799523542	0.6306401766115	0.0332413112459206
down	RHOD; GREM1; EPHA3; EFNA5; PTK2; GPM6B; CAMSAP3; LIMCH1;	GO:0051893~regulation of focal adhesion assembly	8	23	34.7826086956522	0.00011836339651116	0.00361683486542389	0.630995266801034	0.651590497793977	0.421731799523542	0.6306401766115	0.0332413112459206
down	DSP; DSG2; GRHL1; PKP2; PERP;	GO:0002934~desmosome organization	5	6	83.3333333333333	0.00011851710738075	0.00361683486542389	0.631340631017285	0.65243667613106	0.422026077314476	0.631222113909904	0.0332413112459206
down	OVOL1; SNAI2; FBLN1; KDF1; OVOL2;	GO:2000647~negative regulation of stem cell proliferation	5	6	83.3333333333333	0.00011851710738075	0.00361683486542389	0.631340631017285	0.65243667613106	0.422026077314476	0.631222113909904	0.0332413112459206
down	FUT1; FUT3; FUT2; FUT7; FUT6; FUT10;	GO:0036065~fucosylation	6	11	54.5454545454545	0.00012787294961313	0.00382576406315398	0.680539837841127	0.703940587620331	0.437074188174984	0.680539837841127	0.0351615206965923
down	EGFR; BDNF; EDNRA; GNA15; AVPR1A; NTRK2; P2RY12; NMUR1; GPR55;	GO:0007202~activation of phospholipase C activity	9	31	29.0322580645161	0.00014152865999761	0.00414423017705779	0.752932471187306	0.779115273286865	0.45911897303226	0.752649413867311	0.0380884531133188
down	CCL21; KIT; CD19; FGFR3; FLT3; PTK2; PRKD1; TNFAIP8L3; P2RY12;	GO:0043552~positive regulation of phosphatidylinositol 3-kinase activity	9	31	29.0322580645161	0.00014152865999761	0.00414423017705779	0.752932471187306	0.779115273286865	0.45911897303226	0.752649413867311	0.0380884531133188
down	MEIS2; CCNB1; TAL1; DYNLT3; FOXA1; TTL; LGMN; SMOC2; CDC25C;	GO:0045931~positive regulation of mitotic cell cycle	9	31	29.0322580645161	0.00014152865999761	0.00414423017705779	0.752932471187306	0.779115273286865	0.45911897303226	0.752649413867311	0.0380884531133188
down	PLK1; CDC20; TRIP13; SPDL1; AURKB; TTK; BUB1; BUB1B;	GO:0007094~mitotic spindle assembly checkpoint	8	24	33.3333333333333	0.00015083331880694	0.00434731633524721	0.801980756096512	0.830337420032217	0.472409954503343	0.801679089458898	0.0399549608321669
down	HPN; WNT5A; SOX9; TIFAB; GRHL3; FRZB; EYA1; VANGL2;	GO:0090103~cochlea morphogenesis	8	24	33.3333333333333	0.00015083331880694	0.00434731633524721	0.801980756096512	0.830337420032217	0.472409954503343	0.801679089458898	0.0399549608321669
down	CLDN4; HRAS; ANXA1; ADRA2A; PTK2; KANK1; OCLN; DUOX1;	GO:0090303~positive regulation of wound healing	8	24	33.3333333333333	0.00015083331880694	0.00434731633524721	0.801980756096512	0.830337420032217	0.472409954503343	0.801679089458898	0.0399549608321669
down	E2F8; FLT4; CDH13; ANGPT1; ESM1; PARVA; KDR; VEGFD; VEGFA;	GO:0002040~sprouting angiogenesis	9	32	28.125	0.00017322531557695	0.00489028390898012	0.919999651029195	0.953605362251124	0.50079438733297	0.919999651029195	0.0449452229775144
down	FUT3; SOX2; FUT7; MAGI1; NODAL; MYO10; SIRPG;	GO:0022409~positive regulation of cell-cell adhesion	7	18	38.8888888888889	0.00018159874457324	0.00502362356218942	0.964289333683912	0.999701088875694	0.510292472250808	0.963744537450192	0.0461707102000929
down	ALOX15B; MT1E; MT1G; IGFBP5; MT1H; MT1X; PTK6;	GO:0045926~negative regulation of growth	7	18	38.8888888888889	0.00018159874457324	0.00502362356218942	0.964289333683912	0.999701088875694	0.510292472250808	0.963744537450192	0.0461707102000929
down	EDN2; CTTN; NPNT; MYOCD; PROK2; NMU; ADRA1D;	GO:0045987~positive regulation of smooth muscle contraction	7	18	38.8888888888889	0.00018159874457324	0.00502362356218942	0.964289333683912	0.999701088875694	0.510292472250808	0.963744537450192	0.0461707102000929
down	GREM1; VEGFA; SOX9; SOX8; WNT2B; SMO; LGR4;	GO:0090190~positive regulation of branching involved in ureteric bud morphogenesis	7	18	38.8888888888889	0.00018159874457324	0.00502362356218942	0.964289333683912	0.999701088875694	0.510292472250808	0.963744537450192	0.0461707102000929
down	PCDH17; PTPRF; PTPRD; EFNA5; SPARCL1; FLRT3; IGSF9B; NTNG1;	GO:0099560~synaptic membrane adhesion	8	25	32	0.00019029453672225	0.00521179813261705	1	1	0.520077826197035	0.999999717377143	0.0479001697128703
down	SPRY2; SPRY1; BMP4; FGFR2; YAP1;	GO:0060449~bud elongation involved in lung branching	5	7	71.4285714285714	0.00019467716411003	0.00527929945037313	1	1	0.525044311604765	0.999999717377143	0.048520555325299
down	UNC13B; GIPC1; SNCG; DBH; SLC6A1; SLC1A3; SLC1A1; HTR3A; PMP22; RAPSN; GRIK4; SYPL1; CEP89; LPAR3; PCDHB14; PCDHB13; GABRB3; GABRP; GABRQ; HRH2; CHRFAM7A; GABRE; CHRNB4; CACNB2; CACNB3; LRP6; DLG2; HRH1; CHRNG;	GO:0007268~chemical synaptic transmission	29	249	11.6465863453815	0.00020567825225792	0.00552321355453595	1	1	0.535900694344683	0.999999717377143	0.0507623012040664
down	RHOD; ABLIM3; KIT; CDH13; CYFIP1; AJUBA; P2RY12; ARHGEF4; ABLIM2;	GO:0030032~lamellipodium assembly	9	33	27.2727272727273	0.00021061626845131	0.00557424306646385	1	1	0.540628274893412	0.999999717377143	0.0512312990853186
down	TGFB3; BMP4; SDC1; FGFR2; PAX9; OSR1; AQP3; PITX2; WNT10A;	GO:0042476~odontogenesis	9	33	27.2727272727273	0.00021061626845131	0.00557424306646385	1	1	0.540628274893412	0.999999717377143	0.0512312990853186
down	MATN2; NCKAP5; FLRT2; HSPA12A; PI15; PLCH2; SORBS2; TM4SF1; PNPLA4; XG; TMEM132B; PDGFRL; FAM189A2; TMEM132A; KRT24; PRICKLE4; TMEM35A; TTC39A; TRAPPC3L; GGT6; SBSN; BTNL3; DLEU7; KNDC1; TMPRSS11B; KRT73; DMRTC2; SLC35F2; RBFA; IL22RA1; GIPC2; CASKIN2; S100Z; TMEM54; TMEM125; CYYR1; DEPDC7; CDCA3; P2RY13; TMEM47; GSDMC; UACA; HDHD2; RNF39; MRPL46; ADAMTS10; PLEKHA5; EPB41L4A; SERHL; ETNK2; TMEM51; NYNRIN; TRIM10; FETUB; PCDHGB5;	GO:0008150~biological_process	55	603	9.12106135986733	0.00022445751034083	0.00585610708258912	1	1	0.553736678010843	0.999999717377143	0.0538218319234683
up	AKR1B15; AKR1B10; CYP1A1;	GO:0042572~retinol metabolic process	3	44	6.81818181818182	0.00023391476133005	0.00660159437531492	0.114852147813058	0.118828698755669	0.100349432610594	0.114852147813058	0.0449481504670866
down	LRP4; DKK1; MDK; SOX9; SFRP1; KREMEN2; KREMEN1;	GO:0030279~negative regulation of ossification	7	19	36.8421052631579	0.00023766894949006	0.00617154512708875	1	1	0.566260518432132	0.999999717377143	0.0567209342065878
down	ERBB2; GLI3; GJA1; PTN; ERBB3; EDNRA; LOX; GNA11; PPARG; ID1; OXCT1; CXADR; RBM20; OSR1; FOXJ1; ALPK3; PKP2; MIXL1; FLRT3; PDLIM5; PRICKLE4; PDLIM1; PDLIM4; SOX9;	GO:0007507~heart development	24	190	12.6315789473684	0.00024017427406675	0.00617831485391339	1	1	0.568252332441933	0.999999717377143	0.0567831528604111
down	KALRN; ERBB2; LAMB2; CACNB2; CACNB3; PPFIBP2; PPFIBP1; PDZRN3; UNC13B;	GO:0007528~neuromuscular junction development	9	34	26.4705882352941	0.0002544713290824	0.00639756165763932	1	1	0.579913275977529	0.999999717377143	0.0587981885237749
down	NRP2; VEGFA; FLT4; KDR; FLT3; VEGFD;	GO:0038084~vascular endothelial growth factor signaling pathway	6	13	46.1538461538462	0.00025683217553829	0.00639756165763932	1	1	0.581757101996547	0.999999717377143	0.0587981885237749
down	MELTF; TACSTD2; FBLN1; EFNA5; KANK1; POSTN;	GO:1900025~negative regulation of substrate adhesion-dependent cell spreading	6	13	46.1538461538462	0.00025683217553829	0.00639756165763932	1	1	0.581757101996547	0.999999717377143	0.0587981885237749
up	S100A8; S100A9; S100A12; WFDC12; FCER1G;	GO:0042742~defense response to bacterium	5	216	2.31481481481481	0.00025689753311086	0.00676494491760151	0.125879791224325	0.13050394682032	0.108153861439675	0.125879791224325	0.0460603522074771
down	TARM1; FCN1; SIGLEC5; TYROBP; FCGR3B; TRPM2; NFASC; C3; ORM1; CSTB; ANXA2; CAPN1; HSPA1B; FCGR2A; CEACAM1; CD59; JUP; DSP; BPI; CD53; ORM2; NME2; MMP8; FCAR; CXCR1; CHRNB4; PRSS3; CEACAM3; CEACAM6; MNDA; FRK; P2RX1; HK3; NCKAP1L; TUBB4B; SIGLEC14; PLD1; CLEC12A; CYFIP1; LILRB2; CLEC4C; MS4A3; VAT1; ADGRE3; NIT2; CD300A;	GO:0043312~neutrophil degranulation	46	483	9.52380952380952	0.0002978609704658	0.00725541877174442	1	1	0.610783283642881	0.999999717377143	0.0666825118051899
down	TERT; PRL; NGFR; SPI1; IL10; TEAD1; KLF5; ATOH8; SREBF2;	GO:1902895~positive regulation of pri-miRNA transcription by RNA polymerase II	9	35	25.7142857142857	0.00030562803563694	0.00731321158666032	1	1	0.615326683988395	0.999999717377143	0.0672136693005908
down	TERT; SNAI2; PF4; HSPA1B; GATA1; CX3CL1; UNC5B; EYA2; EYA1;	GO:2001240~negative regulation of extrinsic apoptotic signaling pathway in absence of ligand	9	35	25.7142857142857	0.00030562803563694	0.00731321158666032	1	1	0.615326683988395	0.999999717377143	0.0672136693005908
down	NEFH; CYFIP1; NCKAP1L; PARVA; NCKAP1; RHOV; PARVG;	GO:0030031~cell projection assembly	7	20	35	0.00030687590854106	0.00731321158666032	1	1	0.616085762180875	0.999999717377143	0.0672136693005908
down	SNAI2; GREM1; RARB; BMP4; RARG; SOX9; EFEMP1;	GO:0032331~negative regulation of chondrocyte differentiation	7	20	35	0.00030687590854106	0.00731321158666032	1	1	0.616085762180875	0.999999717377143	0.0672136693005908
down	NR2F2; LOX; FLT4; ID1; SLC1A1; EFNB2; LAMA1;	GO:0048514~blood vessel morphogenesis	7	20	35	0.00030687590854106	0.00731321158666032	1	1	0.616085762180875	0.999999717377143	0.0672136693005908
down	WNT5A; GRHL3; DLG3; TP63; INTU; VANGL2;	GO:0001736~establishment of planar polarity	6	14	42.8571428571429	0.00035120950660094	0.00802244121924569	1	1	0.642107484574565	0.999999717377143	0.0737319992323714
down	P2RY10; GPR171; P2RY2; P2RY1; P2RY13; P2RY12;	GO:0035589~G protein-coupled purinergic nucleotide receptor signaling pathway	6	14	42.8571428571429	0.00035120950660094	0.00802244121924569	1	1	0.642107484574565	0.999999717377143	0.0737319992323714
down	ADRA2A; NOS1; STC1; LILRB2; LILRB1; PACSIN3;	GO:0051926~negative regulation of calcium ion transport	6	14	42.8571428571429	0.00035120950660094	0.00802244121924569	1	1	0.642107484574565	0.999999717377143	0.0737319992323714
down	SCNN1A; SCNN1B; CYP4F2; SCN7A; SLC12A3; SLC12A1;	GO:0055078~sodium ion homeostasis	6	14	42.8571428571429	0.00035120950660094	0.00802244121924569	1	1	0.642107484574565	0.999999717377143	0.0737319992323714
down	SNAI2; BMP4; EFNA1; SOX9; JAG1; HEYL; DLL4; ROBO1;	GO:0003180~aortic valve morphogenesis	8	28	28.5714285714286	0.00036218532347076	0.00820506257492412	1	1	0.648628111036174	0.999999717377143	0.0754104207114087
down	TBX3; RARB; BMP4; RARG; MSX1; PITX1; OSR1; TP63;	GO:0035116~embryonic hindlimb morphogenesis	8	28	28.5714285714286	0.00036218532347076	0.00820506257492412	1	1	0.648628111036174	0.999999717377143	0.0754104207114087
down	GAS8; PRRX1; FOXA1; TTC23; ARMC9; SFRP1; DLG5; INTU; SMO;	GO:0045880~positive regulation of smoothened signaling pathway	9	36	25	0.00036499363265829	0.00823479486796686	1	1	0.650233261281914	0.999999717377143	0.0756836818482488
down	TAL1; SOX9; SOX8; GCM1;	GO:0060018~astrocyte fate commitment	4	4	100	0.00038954455196238	0.00847605833420128	1	1	0.664613628764972	0.999999717377143	0.0779010664598706
down	BMP4; BMP7; WNT5A; SULF1;	GO:0060686~negative regulation of prostatic bud formation	4	4	100	0.00038954455196238	0.00847605833420128	1	1	0.664613628764972	0.999999717377143	0.0779010664598706
down	ANXA8; PLA2R1; ANXA1; ANXA8L1;	GO:1900138~negative regulation of phospholipase A2 activity	4	4	100	0.00038954455196238	0.00847605833420128	1	1	0.664613628764972	0.999999717377143	0.0779010664598706
down	TJP1; ANGPT1; OCLN; TJP2;	GO:1905605~positive regulation of maintenance of permeability of blood-brain barrier	4	4	100	0.00038954455196238	0.00847605833420128	1	1	0.664613628764972	0.999999717377143	0.0779010664598706
down	TGFB3; CXADR; TJP1; OCLN; SDK1; MARVELD2; MARVELD3;	GO:0045216~cell-cell junction organization	7	21	33.3333333333333	0.00039135867883655	0.00848200601179218	1	1	0.665701112700973	0.999999717377143	0.0779557298905622
down	NFIB; WNT10B; BMP4; FGFR3; SOX9; HMGA2; OSR1; WNT2B; WNT5B;	GO:0002062~chondrocyte differentiation	9	37	24.3243243243243	0.00043354677303808	0.00921496133426509	1	1	0.68370326108106	0.999999717377143	0.084692115960215
down	MATN2; CD9; P2RY1; CSPG4; NDN;	GO:0008347~glial cell migration	5	9	55.5555555555556	0.00045188791901995	0.00949482058856815	1	1	0.690622704250485	0.999999717377143	0.0872642235967214
down	YES1; SLC2A1; EDNRA; OCLN; FFAR4;	GO:0010827~regulation of glucose transmembrane transport	5	9	55.5555555555556	0.00045188791901995	0.00949482058856815	1	1	0.690622704250485	0.999999717377143	0.0872642235967214
down	FUT1; FUT6; FUT2; FUT7; FUT10;	GO:0042355~L-fucose catabolic process	5	9	55.5555555555556	0.00045188791901995	0.00949482058856815	1	1	0.690622704250485	0.999999717377143	0.0872642235967214
down	PODXL; SPINT2; WNT1; CDH1; JAG1; PTK2;	GO:0022408~negative regulation of cell-cell adhesion	6	15	40	0.00047068414019668	0.00970455502540359	1	1	0.697755525400227	0.999999717377143	0.0891918337733663
down	EPHA3; PRKD1; LILRB1; SNX33; PACSIN1; PACSIN3;	GO:0045806~negative regulation of endocytosis	6	15	40	0.00047068414019668	0.00970455502540359	1	1	0.697755525400227	0.999999717377143	0.0891918337733663
down	IFNG; APOE; ADRA2A; SH3D19; SNX33; PACSIN3;	GO:0051044~positive regulation of membrane protein ectodomain proteolysis	6	15	40	0.00047068414019668	0.00970455502540359	1	1	0.697755525400227	0.999999717377143	0.0891918337733663
down	BMP7; FGFR2; EFNB1; SIM2; DISP1; NODAL; LRP6;	GO:0009880~embryonic pattern specification	7	22	31.8181818181818	0.00049344723091193	0.0100608407635934	1	1	0.704364441539522	0.999999717377143	0.0924663557121114
down	DLG5; VANGL2; DLG2; DLG3; PARD3; LRRC1; PARD3B;	GO:0045197~establishment or maintenance of epithelial cell apical/basal polarity	7	22	31.8181818181818	0.00049344723091193	0.0100608407635934	1	1	0.704364441539522	0.999999717377143	0.0924663557121114
down	HS3ST1; HS6ST1; SDC1; SDC4; GPC1; GALNT5; HS6ST2; HS3ST3A1; UGDH;	GO:0006024~glycosaminoglycan biosynthetic process	9	38	23.6842105263158	0.00051233892310664	0.0103202513358253	1	1	0.709656182068991	0.999999717377143	0.0948505252672328
down	RAB13; OCLN; GRHL2; MARVELD2; PATJ; PARD3; MARVELD3; CRB3; PARD6G;	GO:0070830~bicellular tight junction assembly	9	38	23.6842105263158	0.00051233892310664	0.0103202513358253	1	1	0.709656182068991	0.999999717377143	0.0948505252672328
down	JUP; DSP; KCNJ5; KCNQ1; CACNB2; DSG2; SCN5A; PKP2; KCNE1B;	GO:0086091~regulation of heart rate by cardiac conduction	9	38	23.6842105263158	0.00051233892310664	0.0103202513358253	1	1	0.709656182068991	0.999999717377143	0.0948505252672328
down	EGFR; DBH; GJA1; HRH2; HRH1; ADRA1D; AVPR2; AVPR1A;	GO:0045907~positive regulation of vasoconstriction	8	30	26.6666666666667	0.00053485439875156	0.010581591142822	1	1	0.716076503022234	0.999999717377143	0.0972524258760701
down	MATN2; TYROBP; NTRK1; APOD; CDK1; AIF1; P2RY12; FLRT3;	GO:0048678~response to axon injury	8	30	26.6666666666667	0.00053485439875156	0.010581591142822	1	1	0.716076503022234	0.999999717377143	0.0972524258760701
down	LRP5; TFAP2A; FGFR2; FGFR3; MSX1; RARG; LRP6; RARB;	GO:0060349~bone morphogenesis	8	30	26.6666666666667	0.00053485439875156	0.010581591142822	1	1	0.716076503022234	0.999999717377143	0.0972524258760701
up	MUC3A; MUCL1; MUC13;	GO:0016266~O-glycan processing	3	60	5	0.00055622374623554	0.0122852896994632	0.270324740670473	0.282561663087654	0.174313410193359	0.270324740670473	0.0836466190664554
up	S100A9; S100A12; CXCL11;	GO:0061844~antimicrobial humoral immune response mediated by antimicrobial peptide	3	62	4.83870967741935	0.00060956880461793	0.0129025396977462	0.295640870239697	0.30966095274591	0.183069339554671	0.295640870239697	0.0878492774276502
down	TLCD2; SPTA1; BAIAP2L2; TLCD1; A4GALT; BAIAP2L1; BAIAP2;	GO:0007009~plasma membrane organization	7	23	30.4347826086957	0.00061566107115773	0.0119255765340667	1	1	0.738793285389283	0.999999717377143	0.109604617325955
down	DLL1; SOX2; PRRX1; JAG1; HES1; FUT10; PROX1;	GO:0097150~neuronal stem cell population maintenance	7	23	30.4347826086957	0.00061566107115773	0.0119255765340667	1	1	0.738793285389283	0.999999717377143	0.109604617325955
down	TP73; MT-ND5; CYP2E1; CCND1; FLT3; MGST2;	GO:0010243~response to organonitrogen compound	6	16	37.5	0.00061956673728302	0.0119255765340667	1	1	0.73986240742583	0.999999717377143	0.109604617325955
down	CNTN1; SCN5A; CNKSR3; GPD1L; PKP2; PRSS8;	GO:0010765~positive regulation of sodium ion transport	6	16	37.5	0.00061956673728302	0.0119255765340667	1	1	0.73986240742583	0.999999717377143	0.109604617325955
down	SQLE; CYB5R2; DHCR7; SC5D; MSMO1; TM7SF2;	GO:0016126~sterol biosynthetic process	6	16	37.5	0.00061956673728302	0.0119255765340667	1	1	0.73986240742583	0.999999717377143	0.109604617325955
down	ZWINT; NEK2; PLK1; ESPL1; SPAG5; KIFC1; CDCA8; KIF18B;	GO:0000070~mitotic sister chromatid segregation	8	31	25.8064516129032	0.00064324986150643	0.0122529082615672	1	1	0.746615803270669	0.999999717377143	0.112613031101914
down	PRL; APOE; GJA1; NR2F2; XDH; CAV2; SULF1; ATOH8;	GO:0001937~negative regulation of endothelial cell proliferation	8	31	25.8064516129032	0.00064324986150643	0.0122529082615672	1	1	0.746615803270669	0.999999717377143	0.112613031101914
down	NRG2; EGFR; ERBB2; ERBB3; BTC; MATK; PTK6; GRB7;	GO:0038128~ERBB2 signaling pathway	8	31	25.8064516129032	0.00064324986150643	0.0122529082615672	1	1	0.746615803270669	0.999999717377143	0.112613031101914
down	PODXL; ATP8B1; PLD1; KLF5;	GO:0032534~regulation of microvillus assembly	4	5	80	0.00067301113717532	0.0126881038018842	1	1	0.755035556976804	0.999999717377143	0.116612790821886
down	HSPB1; VEGFA; KDR; PRKD1;	GO:0038033~positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway	4	5	80	0.00067301113717532	0.0126881038018842	1	1	0.755035556976804	0.999999717377143	0.116612790821886
down	CD1A; CD1C; CD1E; CD1B;	GO:0048006~antigen processing and presentation, endogenous lipid antigen via MHC class Ib	4	5	80	0.00067301113717532	0.0126881038018842	1	1	0.755035556976804	0.999999717377143	0.116612790821886
down	SNAI2; BMP7; FGFR2; WNT5A; SOX9; HMGA2; WNT4; DLG5; FAM83D;	GO:0001837~epithelial to mesenchymal transition	9	40	22.5	0.00070521642067689	0.0131155959318456	1	1	0.764027072204514	0.999999717377143	0.120541750665498
down	TM7SF2; LSS; PRKAA2; SQLE; DHCR24; NSDHL; MSMO1; DHCR7; NPC1L1;	GO:0006695~cholesterol biosynthetic process	9	40	22.5	0.00070521642067689	0.0131155959318456	1	1	0.764027072204514	0.999999717377143	0.120541750665498
down	ADCY6; ADCY5; EDNRA; ADORA2B; AVPR2; CAP2; GLP1R; RXFP2; LGR4;	GO:0007190~activation of adenylate cyclase activity	9	40	22.5	0.00070521642067689	0.0131155959318456	1	1	0.764027072204514	0.999999717377143	0.120541750665498
down	HRAS; PF4; IL10; IRF8; IRF4; BATF; GBP6;	GO:0042832~defense response to protozoan	7	24	29.1666666666667	0.0007607062262922	0.0140056447349117	1	1	0.774832115069386	0.999999717377143	0.128721938699411
down	TSPAN12; ERBB2; EFNA1; EPHA2; ID1; EMP2; SFRP1; PROK2;	GO:0045765~regulation of angiogenesis	8	32	25	0.00076868016174136	0.0140386183648509	1	1	0.776207317550451	0.999999717377143	0.129024990051353
down	GREM1; LRP4; DKK1; NR2F2; KREMEN2; KREMEN1; INTU; ZNRF3;	GO:0060173~limb development	8	32	25	0.00076868016174136	0.0140386183648509	1	1	0.776207317550451	0.999999717377143	0.129024990051353
down	EFNA5; EPHB3; WNT4; FUT7; CELSR2;	GO:0022407~regulation of cell-cell adhesion	5	11	45.4545454545455	0.00090558241242588	0.0160582934461892	1	1	0.799309263991621	0.999999717377143	0.147587255261802
down	LAMA5; BMP7; FGFR2; LAMA1; ESRP2;	GO:0060445~branching involved in salivary gland morphogenesis	5	11	45.4545454545455	0.00090558241242588	0.0160582934461892	1	1	0.799309263991621	0.999999717377143	0.147587255261802
down	DSP; ITGB5; PLEKHA7; KIFC3; CAMSAP3;	GO:0090136~epithelial cell-cell adhesion	5	11	45.4545454545455	0.00090558241242588	0.0160582934461892	1	1	0.799309263991621	0.999999717377143	0.147587255261802
down	CCL26; CX3CL1; XCL2; CCL20; CCL2; CCL24; CCL21; CCL17;	GO:0048247~lymphocyte chemotaxis	8	33	24.2424242424242	0.00091303285170885	0.0160582934461892	1	1	0.800605723150638	0.999999717377143	0.147587255261802
down	DLL1; NOS1; YAP1; CX3CL1; DLL4; HEYL; HES1; BHLHE40;	GO:0050767~regulation of neurogenesis	8	33	24.2424242424242	0.00091303285170885	0.0160582934461892	1	1	0.800605723150638	0.999999717377143	0.147587255261802
down	TRAV19; TNFRSF21; HRAS; TRAV8-4; TRBC1; HLA-DQA2; THY1; TRBV7-9; HLA-DQB2; CD3G; CACNB3; BCAR1; TRAT1; SKAP1; PSMA8; CD276; BTNL3; HHLA2; CTLA4; BTN1A1; BTNL8;	GO:0050852~T cell receptor signaling pathway	21	174	12.0689655172414	0.00096365144155274	0.0167876619802148	1	1	0.809112891074856	0.999999717377143	0.154290676168381
down	KCNQ1; SNTA1; SCN5A; GPD1L; PKP2; KCNE1B;	GO:0086005~ventricular cardiac muscle cell action potential	6	18	33.3333333333333	0.00102442410235326	0.0177900778657877	1	1	0.819432118196707	0.999999717377143	0.163503598430531
down	JUP; DSP; DSG2; PKP2;	GO:0086073~bundle of His cell-Purkinje myocyte adhesion involved in cell communication	4	6	66.6666666666667	0.00107670492321277	0.0184924670340611	1	1	0.828072968527941	0.999999717377143	0.169959059580152
down	GJB6; GJB2; GJB4; GJA3;	GO:1990349~gap junction-mediated intercellular transport	4	6	66.6666666666667	0.00107670492321277	0.0184924670340611	1	1	0.828072968527941	0.999999717377143	0.169959059580152
down	OVOL1; GJB3; DHCR24; DACT2; SLC27A4; WNT10A; ABCB6; DSP;	GO:0043588~skin development	8	34	23.5294117647059	0.00107830734204062	0.0184924670340611	1	1	0.828375878336775	0.999999717377143	0.169959059580152
down	SNAI2; EGFR; ERBB2; VIL1; ID1; SOX9; SKAP1; GAREM1; BAIAP2;	GO:0071364~cellular response to epidermal growth factor stimulus	9	43	20.9302325581395	0.00110189314449394	0.0188382663367675	1	1	0.832407623373263	0.999999717377143	0.173137203641904
down	ABCC5; SLC2A1; SLC18A1; SLC47A2; SLC47A1;	GO:0042908~xenobiotic transport	5	12	41.6666666666667	0.00122962802190707	0.0209569729430292	1	1	0.850349201250692	0.999999717377143	0.192609639724296
down	DLL1; EDN2; NMU; PRKAA2; IRX3; PM20D1; TRPV4; PPARGC1A;	GO:0097009~energy homeostasis	8	35	22.8571428571429	0.00126661271636219	0.0215206882826354	1	1	0.85450495459308	0.999999717377143	0.197790588746074
down	MAPK13; EGFR; FMO1; MAP7; LRRC8A; MARVELD3;	GO:0006970~response to osmotic stress	6	19	31.5789473684211	0.00129057947854694	0.0218604308596951	1	1	0.857068870068653	0.999999717377143	0.200913067147146
up	S100A8; EPB41L4B; SPRR3;	GO:0042060~wound healing	3	82	3.65853658536585	0.00132861592912747	0.0224978963998919	0.63640703005206	0.674936891996757	0.272366265471132	0.63640703005206	0.15318100069228
down	NFASC; ERBB2; ERBB3; ALDH3A2; SOX8; PMP22; BDNF;	GO:0007422~peripheral nervous system development	7	27	25.9259259259259	0.00136258043716286	0.0224580997203041	1	1	0.865238577598418	0.999999717377143	0.206406073423829
down	WNT10B; CDK1; CCNB1; CCND1; HSPA2; MTA3; CDC25C;	GO:0010971~positive regulation of G2/M transition of mitotic cell cycle	7	27	25.9259259259259	0.00136258043716286	0.0224580997203041	1	1	0.865238577598418	0.999999717377143	0.206406073423829
down	F13A1; CSTA; ANXA1; DSP; TGM1; EVPL; TGM5;	GO:0018149~peptide cross-linking	7	27	25.9259259259259	0.00136258043716286	0.0224580997203041	1	1	0.865238577598418	0.999999717377143	0.206406073423829
down	RAPGEF3; GLP1R; SOX9; DEFB1; ADGRG6; RAPGEF4; PCLO;	GO:0019933~cAMP-mediated signaling	7	27	25.9259259259259	0.00136258043716286	0.0224580997203041	1	1	0.865238577598418	0.999999717377143	0.206406073423829
down	CTNND1; PLEKHA7; CDH26; CDH24; CDH3; CDH13; CDH1;	GO:0044331~cell-cell adhesion mediated by cadherin	7	27	25.9259259259259	0.00136258043716286	0.0224580997203041	1	1	0.865238577598418	0.999999717377143	0.206406073423829
down	RHOD; THY1; CTTN; TRIP6; AJUBA; DLC1; SORBS1;	GO:0048041~focal adhesion assembly	7	27	25.9259259259259	0.00136258043716286	0.0224580997203041	1	1	0.865238577598418	0.999999717377143	0.206406073423829
down	SRPX2; EPHA2; DST; PTK2; CTTN; PLD1; PLD2;	GO:0048870~cell motility	7	27	25.9259259259259	0.00136258043716286	0.0224580997203041	1	1	0.865238577598418	0.999999717377143	0.206406073423829
down	PDLIM1; FOXE1; TBX3; SOX15; EGFR; APOE; ERBB2; TFAP2A; HOXC6; KIT; VEGFA; TAL1; PPARG; IRX5; IRX3; TEAD4; ECM1; DMRTA1; NFE4; DMRTC2; ARNTL2; TFAP2C; ISL2; TEAD3; PITX2; SOX7; STOX2; THAP10; GTF2IRD1; POU2F3; SOX21; VENTX; BARX1; NHLH2; BATF; NR2F6; HMGB3; SP6; PIAS3; EPAS1; KLF8; FOXA1; ETV4; GRHL3; TFCP2L1; KLF5; GRHL1; HOPX; SPI1; GRHL2; NR2C1; ETV5; FOXQ1; SPIB; ELF5; ERG; EHF; NR2F2; ELF3; BARX2; SIM2;	GO:0006357~regulation of transcription by RNA polymerase II	61	747	8.16599732262383	0.00140852710718709	0.0231460947016863	1	1	0.870469752241619	0.999999717377143	0.212729241653152
down	TP73; APOD; LPL; IGFBP2; MDK; CDH3; CCNO; BDNF; CCND1; AK4; LOX; ALDH3A1; SLC6A4; SLC6A11; NCKAP1L; SFRP1; RAD54L; NPAS2; WFDC1; NPC1L1; MYO6; ANXA1;	GO:0042493~response to drug	22	193	11.3989637305699	0.00144648453170326	0.0235507436756451	1	1	0.874636631684237	0.999999717377143	0.216448256479429
down	CDH13; AJUBA; PCDHGC3; PCDHB14; PCDHB13; CDH1; CDH26; CDH24; CDH3;	GO:0016339~calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules	9	45	20	0.0014545418437274	0.0235507436756451	1	1	0.875627955375403	0.999999717377143	0.216448256479429
down	LRRTM2; S100B; PTN; MPP2; NTRK2; SYT12; PLK2; SHANK2; SHANK1;	GO:0060291~long-term synaptic potentiation	9	45	20	0.0014545418437274	0.0235507436756451	1	1	0.875627955375403	0.999999717377143	0.216448256479429
down	BIRC5; BUB1; KALRN; BUB1B; MAP3K6; ERBB2; NTRK1; CDK1; ERG; CCL2; NPR1; CCNO; CCND1; LAMA1; LTK; MATK; FRK; NEK2; PLK1; MAPK10; RIPK4; MAP3K9; TNK1; PTK6; PRKD1; CDC42BPG; NEK11; AURKB; WNK4; ALPK3; PKMYT1; PLK2; MARK1; HSPB8; MOK; CDC42BPB; HUNK; CDK10; MELK; CDK16; PHKA1; PRKAA2; NRBP2;	GO:0006468~protein phosphorylation	43	482	8.92116182572614	0.00150083817819879	0.0241582285701297	1	1	0.880772403583238	0.999999717377143	0.222031479160621
down	TULP1; PPEF2; OAT; TACSTD2; PDE6A; CDH3; CNGA1; RCVRN; GPR143; LAMB2; CABP4; IRX5; CACNB2; EFEMP1; ADGRV1; RDH12; HMCN1; EPAS1; KIFC3; SLITRK6; DLL4; GJA3; LAMC3;	GO:0007601~visual perception	23	207	11.1111111111111	0.0015522830984338	0.0249134648888574	1	1	0.886353649205702	0.999999717377143	0.228972643595594
up	S100A8; S100A9; PYCARD;	GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process	3	87	3.44827586206897	0.00156585917687746	0.0248580144329297	0.746914827370548	0.79545646185375	0.297513243606717	0.746914827370548	0.1692502915996
down	EDN2; AVPR1A; SLC1A1; NMU; RGS4; KCNQ1;	GO:0010460~positive regulation of heart rate	6	20	30	0.00160645263726966	0.0251649597416158	1	1	0.892505762183393	0.999999717377143	0.231284062001009
down	NTRK1; NGFR; BDNF; BCAR1; NTRK2; NDN;	GO:0048011~neurotrophin TRK receptor signaling pathway	6	20	30	0.00160645263726966	0.0251649597416158	1	1	0.892505762183393	0.999999717377143	0.231284062001009
down	BMP4; EPHA2; SEMA5A; NRARP;	GO:0002043~blood vessel endothelial cell proliferation involved in sprouting angiogenesis	4	7	57.1428571428571	0.00162424081795376	0.0251649597416158	1	1	0.894553431128603	0.999999717377143	0.231284062001009
down	KIT; BMP4; SPI1; BATF;	GO:0002320~lymphoid progenitor cell differentiation	4	7	57.1428571428571	0.00162424081795376	0.0251649597416158	1	1	0.894553431128603	0.999999717377143	0.231284062001009
down	BDNF; SLC6A1; CNR2; STXBP1;	GO:0032229~negative regulation of synaptic transmission, GABAergic	4	7	57.1428571428571	0.00162424081795376	0.0251649597416158	1	1	0.894553431128603	0.999999717377143	0.231284062001009
down	CD1C; CD1A; CD1B; CD1E;	GO:0048007~antigen processing and presentation, exogenous lipid antigen via MHC class Ib	4	7	57.1428571428571	0.00162424081795376	0.0251649597416158	1	1	0.894553431128603	0.999999717377143	0.231284062001009
down	SNAI2; FOXJ1; RARG; RARB;	GO:0060429~epithelium development	4	7	57.1428571428571	0.00162424081795376	0.0251649597416158	1	1	0.894553431128603	0.999999717377143	0.231284062001009
down	YAP1; SOX9; FOXA1; GRHL2;	GO:0060487~lung epithelial cell differentiation	4	7	57.1428571428571	0.00162424081795376	0.0251649597416158	1	1	0.894553431128603	0.999999717377143	0.231284062001009
down	NRP2; RARB; BMP4; FGFR2; TBX2; PARVA; ROBO1;	GO:0003148~outflow tract septum morphogenesis	7	28	25	0.00162954909090729	0.0251649597416158	1	1	0.89496857496955	0.999999717377143	0.231284062001009
down	COL6A1; ITGB5; MMP8; HMGA2; LAMB3; NODAL; MIXL1;	GO:0035987~endodermal cell differentiation	7	28	25	0.00162954909090729	0.0251649597416158	1	1	0.89496857496955	0.999999717377143	0.231284062001009
down	MAL; SHROOM2; DLG5; SHROOM3; VANGL2;	GO:0045176~apical protein localization	5	13	38.4615384615385	0.00163195106771241	0.0251649597416158	1	1	0.895385618782308	0.999999717377143	0.231284062001009
down	TBX3; EPHA2; DDR1; LRP5; LRP6;	GO:0060444~branching involved in mammary gland duct morphogenesis	5	13	38.4615384615385	0.00163195106771241	0.0251649597416158	1	1	0.895385618782308	0.999999717377143	0.231284062001009
down	IRF6; PRLR; HOXA5; SMO; ELF5;	GO:0060644~mammary gland epithelial cell differentiation	5	13	38.4615384615385	0.00163195106771241	0.0251649597416158	1	1	0.895385618782308	0.999999717377143	0.231284062001009
down	E2F8; WNT1; CPS1; PROX1; ANXA1;	GO:0070365~hepatocyte differentiation	5	13	38.4615384615385	0.00163195106771241	0.0251649597416158	1	1	0.895385618782308	0.999999717377143	0.231284062001009
down	KIT; BMP4; GATA1; TAL1; SPI1; EPAS1; SFXN1; TRIM10; C15orf41;	GO:0030218~erythrocyte differentiation	9	46	19.5652173913043	0.00166204271125758	0.0254861981210947	1	1	0.898791962651556	0.999999717377143	0.234236473530348
down	TULP3; WNT1; PLS3; GJA1; FGFR2; STC1; SPNS2; SULF1; TTC9;	GO:0060348~bone development	9	46	19.5652173913043	0.00166204271125758	0.0254861981210947	1	1	0.898791962651556	0.999999717377143	0.234236473530348
down	E2F8; GJB3; DCN; PPARG; PTK2; NODAL; ETNK2; PHLDA2;	GO:0001890~placenta development	8	37	21.6216216216216	0.00172128297252627	0.0261758639882794	1	1	0.905394843548819	0.999999717377143	0.240574998400791
down	LILRA5; IFNG; LPL; AIF1; LILRA2; IL17RC; TRPV4; TLR8;	GO:2000778~positive regulation of interleukin-6 secretion	8	37	21.6216216216216	0.00172128297252627	0.0261758639882794	1	1	0.905394843548819	0.999999717377143	0.240574998400791
down	VCAM1; PTPRD; CEACAM6; CXADR; CADM1; CD209; TENM2; NECTIN4; HMCN1;	GO:0007157~heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules	9	47	19.1489361702128	0.00189259150306442	0.0285444280119716	1	1	0.924457001804331	0.999999717377143	0.262343803681376
down	GREM1; DKK1; WNT1; WNT5A; NBL1; SOSTDC1; RBPMS2; SFRP1; CHRDL1;	GO:0030514~negative regulation of BMP signaling pathway	9	47	19.1489361702128	0.00189259150306442	0.0285444280119716	1	1	0.924457001804331	0.999999717377143	0.262343803681376
down	RAB13; NCKAP1L; EPB41L1; EHD2; CIT; LLGL2; NCKAP1;	GO:0030866~cortical actin cytoskeleton organization	7	29	24.1379310344828	0.00193546448306559	0.0286417526324625	1	1	0.929047496612145	0.999999717377143	0.263238286875109
down	ORM1; BPI; IL10; NCKAP1L; CX3CL1; SLAMF1; TLR9;	GO:0032715~negative regulation of interleukin-6 production	7	29	24.1379310344828	0.00193546448306559	0.0286417526324625	1	1	0.929047496612145	0.999999717377143	0.263238286875109
down	TPPP; ERBB2; GLI3; SOX8; NTRK2; BOK; SOX9;	GO:0048709~oligodendrocyte differentiation	7	29	24.1379310344828	0.00193546448306559	0.0286417526324625	1	1	0.929047496612145	0.999999717377143	0.263238286875109
down	EGFR; ERBB2; CEACAM1; FGFR2; EPHA2; ARHGEF5; FAM83D;	GO:0070372~regulation of ERK1 and ERK2 cascade	7	29	24.1379310344828	0.00193546448306559	0.0286417526324625	1	1	0.929047496612145	0.999999717377143	0.263238286875109
down	GREM1; VEGFA; KDR; EFNB2; MMRN2; ROBO1;	GO:0002042~cell migration involved in sprouting angiogenesis	6	21	28.5714285714286	0.00197776027392871	0.0290335208212734	1	1	0.932700683101047	0.999999717377143	0.266838918030545
down	PLPP1; PLPP3; PLPP2; FUT3; FUT6; FUT7;	GO:0006672~ceramide metabolic process	6	21	28.5714285714286	0.00197776027392871	0.0290335208212734	1	1	0.932700683101047	0.999999717377143	0.266838918030545
down	SRPX2; ANXA1; VEGFA; KDR; FGFBP1; PLK2;	GO:0090050~positive regulation of cell migration involved in sprouting angiogenesis	6	21	28.5714285714286	0.00197776027392871	0.0290335208212734	1	1	0.932700683101047	0.999999717377143	0.266838918030545
down	TYROBP; DKK1; IFNG; C1QA; FCGR2B; WNT5A; EFNB2; PPP1R13B;	GO:1901216~positive regulation of neuron death	8	38	21.0526315789474	0.00199238533032953	0.0291704288390001	1	1	0.933520844245579	0.999999717377143	0.268097201087044
down	GHR; CRHBP; ALDH9A1; FOXA1; WNT4;	GO:0042445~hormone metabolic process	5	14	35.7142857142857	0.00212306495778769	0.0304361265432845	1	1	0.940850018986768	0.999999717377143	0.279729872441098
down	CD276; IL27; TLR9; TLR8; TLR7;	GO:0045078~positive regulation of interferon-gamma biosynthetic process	5	14	35.7142857142857	0.00212306495778769	0.0304361265432845	1	1	0.940850018986768	0.999999717377143	0.279729872441098
down	EGFR; EPHB3; SFRP1; NODAL; VANGL2;	GO:0048546~digestive tract morphogenesis	5	14	35.7142857142857	0.00212306495778769	0.0304361265432845	1	1	0.940850018986768	0.999999717377143	0.279729872441098
down	E2F8; SOX15; GJB5; NR2F2; MDFI;	GO:0060707~trophoblast giant cell differentiation	5	14	35.7142857142857	0.00212306495778769	0.0304361265432845	1	1	0.940850018986768	0.999999717377143	0.279729872441098
down	WNT10B; WNT1; WNT5A; MECOM; WNT2B;	GO:0071425~hematopoietic stem cell proliferation	5	14	35.7142857142857	0.00212306495778769	0.0304361265432845	1	1	0.940850018986768	0.999999717377143	0.279729872441098
down	TAL1; PTN; HMGA2; NODAL; SMO;	GO:2000036~regulation of stem cell population maintenance	5	14	35.7142857142857	0.00212306495778769	0.0304361265432845	1	1	0.940850018986768	0.999999717377143	0.279729872441098
down	MYO1C; SNAI2; GJA1; TJP1; OCLN;	GO:2000810~regulation of bicellular tight junction assembly	5	14	35.7142857142857	0.00212306495778769	0.0304361265432845	1	1	0.940850018986768	0.999999717377143	0.279729872441098
down	FOXP2; CKB; PTN; FCGR2B; SSTR3; AIF1; CNTN1; SCN5A; PPARGC1A;	GO:0021549~cerebellum development	9	48	18.75	0.00214797179540616	0.0304953732685021	1	1	0.942430971862877	0.999999717377143	0.280274392416862
down	EGFR; WNT1; ANXA2; NGFR; CCNB1; CCNA2; BTC; WNT5A; CDC6;	GO:0048146~positive regulation of fibroblast proliferation	9	48	18.75	0.00214797179540616	0.0304953732685021	1	1	0.942430971862877	0.999999717377143	0.280274392416862
down	LAMA5; ABLIM3; CCNO; ARMC9; TMEM17; SPAG16; NME8; TTC8; FOXJ1; WDR34; WDR90; TMEM237; CEP89; DNAI2; WWTR1; CCDC113; CELSR2; PARVA; EHD3; INTU; B9D1;	GO:0060271~cilium assembly	21	187	11.2299465240642	0.00215473611257022	0.0304953732685021	1	1	0.942752141817237	0.999999717377143	0.280274392416862
up	CTSV; CTSE; FCER1G;	GO:0019886~antigen processing and presentation of exogenous peptide antigen via MHC class II	3	98	3.06122448979592	0.00217687694759516	0.0335107117993437	1	1	0.336163660549353	0.764540252498336	0.228163748116412
down	GNA15; GPR157; LPAR3; GPR65; P2RY10; F2RL3; GPR174; GPR55;	GO:0051482~positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway	8	39	20.5128205128205	0.00229598459326885	0.0313292449149711	1	1	0.950634262540703	0.999999717377143	0.287938272016235
down	LILRA5; GREM1; TAL1; EFNA1; ERBB3; CD24; AFAP1L2; DLG3;	GO:0061098~positive regulation of protein tyrosine kinase activity	8	39	20.5128205128205	0.00229598459326885	0.0313292449149711	1	1	0.950634262540703	0.999999717377143	0.287938272016235
down	SFN; KDF1; TP63;	GO:0010482~regulation of epidermal cell division	3	3	100	0.00231057439382742	0.0313292449149711	1	1	0.951737662906523	0.999999717377143	0.287938272016235
down	PLEKHA7; KIFC3; CAMSAP3;	GO:0045218~zonula adherens maintenance	3	3	100	0.00231057439382742	0.0313292449149711	1	1	0.951737662906523	0.999999717377143	0.287938272016235
down	PTN; SOX9; SOX8;	GO:0060221~retinal rod cell differentiation	3	3	100	0.00231057439382742	0.0313292449149711	1	1	0.951737662906523	0.999999717377143	0.287938272016235
down	HOXA5; WNT5A; WNT2B;	GO:0060638~mesenchymal-epithelial cell signaling	3	3	100	0.00231057439382742	0.0313292449149711	1	1	0.951737662906523	0.999999717377143	0.287938272016235
down	EMP2; PDPN; PARVA;	GO:0070252~actin-mediated cell contraction	3	3	100	0.00231057439382742	0.0313292449149711	1	1	0.951737662906523	0.999999717377143	0.287938272016235
down	SOX9; WNT4; SOX8;	GO:0072034~renal vesicle induction	3	3	100	0.00231057439382742	0.0313292449149711	1	1	0.951737662906523	0.999999717377143	0.287938272016235
down	LILRA5; LILRB1; TLR8;	GO:2001183~negative regulation of interleukin-12 secretion	3	3	100	0.00231057439382742	0.0313292449149711	1	1	0.951737662906523	0.999999717377143	0.287938272016235
down	ADCY5; ADORA2B; P2RY1; P2RY12;	GO:0001973~G protein-coupled adenosine receptor signaling pathway	4	8	50	0.00233902264487795	0.0313292449149711	1	1	0.953238203574951	0.999999717377143	0.287938272016235
down	PLPP1; PLPP3; PLPP2; SGPP2;	GO:0006670~sphingosine metabolic process	4	8	50	0.00233902264487795	0.0313292449149711	1	1	0.953238203574951	0.999999717377143	0.287938272016235
down	CEACAM1; PTN; EMP2; PTK2;	GO:0010594~regulation of endothelial cell migration	4	8	50	0.00233902264487795	0.0313292449149711	1	1	0.953238203574951	0.999999717377143	0.287938272016235
down	PDLIM1; NCKAP1L; DST; DLG5;	GO:0030011~maintenance of cell polarity	4	8	50	0.00233902264487795	0.0313292449149711	1	1	0.953238203574951	0.999999717377143	0.287938272016235
down	DBH; MAOA; MAOB; MOXD1;	GO:0042420~dopamine catabolic process	4	8	50	0.00233902264487795	0.0313292449149711	1	1	0.953238203574951	0.999999717377143	0.287938272016235
down	IGFBP2; IGFBP4; IGFBP6; IGFBP5;	GO:0043567~regulation of insulin-like growth factor receptor signaling pathway	4	8	50	0.00233902264487795	0.0313292449149711	1	1	0.953238203574951	0.999999717377143	0.287938272016235
down	SULT2B1; BMP4; SFN; KDF1;	GO:0045606~positive regulation of epidermal cell differentiation	4	8	50	0.00233902264487795	0.0313292449149711	1	1	0.953238203574951	0.999999717377143	0.287938272016235
down	TOM1L1; BMP4; BMP7; TOM1L2;	GO:0045839~negative regulation of mitotic nuclear division	4	8	50	0.00233902264487795	0.0313292449149711	1	1	0.953238203574951	0.999999717377143	0.287938272016235
down	BDNF; CRABP2; EFNA5; LPAR3;	GO:0048672~positive regulation of collateral sprouting	4	8	50	0.00233902264487795	0.0313292449149711	1	1	0.953238203574951	0.999999717377143	0.287938272016235
down	BMP7; FGFR2; HMGA2; WWTR1;	GO:0048762~mesenchymal cell differentiation	4	8	50	0.00233902264487795	0.0313292449149711	1	1	0.953238203574951	0.999999717377143	0.287938272016235
down	DKK1; C1QA; C1QC; CX3CL1;	GO:0098883~synapse pruning	4	8	50	0.00233902264487795	0.0313292449149711	1	1	0.953238203574951	0.999999717377143	0.287938272016235
down	APOE; DCN; NR2F2; STC1; DLL4; ADAMTS9;	GO:0010596~negative regulation of endothelial cell migration	6	22	27.2727272727273	0.00241041525443741	0.0321291427982517	1	1	0.957143569684129	0.999999717377143	0.295289908320473
down	KRT3; DST; FAM83H; PPL; DSP; EVPL;	GO:0045104~intermediate filament cytoskeleton organization	6	22	27.2727272727273	0.00241041525443741	0.0321291427982517	1	1	0.957143569684129	0.999999717377143	0.295289908320473
down	TBX3; GJB3; GLI3; TGFB3; CCNB1; VEGFA; GATA1; FGFR2; EDNRA; MSX1; TIE1; WNT7B; SOX8; MYO1E; DSC3; ANGPT1; NXN; SMO; ARNT2; ETNK2; CAMSAP3; B9D1;	GO:0001701~in utero embryonic development	22	203	10.8374384236453	0.00256206063884334	0.0340574642875416	1	1	0.965835314261766	0.999999717377143	0.313012568378985
up	KCTD14; PRMT8; PYCARD;	GO:0051260~protein homooligomerization	3	105	2.85714285714286	0.00263282461973824	0.0371520807451951	1	1	0.360696972904139	0.764540252498336	0.252956667823251
down	TULP1; JCHAIN; IGKC; IGHG3; IGHA2; TF; HSPB1; CDH3;	GO:0001895~retina homeostasis	8	40	20	0.00263468242087739	0.0347815988655396	1	1	0.968106608361578	0.999999717377143	0.319667885468875
down	CCNB1; CEP55; CDCA8; CHMP4C; SPDL1; CDCA5; KIF2C; KIFC1;	GO:0007080~mitotic metaphase plate congression	8	40	20	0.00263468242087739	0.0347815988655396	1	1	0.968106608361578	0.999999717377143	0.319667885468875
down	SPRY2; SPRY1; GJA1; PLK1; GPSM2; SAPCD2; SPDL1;	GO:0000132~establishment of mitotic spindle orientation	7	31	22.5806451612903	0.00267897444424525	0.0349855441342291	1	1	0.969689840722946	0.999999717377143	0.321542289030523
down	BUB1; BUB1B; ZWINT; HRAS; CDKN2B; TICRR; PLK2;	GO:0007093~mitotic cell cycle checkpoint	7	31	22.5806451612903	0.00267897444424525	0.0349855441342291	1	1	0.969689840722946	0.999999717377143	0.321542289030523
down	JCHAIN; IGKV3-20; IGHA2; SEMG1; DEFB1; RNASE6; RNASE7;	GO:0019731~antibacterial humoral response	7	31	22.5806451612903	0.00267897444424525	0.0349855441342291	1	1	0.969689840722946	0.999999717377143	0.321542289030523
down	FGFR2; WNT7B; RARB; TEAD4; RARG; TEAD1; TEAD3;	GO:0048568~embryonic organ development	7	31	22.5806451612903	0.00267897444424525	0.0349855441342291	1	1	0.969689840722946	0.999999717377143	0.321542289030523
down	OPLAH; GGT5; GGT6; MGST2; CHAC1;	GO:0006750~glutathione biosynthetic process	5	15	33.3333333333333	0.00271368344147427	0.0349855441342291	1	1	0.970777805525117	0.999999717377143	0.321542289030523
down	NRP2; NGFR; SEMA3F; NRTN; BDNF;	GO:0021675~nerve development	5	15	33.3333333333333	0.00271368344147427	0.0349855441342291	1	1	0.970777805525117	0.999999717377143	0.321542289030523
down	NLRP6; TYRO3; IRF4; LGR4; TLR9;	GO:0034122~negative regulation of toll-like receptor signaling pathway	5	15	33.3333333333333	0.00271368344147427	0.0349855441342291	1	1	0.970777805525117	0.999999717377143	0.321542289030523
down	IFNG; FCER2; CCL2; KDR; TLR9;	GO:0051770~positive regulation of nitric-oxide synthase biosynthetic process	5	15	33.3333333333333	0.00271368344147427	0.0349855441342291	1	1	0.970777805525117	0.999999717377143	0.321542289030523
down	SRPX2; GLI3; MYH14; SHANK2; SHANK1;	GO:0071625~vocalization behavior	5	15	33.3333333333333	0.00271368344147427	0.0349855441342291	1	1	0.970777805525117	0.999999717377143	0.321542289030523
down	MYO1D; TMEM132D; DLG2; SH3RF2; CSRNP3; DLG3; PKMYT1; SH2D4A; CAMSAP3;	GO:0010923~negative regulation of phosphatase activity	9	50	18	0.00274068824933249	0.0351689715910848	1	1	0.971611517683302	0.999999717377143	0.323228119158593
down	DLL1; EPN2; WNT1; KIT; JAG1; ELF3; HES1; TP63; DLL4;	GO:0045747~positive regulation of Notch signaling pathway	9	50	18	0.00274068824933249	0.0351689715910848	1	1	0.971611517683302	0.999999717377143	0.323228119158593
down	LDLR; APOE; VEGFA; PRRX1; HES1; NOTCH3;	GO:0048844~artery morphogenesis	6	23	26.0869565217391	0.00291049386929165	0.0370885850704874	1	1	0.977150347219522	0.999999717377143	0.340870746349206
down	EGFR; NTRK1; CCL2; CCR2; SHANK1; SHANK2;	GO:0051968~positive regulation of synaptic transmission, glutamatergic	6	23	26.0869565217391	0.00291049386929165	0.0370885850704874	1	1	0.977150347219522	0.999999717377143	0.340870746349206
down	CRYAB; WNT5A; LIM2; UNC45B; SIX5; PROX1; WNT2B; SLITRK6;	GO:0002088~lens development in camera-type eye	8	41	19.5121951219512	0.00301116359158415	0.0380193935130063	1	1	0.979776467956794	0.999999717377143	0.349425544757034
down	CPS1; SSTR3; PPARG; OXCT1; FSTL1; AACS; LRP11; PPARGC1A;	GO:0042594~response to starvation	8	41	19.5121951219512	0.00301116359158415	0.0380193935130063	1	1	0.979776467956794	0.999999717377143	0.349425544757034
down	TFAP2A; BMP4; FGFR2; PRRX1; IRX5; GRHL2; NODAL;	GO:0048701~embryonic cranial skeleton morphogenesis	7	32	21.875	0.00312428919676788	0.039267607370336	1	1	0.982875837535262	0.999999717377143	0.36089752699477
down	KRT6A; KRT19; KRT3; KRT13; KRT5; JUP; DSP; KRT15; CDH3; SFN; DSG3; DSG2; DSC3; KRT24; DSG4; KRT73; KRT78; PKP2; CNFN; PKP3;	GO:0031424~keratinization	20	181	11.0497237569061	0.00320076190217833	0.0399495398024171	1	1	0.98497450480402	0.999999717377143	0.367164976039844
down	ALDH3A1; ALDH9A1; ALDH7A1; ALDH3A2;	GO:0006081~cellular aldehyde metabolic process	4	9	44.4444444444444	0.00324385909022351	0.0399495398024171	1	1	0.986133163427947	0.999999717377143	0.367164976039844
down	SLC22A3; SLC22A16; SLC7A8; SLC47A1;	GO:0015695~organic cation transport	4	9	44.4444444444444	0.00324385909022351	0.0399495398024171	1	1	0.986133163427947	0.999999717377143	0.367164976039844
down	SASH1; LY86; SCIMP; CD180;	GO:0031666~positive regulation of lipopolysaccharide-mediated signaling pathway	4	9	44.4444444444444	0.00324385909022351	0.0399495398024171	1	1	0.986133163427947	0.999999717377143	0.367164976039844
down	LOX; MYH11; MFAP4; THSD4;	GO:0048251~elastic fiber assembly	4	9	44.4444444444444	0.00324385909022351	0.0399495398024171	1	1	0.986133163427947	0.999999717377143	0.367164976039844
down	AIF1; BAIAP2; BAIAP2L1; BAIAP2L2;	GO:0051764~actin crosslink formation	4	9	44.4444444444444	0.00324385909022351	0.0399495398024171	1	1	0.986133163427947	0.999999717377143	0.367164976039844
down	SPINT1; FGFR2; IL10; GCM1;	GO:0060670~branching involved in labyrinthine layer morphogenesis	4	9	44.4444444444444	0.00324385909022351	0.0399495398024171	1	1	0.986133163427947	0.999999717377143	0.367164976039844
down	PODXL; BMP4; JAG1; MYO1E;	GO:0072015~glomerular visceral epithelial cell development	4	9	44.4444444444444	0.00324385909022351	0.0399495398024171	1	1	0.986133163427947	0.999999717377143	0.367164976039844
down	NES; WNT7B; RNF43; ZNRF3;	GO:0072089~stem cell proliferation	4	9	44.4444444444444	0.00324385909022351	0.0399495398024171	1	1	0.986133163427947	0.999999717377143	0.367164976039844
down	THY1; BMP7; IL10; CEACAM6; SKAP1;	GO:0034116~positive regulation of heterotypic cell-cell adhesion	5	16	31.25	0.0034146207231367	0.0415686868467807	1	1	0.990534610295277	0.999999717377143	0.38204610079595
down	EDN2; KEL; EDNRA; BDKRB2; SLC6A4;	GO:0042310~vasoconstriction	5	16	31.25	0.0034146207231367	0.0415686868467807	1	1	0.990534610295277	0.999999717377143	0.38204610079595
down	ALOX15B; TRIM16; NME2; OVOL2; H2AFY2;	GO:0045618~positive regulation of keratinocyte differentiation	5	16	31.25	0.0034146207231367	0.0415686868467807	1	1	0.990534610295277	0.999999717377143	0.38204610079595
down	VEGFA; PRLR; HOXA5; CCND1; DDR1;	GO:0060749~mammary gland alveolus development	5	16	31.25	0.0034146207231367	0.0415686868467807	1	1	0.990534610295277	0.999999717377143	0.38204610079595
down	LAMA5; WNT1; GLI3; BMP4; SOX9; WNT4; NPNT; EYA1;	GO:0001658~branching involved in ureteric bud morphogenesis	8	42	19.047619047619	0.00342818961461189	0.0415686868467807	1	1	0.990884060002958	0.999999717377143	0.38204610079595
down	SLC26A4; CA12; CA4; CA6; HBA1; CYB5R2; CA13; SLC4A11;	GO:0015701~bicarbonate transport	8	42	19.047619047619	0.00342818961461189	0.0415686868467807	1	1	0.990884060002958	0.999999717377143	0.38204610079595
down	ADGRV1; GABRQ; HTR3A; CHRNB4; GABRP; GABRE; GABRB3; CHRFAM7A; CHRNG;	GO:0050877~nervous system process	9	52	17.3076923076923	0.00345572912063108	0.0417188351076186	1	1	0.99179425762112	0.999999717377143	0.383426071200256
down	RAPGEF3; TGFB3; EPHA1; SDC4; WNT4; ARHGEF5; GPR65; SFRP1; LIMCH1;	GO:0051496~positive regulation of stress fiber assembly	9	52	17.3076923076923	0.00345572912063108	0.0417188351076186	1	1	0.99179425762112	0.999999717377143	0.383426071200256
down	HPN; EFNA1; FOXA1; VASN; SFRP1; OVOL2;	GO:0010719~negative regulation of epithelial to mesenchymal transition	6	24	25	0.00348420206875244	0.0419705303905518	1	1	0.992671942228304	0.999999717377143	0.385739331702994
down	ERBB2; ERBB3; LTK; TYRO3; NYAP1; PIK3R5; PIK3C2G;	GO:0014065~phosphatidylinositol 3-kinase signaling	7	33	21.2121212121212	0.00362396384042374	0.0432753165759928	1	1	0.996463982754643	0.999999717377143	0.397731254285431
down	GPR55; ROBO1; NET1; GPR174; GPR65; F2RL3; P2RY10;	GO:0035025~positive regulation of Rho protein signal transduction	7	33	21.2121212121212	0.00362396384042374	0.0432753165759928	1	1	0.996463982754643	0.999999717377143	0.397731254285431
down	SPINT1; SPINT2; BMP4; BMP7; SOX9; SFRP1; HEYL;	GO:0071773~cellular response to BMP stimulus	7	33	21.2121212121212	0.00362396384042374	0.0432753165759928	1	1	0.996463982754643	0.999999717377143	0.397731254285431
up	TNFSF13; PSMB4; PYCARD;	GO:0033209~tumor necrosis factor-mediated signaling pathway	3	120	2.5	0.00379700585871379	0.0494584352878616	1	1	0.422990359080566	0.764540252498336	0.336746710688268
down	CCL2; CNR2; CCR2; BDKRB1; P2RY1; NMU; DLG2; NDN; PROK2;	GO:0019233~sensory perception of pain	9	53	16.9811320754717	0.00386422823056498	0.0444431704979054	1	1	0.999999717377144	0.999999717377143	0.40846467097503
down	JUP; PKP2; PKP3;	GO:0002159~desmosome assembly	3	4	75	0.00389130030517537	0.0444431704979054	1	1	0.999999717377144	0.999999717377143	0.40846467097503
down	LMNA; KIF2C; CAMSAP3;	GO:0030951~establishment or maintenance of microtubule cytoskeleton polarity	3	4	75	0.00389130030517537	0.0444431704979054	1	1	0.999999717377144	0.999999717377143	0.40846467097503
down	WWC1; REEP6; REEP1;	GO:0032386~regulation of intracellular transport	3	4	75	0.00389130030517537	0.0444431704979054	1	1	0.999999717377144	0.999999717377143	0.40846467097503
down	SC5D; DHCR24; DHCR7;	GO:0033489~cholesterol biosynthetic process via desmosterol	3	4	75	0.00389130030517537	0.0444431704979054	1	1	0.999999717377144	0.999999717377143	0.40846467097503
down	SC5D; DHCR24; DHCR7;	GO:0033490~cholesterol biosynthetic process via lathosterol	3	4	75	0.00389130030517537	0.0444431704979054	1	1	0.999999717377144	0.999999717377143	0.40846467097503
down	OSM; LIFR; OSMR;	GO:0038165~oncostatin-M-mediated signaling pathway	3	4	75	0.00389130030517537	0.0444431704979054	1	1	0.999999717377144	0.999999717377143	0.40846467097503
down	MSX1; PAX9; SP6;	GO:0042481~regulation of odontogenesis	3	4	75	0.00389130030517537	0.0444431704979054	1	1	0.999999717377144	0.999999717377143	0.40846467097503
down	TLR9; TLR8; TLR7;	GO:0045356~positive regulation of interferon-alpha biosynthetic process	3	4	75	0.00389130030517537	0.0444431704979054	1	1	0.999999717377144	0.999999717377143	0.40846467097503
down	HOXA5; JAG1; CSF3;	GO:0045639~positive regulation of myeloid cell differentiation	3	4	75	0.00389130030517537	0.0444431704979054	1	1	0.999999717377144	0.999999717377143	0.40846467097503
down	PLD2; PLD1; TNFAIP8L3;	GO:0048017~inositol lipid-mediated signaling	3	4	75	0.00389130030517537	0.0444431704979054	1	1	0.999999717377144	0.999999717377143	0.40846467097503
down	HOXA5; WNT7B; LRP6;	GO:0060535~trachea cartilage morphogenesis	3	4	75	0.00389130030517537	0.0444431704979054	1	1	0.999999717377144	0.999999717377143	0.40846467097503
down	BMP4; SOX9; SOX8;	GO:0090184~positive regulation of kidney development	3	4	75	0.00389130030517537	0.0444431704979054	1	1	0.999999717377144	0.999999717377143	0.40846467097503
down	DKK1; SFRP1; LRP6;	GO:0090244~Wnt signaling pathway involved in somitogenesis	3	4	75	0.00389130030517537	0.0444431704979054	1	1	0.999999717377144	0.999999717377143	0.40846467097503
down	NUPR1; MDK; YAP1;	GO:1904036~negative regulation of epithelial cell apoptotic process	3	4	75	0.00389130030517537	0.0444431704979054	1	1	0.999999717377144	0.999999717377143	0.40846467097503
down	LILRA5; TNFRSF21; ARG2;	GO:2000666~negative regulation of interleukin-13 secretion	3	4	75	0.00389130030517537	0.0444431704979054	1	1	0.999999717377144	0.999999717377143	0.40846467097503
down	OAT; PYCR1; ASPA; FOLH1; ASPG; GPT2;	GO:0008652~cellular amino acid biosynthetic process	6	25	24	0.00413784107097093	0.0468699899088373	1	1	0.999999717377144	0.999999717377143	0.430768885123048
down	DKK1; DMD; BDKRB2; CNKSR3; GPD1L; INPP5J;	GO:0033137~negative regulation of peptidyl-serine phosphorylation	6	25	24	0.00413784107097093	0.0468699899088373	1	1	0.999999717377144	0.999999717377143	0.430768885123048
down	THY1; VEGFA; SDC4; KDR; WNT4; SFRP1;	GO:0051894~positive regulation of focal adhesion assembly	6	25	24	0.00413784107097093	0.0468699899088373	1	1	0.999999717377144	0.999999717377143	0.430768885123048
down	LMNA; BMP4; BMP7; MSX1; SOX9; HHEX; SMO;	GO:0034504~protein localization to nucleus	7	34	20.5882352941176	0.00418209669103031	0.0470221941810697	1	1	0.999999717377144	0.999999717377143	0.43216775174939
down	KRT6A; SERPINB5; RIPK4; SOX9; SOX8;	GO:0002009~morphogenesis of an epithelium	5	17	29.4117647058824	0.00423669542485205	0.0470221941810697	1	1	0.999999717377144	0.999999717377143	0.43216775174939
down	CCL21; TRPM2; CXCR1; CCR2; CCR5;	GO:0002407~dendritic cell chemotaxis	5	17	29.4117647058824	0.00423669542485205	0.0470221941810697	1	1	0.999999717377144	0.999999717377143	0.43216775174939
down	COL6A1; SCARA3; MATN2; VWA1; VWA2;	GO:0003429~growth plate cartilage chondrocyte morphogenesis	5	17	29.4117647058824	0.00423669542485205	0.0470221941810697	1	1	0.999999717377144	0.999999717377143	0.43216775174939
down	EDNRA; BDKRB2; CHRNB4; MYH11; NMUR1;	GO:0006939~smooth muscle contraction	5	17	29.4117647058824	0.00423669542485205	0.0470221941810697	1	1	0.999999717377144	0.999999717377143	0.43216775174939
down	PIR; BMP4; MT1G; VEGFA; PPARG;	GO:0030224~monocyte differentiation	5	17	29.4117647058824	0.00423669542485205	0.0470221941810697	1	1	0.999999717377144	0.999999717377143	0.43216775174939
down	KIT; GATA1; TAL1; KITLG; KDR;	GO:0035162~embryonic hemopoiesis	5	17	29.4117647058824	0.00423669542485205	0.0470221941810697	1	1	0.999999717377144	0.999999717377143	0.43216775174939
down	GJA1; EPHA2; LGR4; LRP5; LRP6;	GO:0046849~bone remodeling	5	17	29.4117647058824	0.00423669542485205	0.0470221941810697	1	1	0.999999717377144	0.999999717377143	0.43216775174939
down	SPRY2; NRG2; BARX1; BARX2; SPRY1;	GO:0048513~animal organ development	5	17	29.4117647058824	0.00423669542485205	0.0470221941810697	1	1	0.999999717377144	0.999999717377143	0.43216775174939
down	SDC4; HES1; USH1G; ADGRV1; VANGL2;	GO:0060122~inner ear receptor cell stereocilium organization	5	17	29.4117647058824	0.00423669542485205	0.0470221941810697	1	1	0.999999717377144	0.999999717377143	0.43216775174939
down	NR2F2; AVPR2; AVPR1A; NMU;	GO:0003084~positive regulation of systemic arterial blood pressure	4	10	40	0.00436064755870724	0.0476296920846892	1	1	0.999999717377144	0.999999717377143	0.437751093993879
down	EGFR; CPS1; WNT5A; SMO;	GO:0007494~midgut development	4	10	40	0.00436064755870724	0.0476296920846892	1	1	0.999999717377144	0.999999717377143	0.437751093993879
down	ALOX15B; GLI3; SOX9; ANXA1;	GO:0030850~prostate gland development	4	10	40	0.00436064755870724	0.0476296920846892	1	1	0.999999717377144	0.999999717377143	0.437751093993879
down	EMP1; EMP2; PMP22; LPAR3;	GO:0032060~bleb assembly	4	10	40	0.00436064755870724	0.0476296920846892	1	1	0.999999717377144	0.999999717377143	0.437751093993879
down	LMNA; CDK1; CCNB1; FHL2;	GO:0055015~ventricular cardiac muscle cell development	4	10	40	0.00436064755870724	0.0476296920846892	1	1	0.999999717377144	0.999999717377143	0.437751093993879
down	NTRK1; SDC1; SOX9; SOX8;	GO:0060009~Sertoli cell development	4	10	40	0.00436064755870724	0.0476296920846892	1	1	0.999999717377144	0.999999717377143	0.437751093993879
down	PDLIM4; PDLIM5; PRICKLE4; PDLIM1;	GO:0061061~muscle structure development	4	10	40	0.00436064755870724	0.0476296920846892	1	1	0.999999717377144	0.999999717377143	0.437751093993879
down	VEGFA; FLT4; WNT5A; ADGRV1;	GO:0090037~positive regulation of protein kinase C signaling	4	10	40	0.00436064755870724	0.0476296920846892	1	1	0.999999717377144	0.999999717377143	0.437751093993879
down	SULT2B1; CYP2E1; CYP2A6; AKR1C2; MSMO1; UGT2B28; DHCR24; AKR1C1;	GO:0008202~steroid metabolic process	8	44	18.1818181818182	0.00439526437427751	0.0479127334265301	1	1	0.999999717377144	0.999999717377143	0.440352447301308
down	C3; PRL; APOE; TF; SEMG1; MELTF; BMP4; IGFBP2; IGFBP4; IGFBP6; IGFBP5; ADORA2B; LAMB2; FSTL1; SPARCL1; TMEM132A; VWA1; PCSK9; CHRDL1; LMCD1; SNCAIP;	GO:0044267~cellular protein metabolic process	21	200	10.5	0.00440770031436466	0.0479533403766353	1	1	0.999999717377144	0.999999717377143	0.440725654350405
down	CDC25C; SFN; CDKN2B; PKMYT1; CDC6; CCND1; CCNA2; CCNO; CCNB1;	GO:0000079~regulation of cyclin-dependent protein serine/threonine kinase activity	9	55	16.3636363636364	0.00479384401878402	0.0518425771728971	1	1	0.999999717377144	0.999999717377143	0.476470535071818
down	CD300LD; IDO2; CD300LF; IRF6; CTLA4; IRF8; IRF4;	GO:0002376~immune system process	7	35	20	0.00480285456097684	0.0518425771728971	1	1	0.999999717377144	0.999999717377143	0.476470535071818
down	ANXA9; APOE; RAPSN; CHRFAM7A; CHRNB4; CHRNG;	GO:0007271~synaptic transmission, cholinergic	6	26	23.0769230769231	0.00487777270882861	0.0522415151013648	1	1	0.999999717377144	0.999999717377143	0.480137061286429
down	LDLR; CETP; PITPNB; PLTP; TNFAIP8L3; OSBPL10;	GO:0015914~phospholipid transport	6	26	23.0769230769231	0.00487777270882861	0.0522415151013648	1	1	0.999999717377144	0.999999717377143	0.480137061286429
down	MET; TACSTD2; TJP1; CGNL1; DLC1; ARHGAP28;	GO:0051497~negative regulation of stress fiber assembly	6	26	23.0769230769231	0.00487777270882861	0.0522415151013648	1	1	0.999999717377144	0.999999717377143	0.480137061286429
down	CES2; HPGD; AKR1C2; PTGR1; AKR1C1;	GO:0006693~prostaglandin metabolic process	5	18	27.7777777777778	0.0051906393508091	0.0548454311443457	1	1	0.999999717377144	0.999999717377143	0.504068920733606
down	BMP4; AVPR2; AVPR1A; HES1; SCN5A;	GO:0021537~telencephalon development	5	18	27.7777777777778	0.0051906393508091	0.0548454311443457	1	1	0.999999717377144	0.999999717377143	0.504068920733606
down	MEIS1; DLL1; GPR171; MEIS2; HMGB3;	GO:0045638~negative regulation of myeloid cell differentiation	5	18	27.7777777777778	0.0051906393508091	0.0548454311443457	1	1	0.999999717377144	0.999999717377143	0.504068920733606
down	CCR2; AIF1; CXCL17; LGMN; S100A14;	GO:0090026~positive regulation of monocyte chemotaxis	5	18	27.7777777777778	0.0051906393508091	0.0548454311443457	1	1	0.999999717377144	0.999999717377143	0.504068920733606
down	DLL1; VEGFA; FUT1; IL10; TJP1;	GO:1903672~positive regulation of sprouting angiogenesis	5	18	27.7777777777778	0.0051906393508091	0.0548454311443457	1	1	0.999999717377144	0.999999717377143	0.504068920733606
down	TGFB3; IL10; PPARG; CNN1; MYOCD;	GO:1904706~negative regulation of vascular smooth muscle cell proliferation	5	18	27.7777777777778	0.0051906393508091	0.0548454311443457	1	1	0.999999717377144	0.999999717377143	0.504068920733606
down	E2F8; CDK1; CCNB1; MUC1; CDC25C; SFN; TNKS1BP1; PLK2; GTSE1;	GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest	9	56	16.0714285714286	0.00531935822334129	0.0560978295392601	1	1	0.999999717377144	0.999999717377143	0.515579361878495
down	TERT; FGFR2; HHEX; KANK1; SULF1; SFRP1; ATP6V1C2;	GO:0030177~positive regulation of Wnt signaling pathway	7	36	19.4444444444444	0.0054904571418074	0.0577527551205189	1	1	0.999999717377144	0.999999717377143	0.530789317096899
down	OBSL1; C3; APOE; TF; MELTF; BMP4; IGFBP4; IGFBP5; RAB13; LAMB2; RAB38; FSTL1; SPARCL1; TMEM132A; FBXL22; VWA1; SPSB3; PCSK9; FBXO27; PSMA8; DDB2; SPSB1; ANKRD9; FBXO17; SENP8; EPAS1; NEURL2; CHRDL1; GAN; DCAF13; KLHL13;	GO:0043687~post-translational protein modification	31	344	9.01162790697674	0.00549726497423286	0.0577527551205189	1	1	0.999999717377144	0.999999717377143	0.530789317096899
down	TULP1; BMP7; BDNF; IGSF9; BAIAP2; GRIP1; LAMC2; NTN1;	GO:0016358~dendrite development	8	46	17.3913043478261	0.00555926288204323	0.0582928422202818	1	1	0.999999717377144	0.999999717377143	0.535753105616732
down	VEGFA; KITLG; BDKRB1; TNFSF18;	GO:0002687~positive regulation of leukocyte migration	4	11	36.3636363636364	0.00571011805117549	0.0584306108268967	1	1	0.999999717377144	0.999999717377143	0.537019298103479
down	SLC26A4; RACGAP1; SLC13A4; SLC25A10;	GO:0008272~sulfate transport	4	11	36.3636363636364	0.00571011805117549	0.0584306108268967	1	1	0.999999717377144	0.999999717377143	0.537019298103479
down	LAMA5; FGFR2; KDF1; TBX18;	GO:0016331~morphogenesis of embryonic epithelium	4	11	36.3636363636364	0.00571011805117549	0.0584306108268967	1	1	0.999999717377144	0.999999717377143	0.537019298103479
down	CDK1; SPDL1; AURKB; TTK;	GO:0034501~protein localization to kinetochore	4	11	36.3636363636364	0.00571011805117549	0.0584306108268967	1	1	0.999999717377144	0.999999717377143	0.537019298103479
down	YES1; NPR1; BDKRB2; HRH1;	GO:0043114~regulation of vascular permeability	4	11	36.3636363636364	0.00571011805117549	0.0584306108268967	1	1	0.999999717377144	0.999999717377143	0.537019298103479
down	EGFR; GLI3; KIT; WNT10A;	GO:0043586~tongue development	4	11	36.3636363636364	0.00571011805117549	0.0584306108268967	1	1	0.999999717377144	0.999999717377143	0.537019298103479
down	CA12; SLC12A8; SLC12A1; SLC12A3;	GO:0055064~chloride ion homeostasis	4	11	36.3636363636364	0.00571011805117549	0.0584306108268967	1	1	0.999999717377144	0.999999717377143	0.537019298103479
down	SNAI2; JAG1; HEYL; DLL4;	GO:0061314~Notch signaling involved in heart development	4	11	36.3636363636364	0.00571011805117549	0.0584306108268967	1	1	0.999999717377144	0.999999717377143	0.537019298103479
down	JUP; DSP; DSG2; PKP2;	GO:0098911~regulation of ventricular cardiac muscle cell action potential	4	11	36.3636363636364	0.00571011805117549	0.0584306108268967	1	1	0.999999717377144	0.999999717377143	0.537019298103479
down	ADCY6; ADCY5; EFNA5; GNAI1;	GO:1904322~cellular response to forskolin	4	11	36.3636363636364	0.00571011805117549	0.0584306108268967	1	1	0.999999717377144	0.999999717377143	0.537019298103479
down	IFNG; C1QA; AIF1; CX3CL1; TLR8; TLR7;	GO:0001774~microglial cell activation	6	27	22.2222222222222	0.00571038485465403	0.0584306108268967	1	1	0.999999717377144	0.999999717377143	0.537019298103479
down	ALOX15B; ALOX12; CYP4F2; FAAH2; MGLL; CYP4F11;	GO:0019369~arachidonic acid metabolic process	6	27	22.2222222222222	0.00571038485465403	0.0584306108268967	1	1	0.999999717377144	0.999999717377143	0.537019298103479
down	APOE; LPL; CETP; IL18; GCKR; ANGPTL4;	GO:0070328~triglyceride homeostasis	6	27	22.2222222222222	0.00571038485465403	0.0584306108268967	1	1	0.999999717377144	0.999999717377143	0.537019298103479
down	CEACAM4; LDLR; ANXA1; ICAM3; IRF8; SLAMF1; CEBPE; ELMO3; TYRO3;	GO:0006909~phagocytosis	9	57	15.7894736842105	0.00588833879640982	0.0600872630835776	1	1	0.999999717377144	0.999999717377143	0.552245122709693
down	RACGAP1; ANLN; RTKN;	GO:0000915~actomyosin contractile ring assembly	3	5	60	0.00599235375710883	0.0600872630835776	1	1	0.999999717377144	0.999999717377143	0.552245122709693
down	TRPM2; SLC6A1; AACS;	GO:0014074~response to purine-containing compound	3	5	60	0.00599235375710883	0.0600872630835776	1	1	0.999999717377144	0.999999717377143	0.552245122709693
down	CNR2; CD300LF; CD84;	GO:0033004~negative regulation of mast cell activation	3	5	60	0.00599235375710883	0.0600872630835776	1	1	0.999999717377144	0.999999717377143	0.552245122709693
down	P2RY1; P2RX1; P2RY12;	GO:0043270~positive regulation of ion transport	3	5	60	0.00599235375710883	0.0600872630835776	1	1	0.999999717377144	0.999999717377143	0.552245122709693
down	GREM1; NBL1; WNT8B;	GO:0048263~determination of dorsal identity	3	5	60	0.00599235375710883	0.0600872630835776	1	1	0.999999717377144	0.999999717377143	0.552245122709693
down	LRP4; SHANK1; SHANK2;	GO:0051124~synaptic growth at neuromuscular junction	3	5	60	0.00599235375710883	0.0600872630835776	1	1	0.999999717377144	0.999999717377143	0.552245122709693
down	BMP4; FGFR2; MYOCD;	GO:0051150~regulation of smooth muscle cell differentiation	3	5	60	0.00599235375710883	0.0600872630835776	1	1	0.999999717377144	0.999999717377143	0.552245122709693
down	LMNA; PTN; WNT5A;	GO:0072201~negative regulation of mesenchymal cell proliferation	3	5	60	0.00599235375710883	0.0600872630835776	1	1	0.999999717377144	0.999999717377143	0.552245122709693
down	GJB5; GJA1; GJB2;	GO:1905867~epididymis development	3	5	60	0.00599235375710883	0.0600872630835776	1	1	0.999999717377144	0.999999717377143	0.552245122709693
down	LDLR; CRYAB; APOE;	GO:1905907~negative regulation of amyloid fibril formation	3	5	60	0.00599235375710883	0.0600872630835776	1	1	0.999999717377144	0.999999717377143	0.552245122709693
down	MEIS2; B4GALT2; DBH; KIT; HRH2; HRH1; TANC1; NDRG4;	GO:0008542~visual learning	8	47	17.0212765957447	0.00622261950679193	0.0622482012129128	1	1	0.999999717377144	0.999999717377143	0.572105696834077
up	FCER1G; S100A10; ABCA12;	GO:0072659~protein localization to plasma membrane	3	144	2.08333333333333	0.00622881447842949	0.0510315957896399	1	1	0.509153646073458	0.764540252498336	0.347457858772011
down	CCL21; VEGFA; PPARG; SOX8; HES1; EPAS1; LHX6;	GO:0048469~cell maturation	7	37	18.9189189189189	0.00624916108558693	0.0622482012129128	1	1	0.999999717377144	0.999999717377143	0.572105696834077
down	EGFR; CCNA2; IL10; CRHBP; SSTR3; SFRP1; PPARGC1A;	GO:0071392~cellular response to estradiol stimulus	7	37	18.9189189189189	0.00624916108558693	0.0622482012129128	1	1	0.999999717377144	0.999999717377143	0.572105696834077
down	SPTLC1; SPNS2; TEX2; SERINC2; TECR;	GO:0006665~sphingolipid metabolic process	5	19	26.3157894736842	0.00628701178462843	0.0622482012129128	1	1	0.999999717377144	0.999999717377143	0.572105696834077
down	LRRC8A; TRPV4; SLC12A3; SLC12A8; SLC12A1;	GO:0006884~cell volume homeostasis	5	19	26.3157894736842	0.00628701178462843	0.0622482012129128	1	1	0.999999717377144	0.999999717377143	0.572105696834077
down	FFAR3; ADORA2B; TSLP; TLR9; TLR7;	GO:0032722~positive regulation of chemokine production	5	19	26.3157894736842	0.00628701178462843	0.0622482012129128	1	1	0.999999717377144	0.999999717377143	0.572105696834077
down	HRAS; CSF3; BAIAP2L1; BAIAP2L2; BAIAP2;	GO:2000251~positive regulation of actin cytoskeleton reorganization	5	19	26.3157894736842	0.00628701178462843	0.0622482012129128	1	1	0.999999717377144	0.999999717377143	0.572105696834077
up	GJB1; PSMB4; SLC44A4; ABCA12;	GO:0055085~transmembrane transport	4	285	1.40350877192982	0.00631929052464053	0.0510315957896399	1	1	0.511468937560357	0.764540252498336	0.347457858772011
down	C3; ADORA2B; FLT4; CXCL17; SULF1; NODAL;	GO:0010575~positive regulation of vascular endothelial growth factor production	6	28	21.4285714285714	0.00664205722976818	0.0655278226700248	1	1	0.999999717377144	0.999999717377143	0.602247774557021
down	GJA1; RCVRN; OPRD1; RGS4; P2RX1; P2RY12;	GO:0051924~regulation of calcium ion transport	6	28	21.4285714285714	0.00664205722976818	0.0655278226700248	1	1	0.999999717377144	0.999999717377143	0.602247774557021
down	TGFB3; BMP4; BMP7; TTK; RBPMS; NODAL; LEFTY1; BMP3;	GO:0010862~positive regulation of pathway-restricted SMAD protein phosphorylation	8	48	16.6666666666667	0.0069442908408871	0.0680219236282625	1	1	0.999999717377144	0.999999717377143	0.625170354469115
down	CCL2; LOX; EPHA2; KDR; SOX9; TYRO3; P2RY12;	GO:0043491~protein kinase B signaling	7	38	18.4210526315789	0.00708324389589265	0.0692597826765348	1	1	0.999999717377144	0.999999717377143	0.636547168571292
down	DKK1; EGFR; S100B; NTRK1; CRHBP; GLP1R; SLC11A2; GATM; LILRB2;	GO:0007611~learning or memory	9	59	15.2542372881356	0.00716587551715397	0.0692780082080014	1	1	0.999999717377144	0.999999717377143	0.636714674301205
up	S100A11; DSG1; CRNN;	GO:0098609~cell-cell adhesion	3	152	1.97368421052632	0.00720413817823717	0.0510315957896399	1	1	0.529968257248979	0.764540252498336	0.347457858772011
down	MET; ID1; STC1; ARHGEF26;	GO:0001886~endothelial cell morphogenesis	4	12	33.3333333333333	0.00731162993076273	0.0692780082080014	1	1	0.999999717377144	0.999999717377143	0.636714674301205
down	FLT4; PTPN14; PDPN; PROX1;	GO:0001946~lymphangiogenesis	4	12	33.3333333333333	0.00731162993076273	0.0692780082080014	1	1	0.999999717377144	0.999999717377143	0.636714674301205
down	DLL1; BMP4; WNT5A; SMO;	GO:0003323~type B pancreatic cell development	4	12	33.3333333333333	0.00731162993076273	0.0692780082080014	1	1	0.999999717377144	0.999999717377143	0.636714674301205
down	ADAMTS9; FBXO27; FBXO17; NCCRP1;	GO:0006516~glycoprotein catabolic process	4	12	33.3333333333333	0.00731162993076273	0.0692780082080014	1	1	0.999999717377144	0.999999717377143	0.636714674301205
down	ALDH7A1; CRYM; AADAT; SLC25A21;	GO:0006554~lysine catabolic process	4	12	33.3333333333333	0.00731162993076273	0.0692780082080014	1	1	0.999999717377144	0.999999717377143	0.636714674301205
down	FARP2; C3; C1QA; CX3CL1;	GO:0016322~neuron remodeling	4	12	33.3333333333333	0.00731162993076273	0.0692780082080014	1	1	0.999999717377144	0.999999717377143	0.636714674301205
down	PTN; OLIG2; SMO; LRP6;	GO:0021794~thalamus development	4	12	33.3333333333333	0.00731162993076273	0.0692780082080014	1	1	0.999999717377144	0.999999717377143	0.636714674301205
down	TULP3; RARG; NES; PPP1R13L;	GO:0031076~embryonic camera-type eye development	4	12	33.3333333333333	0.00731162993076273	0.0692780082080014	1	1	0.999999717377144	0.999999717377143	0.636714674301205
down	KRT5; LAMB3; LAMC2; DST;	GO:0031581~hemidesmosome assembly	4	12	33.3333333333333	0.00731162993076273	0.0692780082080014	1	1	0.999999717377144	0.999999717377143	0.636714674301205
down	LRP5; GATA1; SOX8; TMEM119;	GO:0033690~positive regulation of osteoblast proliferation	4	12	33.3333333333333	0.00731162993076273	0.0692780082080014	1	1	0.999999717377144	0.999999717377143	0.636714674301205
down	HPN; MET; BCAR1; MUC20;	GO:0048012~hepatocyte growth factor receptor signaling pathway	4	12	33.3333333333333	0.00731162993076273	0.0692780082080014	1	1	0.999999717377144	0.999999717377143	0.636714674301205
down	IL2RA; CTLA4; FCGR2B; SPINK5;	GO:0050777~negative regulation of immune response	4	12	33.3333333333333	0.00731162993076273	0.0692780082080014	1	1	0.999999717377144	0.999999717377143	0.636714674301205
down	TLCD2; CETP; TLCD1; LIPG;	GO:0055091~phospholipid homeostasis	4	12	33.3333333333333	0.00731162993076273	0.0692780082080014	1	1	0.999999717377144	0.999999717377143	0.636714674301205
down	CEACAM1; ALOX12; CD9; C1QTNF1;	GO:0090331~negative regulation of platelet aggregation	4	12	33.3333333333333	0.00731162993076273	0.0692780082080014	1	1	0.999999717377144	0.999999717377143	0.636714674301205
down	TRPM2; GATA1; FLT3; LILRB1;	GO:0097028~dendritic cell differentiation	4	12	33.3333333333333	0.00731162993076273	0.0692780082080014	1	1	0.999999717377144	0.999999717377143	0.636714674301205
down	TERT; TBX3; GJA1; HMGA2;	GO:2000648~positive regulation of stem cell proliferation	4	12	33.3333333333333	0.00731162993076273	0.0692780082080014	1	1	0.999999717377144	0.999999717377143	0.636714674301205
down	TNFRSF21; EPHB3; SEMA5A; NDN; CRTAC1;	GO:0007413~axonal fasciculation	5	20	25	0.00753611986119851	0.0707958017677437	1	1	0.999999717377144	0.999999717377143	0.650664287707326
down	CCL24; HRH1; CX3CL1; XCL2; CCL2;	GO:0048245~eosinophil chemotaxis	5	20	25	0.00753611986119851	0.0707958017677437	1	1	0.999999717377144	0.999999717377143	0.650664287707326
down	NRP2; WNT5A; SEMA3F; ABHD17C; LRFN2;	GO:0099175~regulation of postsynapse organization	5	20	25	0.00753611986119851	0.0707958017677437	1	1	0.999999717377144	0.999999717377143	0.650664287707326
down	CCL21; CLDN7; NTN1; TF; DUOX1;	GO:2000147~positive regulation of cell motility	5	20	25	0.00753611986119851	0.0707958017677437	1	1	0.999999717377144	0.999999717377143	0.650664287707326
down	PRLR; FDXR; LSS; DHRS11; SDR42E1; TFCP2L1;	GO:0006694~steroid biosynthetic process	6	29	20.6896551724138	0.00767912787914282	0.0715289322752644	1	1	0.999999717377144	0.999999717377143	0.657402283853445
down	PHGDH; PLXNA2; EPHA2; PROX1; INTU; GRHL2;	GO:0021915~neural tube development	6	29	20.6896551724138	0.00767912787914282	0.0715289322752644	1	1	0.999999717377144	0.999999717377143	0.657402283853445
down	WNT1; FGFR2; MSX1; HES1; DLG5; LRP6;	GO:0030901~midbrain development	6	29	20.6896551724138	0.00767912787914282	0.0715289322752644	1	1	0.999999717377144	0.999999717377143	0.657402283853445
down	NFASC; VCAM1; ITGAD; LILRB2; PERP; PARVA;	GO:0034113~heterotypic cell-cell adhesion	6	29	20.6896551724138	0.00767912787914282	0.0715289322752644	1	1	0.999999717377144	0.999999717377143	0.657402283853445
down	TF; MELTF; STEAP3; STEAP2; EPAS1; STEAP1;	GO:0055072~iron ion homeostasis	6	29	20.6896551724138	0.00767912787914282	0.0715289322752644	1	1	0.999999717377144	0.999999717377143	0.657402283853445
down	S100B; IGFBP2; IL1RN; SDC1; MDK; IL10; ALDH3A1; AIF1; WNT7B;	GO:0051384~response to glucocorticoid	9	60	15	0.0078790816883495	0.0732674741458851	1	1	0.999999717377144	0.999999717377143	0.673380732852553
down	HSPB1; VEGFA; ALOX12; KDR; PRKD1; ANGPT1; AMOTL1;	GO:0043536~positive regulation of blood vessel endothelial cell migration	7	39	17.9487179487179	0.00799698774100954	0.0742384781016147	1	1	0.999999717377144	0.999999717377143	0.682304956908783
up	SAA1; SCGB3A2; PI4KB;	GO:0006898~receptor-mediated endocytosis	3	160	1.875	0.00826501825946957	0.0520079853424166	1	1	0.548384142636009	0.764540252498336	0.354105783809151
down	ADCY6; DKK1; APOE; EFNB2; PMP22; CRMP1; KANK1; INPP5J; TRPV4;	GO:0010977~negative regulation of neuron projection development	9	61	14.7540983606557	0.00864504395582966	0.0769457156612608	1	1	0.999999717377144	0.999999717377143	0.707186415334531
down	PTN; MDK; SLAMF8;	GO:0002232~leukocyte chemotaxis involved in inflammatory response	3	6	50	0.00865202506708818	0.0769457156612608	1	1	0.999999717377144	0.999999717377143	0.707186415334531
down	CD19; CD180; GAPT;	GO:0002322~B cell proliferation involved in immune response	3	6	50	0.00865202506708818	0.0769457156612608	1	1	0.999999717377144	0.999999717377143	0.707186415334531
down	IL10; ANGPT1; LILRB1;	GO:0002740~negative regulation of cytokine secretion involved in immune response	3	6	50	0.00865202506708818	0.0769457156612608	1	1	0.999999717377144	0.999999717377143	0.707186415334531
down	PTPRF; PTN; PTPRD;	GO:0007185~transmembrane receptor protein tyrosine phosphatase signaling pathway	3	6	50	0.00865202506708818	0.0769457156612608	1	1	0.999999717377144	0.999999717377143	0.707186415334531
down	CD9; MAPK10; LRP11;	GO:0009414~response to water deprivation	3	6	50	0.00865202506708818	0.0769457156612608	1	1	0.999999717377144	0.999999717377143	0.707186415334531
down	GJB6; GJA1; GJB2;	GO:0010644~cell communication by electrical coupling	3	6	50	0.00865202506708818	0.0769457156612608	1	1	0.999999717377144	0.999999717377143	0.707186415334531
down	SLC1A3; TIFAB; SLITRK6;	GO:0031223~auditory behavior	3	6	50	0.00865202506708818	0.0769457156612608	1	1	0.999999717377144	0.999999717377143	0.707186415334531
down	ANXA1; ANXA2; DOC2B;	GO:0031340~positive regulation of vesicle fusion	3	6	50	0.00865202506708818	0.0769457156612608	1	1	0.999999717377144	0.999999717377143	0.707186415334531
down	NTRK1; BDNF; NTRK2;	GO:0042490~mechanoreceptor differentiation	3	6	50	0.00865202506708818	0.0769457156612608	1	1	0.999999717377144	0.999999717377143	0.707186415334531
down	PF4; SPI1; IL10;	GO:0045347~negative regulation of MHC class II biosynthetic process	3	6	50	0.00865202506708818	0.0769457156612608	1	1	0.999999717377144	0.999999717377143	0.707186415334531
down	ID1; XDH; JAG1;	GO:0045602~negative regulation of endothelial cell differentiation	3	6	50	0.00865202506708818	0.0769457156612608	1	1	0.999999717377144	0.999999717377143	0.707186415334531
down	HRH2; RARB; RARG;	GO:0048732~gland development	3	6	50	0.00865202506708818	0.0769457156612608	1	1	0.999999717377144	0.999999717377143	0.707186415334531
down	CAPN1; IGFBP5; ELF3;	GO:0060056~mammary gland involution	3	6	50	0.00865202506708818	0.0769457156612608	1	1	0.999999717377144	0.999999717377143	0.707186415334531
down	BMP4; BMP7; SFRP1;	GO:0060687~regulation of branching involved in prostate gland morphogenesis	3	6	50	0.00865202506708818	0.0769457156612608	1	1	0.999999717377144	0.999999717377143	0.707186415334531
down	LRP5; LAMA1; FZD4;	GO:0061304~retinal blood vessel morphogenesis	3	6	50	0.00865202506708818	0.0769457156612608	1	1	0.999999717377144	0.999999717377143	0.707186415334531
down	GREM1; NBL1; SLAMF8;	GO:0090027~negative regulation of monocyte chemotaxis	3	6	50	0.00865202506708818	0.0769457156612608	1	1	0.999999717377144	0.999999717377143	0.707186415334531
down	SLC6A1; SLC6A11; SLC29A2;	GO:0098810~neurotransmitter reuptake	3	6	50	0.00865202506708818	0.0769457156612608	1	1	0.999999717377144	0.999999717377143	0.707186415334531
down	DSP; TJP1; CGNL1;	GO:0150105~protein localization to cell-cell junction	3	6	50	0.00865202506708818	0.0769457156612608	1	1	0.999999717377144	0.999999717377143	0.707186415334531
down	MYO1C; SMOC2; ROBO1;	GO:1900748~positive regulation of vascular endothelial growth factor signaling pathway	3	6	50	0.00865202506708818	0.0769457156612608	1	1	0.999999717377144	0.999999717377143	0.707186415334531
down	EGFR; ERBB2; LGMN;	GO:1901185~negative regulation of ERBB signaling pathway	3	6	50	0.00865202506708818	0.0769457156612608	1	1	0.999999717377144	0.999999717377143	0.707186415334531
down	IFNG; CCL2; CCR2;	GO:1904783~positive regulation of NMDA glutamate receptor activity	3	6	50	0.00865202506708818	0.0769457156612608	1	1	0.999999717377144	0.999999717377143	0.707186415334531
down	LRP6; WNT1; WNT5A;	GO:1904953~Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation	3	6	50	0.00865202506708818	0.0769457156612608	1	1	0.999999717377144	0.999999717377143	0.707186415334531
down	CYFIP1; CTTNBP2; BAIAP2;	GO:1905274~regulation of modification of postsynaptic actin cytoskeleton	3	6	50	0.00865202506708818	0.0769457156612608	1	1	0.999999717377144	0.999999717377143	0.707186415334531
down	C3; CCL2; CD300LF;	GO:2000427~positive regulation of apoptotic cell clearance	3	6	50	0.00865202506708818	0.0769457156612608	1	1	0.999999717377144	0.999999717377143	0.707186415334531
up	CARD16; PYCARD; CXCL11;	GO:0071222~cellular response to lipopolysaccharide	3	163	1.84049079754601	0.00868523795909015	0.0520079853424166	1	1	0.55585522938177	0.764540252498336	0.354105783809151
down	ATP8B1; CEACAM1; AKR1C1; STARD5; SLCO2B1; SLC10A6;	GO:0015721~bile acid and bile salt transport	6	30	20	0.00882786055837603	0.0778804044452886	1	1	0.999999717377144	0.999999717377143	0.715776876868997
down	TXN; MMP8; PPARG; HES1; IRF4; MYOCD;	GO:0043388~positive regulation of DNA binding	6	30	20	0.00882786055837603	0.0778804044452886	1	1	0.999999717377144	0.999999717377143	0.715776876868997
down	ID1; NEK2; HMGA2; ZNF462; MDFI; SMO;	GO:0043392~negative regulation of DNA binding	6	30	20	0.00882786055837603	0.0778804044452886	1	1	0.999999717377144	0.999999717377143	0.715776876868997
down	PEX11A; LAMB3; FFAR4; DIO2; ERO1A; PPARGC1A;	GO:0050873~brown fat cell differentiation	6	30	20	0.00882786055837603	0.0778804044452886	1	1	0.999999717377144	0.999999717377143	0.715776876868997
down	TERT; IL10; KDR; SEMA5A; ANGPT1; ANGPTL4;	GO:2000352~negative regulation of endothelial cell apoptotic process	6	30	20	0.00882786055837603	0.0778804044452886	1	1	0.999999717377144	0.999999717377143	0.715776876868997
down	FMO1; FMO2; CYP2J2; CYP2E1; CYP2A6;	GO:0006082~organic acid metabolic process	5	21	23.8095238095238	0.00894794539071087	0.0781879990093068	1	1	0.999999717377144	0.999999717377143	0.718603891930655
down	FARP2; AIF1; CDH13; CYFIP1; NCKAP1;	GO:0016601~Rac protein signal transduction	5	21	23.8095238095238	0.00894794539071087	0.0781879990093068	1	1	0.999999717377144	0.999999717377143	0.718603891930655
down	EPHX2; CYP2J2; CYP4F2; CYP2E1; CYP2A6;	GO:0019373~epoxygenase P450 pathway	5	21	23.8095238095238	0.00894794539071087	0.0781879990093068	1	1	0.999999717377144	0.999999717377143	0.718603891930655
down	FZD6; WNT5A; FZD4; FRZB; SFRP1;	GO:0035567~non-canonical Wnt signaling pathway	5	21	23.8095238095238	0.00894794539071087	0.0781879990093068	1	1	0.999999717377144	0.999999717377143	0.718603891930655
down	LRP4; THY1; NGFR; PTK2; EFNB3;	GO:0050771~negative regulation of axonogenesis	5	21	23.8095238095238	0.00894794539071087	0.0781879990093068	1	1	0.999999717377144	0.999999717377143	0.718603891930655
down	VEGFD; LRP6; VEGFA; FOXA1; SFRP1;	GO:0071542~dopaminergic neuron differentiation	5	21	23.8095238095238	0.00894794539071087	0.0781879990093068	1	1	0.999999717377144	0.999999717377143	0.718603891930655
down	BAG3; IFNG; CDK1; GLI3; CDH1; JUP; SMO;	GO:0042307~positive regulation of protein import into nucleus	7	40	17.5	0.008994663291786	0.0782546413463278	1	1	0.999999717377144	0.999999717377143	0.719216382892918
up	TSPAN8; CRNN; POGZ;	GO:0010468~regulation of gene expression	3	166	1.80722891566265	0.00911779216773456	0.0520079853424166	1	1	0.564996811719426	0.764540252498336	0.354105783809151
down	SNAI2; BMP4; MSX1; HEYL;	GO:0003198~epithelial to mesenchymal transition involved in endocardial cushion formation	4	13	30.7692307692308	0.00918301513346553	0.0782546413463278	1	1	0.999999717377144	0.999999717377143	0.719216382892918
down	NOS1; SPR; SLC7A2; ARG2;	GO:0006809~nitric oxide biosynthetic process	4	13	30.7692307692308	0.00918301513346553	0.0782546413463278	1	1	0.999999717377144	0.999999717377143	0.719216382892918
down	GREM1; PRLR; EFNA5; ANGPT1;	GO:0007171~activation of transmembrane receptor protein tyrosine kinase activity	4	13	30.7692307692308	0.00918301513346553	0.0782546413463278	1	1	0.999999717377144	0.999999717377143	0.719216382892918
down	MDK; CDH3; TGM1; TP63;	GO:0010838~positive regulation of keratinocyte proliferation	4	13	30.7692307692308	0.00918301513346553	0.0782546413463278	1	1	0.999999717377144	0.999999717377143	0.719216382892918
down	IGFBP5; SEMA6D; PPARGC1A; NDRG4;	GO:0014912~negative regulation of smooth muscle cell migration	4	13	30.7692307692308	0.00918301513346553	0.0782546413463278	1	1	0.999999717377144	0.999999717377143	0.719216382892918
down	CCL21; KIT; CDC42EP1; C15orf62;	GO:0031274~positive regulation of pseudopodium assembly	4	13	30.7692307692308	0.00918301513346553	0.0782546413463278	1	1	0.999999717377144	0.999999717377143	0.719216382892918
down	WNT1; CDH3; IGFBP4; IGFBP5;	GO:0043568~positive regulation of insulin-like growth factor receptor signaling pathway	4	13	30.7692307692308	0.00918301513346553	0.0782546413463278	1	1	0.999999717377144	0.999999717377143	0.719216382892918
down	FFAR3; FUT7; VWA2; BAIAP2L1;	GO:0046626~regulation of insulin receptor signaling pathway	4	13	30.7692307692308	0.00918301513346553	0.0782546413463278	1	1	0.999999717377144	0.999999717377143	0.719216382892918
down	PLPP1; PLPP3; PLPP2; EPHX2;	GO:0046839~phospholipid dephosphorylation	4	13	30.7692307692308	0.00918301513346553	0.0782546413463278	1	1	0.999999717377144	0.999999717377143	0.719216382892918
down	HPN; KIT; ADGRV1; TMC1;	GO:0050910~detection of mechanical stimulus involved in sensory perception of sound	4	13	30.7692307692308	0.00918301513346553	0.0782546413463278	1	1	0.999999717377144	0.999999717377143	0.719216382892918
down	SPTBN2; SPTA1; VIL1; SCIN;	GO:0051693~actin filament capping	4	13	30.7692307692308	0.00918301513346553	0.0782546413463278	1	1	0.999999717377144	0.999999717377143	0.719216382892918
down	WNT5A; SFRP1; GRHL3; VANGL2;	GO:0090179~planar cell polarity pathway involved in neural tube closure	4	13	30.7692307692308	0.00918301513346553	0.0782546413463278	1	1	0.999999717377144	0.999999717377143	0.719216382892918
down	SNX33; PACSIN1; EHD2; PACSIN3;	GO:0097320~plasma membrane tubulation	4	13	30.7692307692308	0.00918301513346553	0.0782546413463278	1	1	0.999999717377144	0.999999717377143	0.719216382892918
down	P2RY1; P2RX1; NCS1; CALB2;	GO:0099509~regulation of presynaptic cytosolic calcium ion concentration	4	13	30.7692307692308	0.00918301513346553	0.0782546413463278	1	1	0.999999717377144	0.999999717377143	0.719216382892918
down	KRT19; GLI3; TGFB3; IGFBP2; CCND1; CD24; PPARG; ZNF366; CITED4;	GO:0043627~response to estrogen	9	62	14.5161290322581	0.00946612569211136	0.0804872242970079	1	1	0.999999717377144	0.999999717377143	0.739735424404977
down	TP73; BIRC5; LRP5; GJA1; LOX; FLT3; SOX9; BCAR1; TP53I3; TNFAIP8L3; BCL2L15; STEAP3; DLG5; PERP; PPP1R13B; RTKN; CARD10; TP63; TP53AIP1; NME2;	GO:0042981~regulation of apoptotic process	20	202	9.9009900990099	0.00947424547583309	0.0804872242970079	1	1	0.999999717377144	0.999999717377143	0.739735424404977
down	PRC1; KIF20A; PLK1; MYO19; KLHL13; PLK2; AURKB;	GO:0032465~regulation of cytokinesis	7	41	17.0731707317073	0.010080513684626	0.0845810425654154	1	1	0.999999717377144	0.999999717377143	0.777360555854936
down	LRRC19; CD276; BTNL3; HHLA2; BTN1A1; BTNL8;	GO:0001817~regulation of cytokine production	6	31	19.3548387096774	0.0100944132544011	0.0845810425654154	1	1	0.999999717377144	0.999999717377143	0.777360555854936
down	DMD; IRX5; SNTA1; SCN5A; GPD1L; EPAS1;	GO:0002027~regulation of heart rate	6	31	19.3548387096774	0.0100944132544011	0.0845810425654154	1	1	0.999999717377144	0.999999717377143	0.777360555854936
down	MID1; SOSTDC1; GRHL3; SHROOM3; FOXJ1; EYA1;	GO:0007389~pattern specification process	6	31	19.3548387096774	0.0100944132544011	0.0845810425654154	1	1	0.999999717377144	0.999999717377143	0.777360555854936
down	SPTLC1; P2RX1; CYP4F22; CERS3; SPTSSB; DEGS2;	GO:0046513~ceramide biosynthetic process	6	31	19.3548387096774	0.0100944132544011	0.0845810425654154	1	1	0.999999717377144	0.999999717377143	0.777360555854936
down	DKK1; TGFB3; MSX1; PAX9; CRISPLD1; LRP6;	GO:0060325~face morphogenesis	6	31	19.3548387096774	0.0100944132544011	0.0845810425654154	1	1	0.999999717377144	0.999999717377143	0.777360555854936
down	NEK2; CDC20; SPICE1; KIFC1; TPX2; BIRC5;	GO:0090307~mitotic spindle assembly	6	31	19.3548387096774	0.0100944132544011	0.0845810425654154	1	1	0.999999717377144	0.999999717377143	0.777360555854936
down	EGFR; GLI3; IL10; CCND1; PTPN3; EZH2;	GO:0097421~liver regeneration	6	31	19.3548387096774	0.0100944132544011	0.0845810425654154	1	1	0.999999717377144	0.999999717377143	0.777360555854936
down	APOE; LPL; SDC1; SDC4; GPC1; ADH7; AKR1C1; RDH12; BCO2;	GO:0001523~retinoid metabolic process	9	63	14.2857142857143	0.010344695944042	0.0862841684423501	1	1	0.999999717377144	0.999999717377143	0.793013506424337
down	IGFBP2; AHCY; ALDH3A1; SLC6A4; PPARG; OXCT1; AACS; LIPG; SLC27A4;	GO:0007584~response to nutrient	9	63	14.2857142857143	0.010344695944042	0.0862841684423501	1	1	0.999999717377144	0.999999717377143	0.793013506424337
down	NR2F6; RARB; BMP4; NR2C1; RARG; BMP7; NR2F2; PPARG;	GO:0043401~steroid hormone mediated signaling pathway	8	52	15.3846153846154	0.0104759895604489	0.0869251745668927	1	1	0.999999717377144	0.999999717377143	0.798904813296033
down	ALDH1L1; CA6; AHCY; SFXN1; SHMT1;	GO:0006730~one-carbon metabolic process	5	22	22.7272727272727	0.0105320783716835	0.0869251745668927	1	1	0.999999717377144	0.999999717377143	0.798904813296033
down	IFNG; BMP4; VEGFA; SPI1; CEBPE;	GO:0030225~macrophage differentiation	5	22	22.7272727272727	0.0105320783716835	0.0869251745668927	1	1	0.999999717377144	0.999999717377143	0.798904813296033
down	MET; TNFAIP1; KANK1; RASIP1; DLC1;	GO:0035024~negative regulation of Rho protein signal transduction	5	22	22.7272727272727	0.0105320783716835	0.0869251745668927	1	1	0.999999717377144	0.999999717377143	0.798904813296033
down	APOD; CCNB1; PTN; MDK; SOX2;	GO:0042246~tissue regeneration	5	22	22.7272727272727	0.0105320783716835	0.0869251745668927	1	1	0.999999717377144	0.999999717377143	0.798904813296033
down	LZTS1; CCND1; CCNB1; CCNA2; CCNO;	GO:0044772~mitotic cell cycle phase transition	5	22	22.7272727272727	0.0105320783716835	0.0869251745668927	1	1	0.999999717377144	0.999999717377143	0.798904813296033
down	MET; BMP4; VEGFA; BMP7; RASIP1;	GO:0048754~branching morphogenesis of an epithelial tube	5	22	22.7272727272727	0.0105320783716835	0.0869251745668927	1	1	0.999999717377144	0.999999717377143	0.798904813296033
down	TGFB3; BMP4; BMP7; MDK; EZH2; PDPN; WWTR1;	GO:0010718~positive regulation of epithelial to mesenchymal transition	7	42	16.6666666666667	0.0112587387000711	0.0915384800024673	1	1	0.999999717377144	0.999999717377143	0.84130440508344
down	FOXP2; EFEMP1; SHROOM2; GRHL2; PITX2; B9D1; LAMA1;	GO:0043010~camera-type eye development	7	42	16.6666666666667	0.0112587387000711	0.0915384800024673	1	1	0.999999717377144	0.999999717377143	0.84130440508344
down	ALOX15B; NUPR1; BMP4; HPGD; BMP7; LILRB1; PPP1R13B;	GO:0045786~negative regulation of cell cycle	7	42	16.6666666666667	0.0112587387000711	0.0915384800024673	1	1	0.999999717377144	0.999999717377143	0.84130440508344
down	FUT3; ST6GALNAC1; B3GALT5; B3GALNT1;	GO:0009312~oligosaccharide biosynthetic process	4	14	28.5714285714286	0.0113404620093883	0.0915384800024673	1	1	0.999999717377144	0.999999717377143	0.84130440508344
down	APOE; PPARG; SLC27A4; SLC27A6;	GO:0015909~long-chain fatty acid transport	4	14	28.5714285714286	0.0113404620093883	0.0915384800024673	1	1	0.999999717377144	0.999999717377143	0.84130440508344
down	JAG1; TBX2; EYA1; ADAMTS9;	GO:0035909~aorta morphogenesis	4	14	28.5714285714286	0.0113404620093883	0.0915384800024673	1	1	0.999999717377144	0.999999717377143	0.84130440508344
down	SRPX2; CD24; PPP1R14C; PPP1R14B;	GO:0042325~regulation of phosphorylation	4	14	28.5714285714286	0.0113404620093883	0.0915384800024673	1	1	0.999999717377144	0.999999717377143	0.84130440508344
down	AKR1C1; CYP27C1; SDR16C5; BCO2;	GO:0042574~retinal metabolic process	4	14	28.5714285714286	0.0113404620093883	0.0915384800024673	1	1	0.999999717377144	0.999999717377143	0.84130440508344
down	CCL2; EDN2; CX3CL1; CXCL17;	GO:0048246~macrophage chemotaxis	4	14	28.5714285714286	0.0113404620093883	0.0915384800024673	1	1	0.999999717377144	0.999999717377143	0.84130440508344
down	SNAI2; PPARG; FFAR4; AACS;	GO:0050872~white fat cell differentiation	4	14	28.5714285714286	0.0113404620093883	0.0915384800024673	1	1	0.999999717377144	0.999999717377143	0.84130440508344
down	GCNT3; ADRA2A; KCNQ1; TJP2;	GO:0050892~intestinal absorption	4	14	28.5714285714286	0.0113404620093883	0.0915384800024673	1	1	0.999999717377144	0.999999717377143	0.84130440508344
down	WNT10B; SCNN1A; SCNN1B; TRPM5;	GO:0050909~sensory perception of taste	4	14	28.5714285714286	0.0113404620093883	0.0915384800024673	1	1	0.999999717377144	0.999999717377143	0.84130440508344
down	TRIM16; NME2; IGFBP5; CPS1;	GO:0060416~response to growth hormone	4	14	28.5714285714286	0.0113404620093883	0.0915384800024673	1	1	0.999999717377144	0.999999717377143	0.84130440508344
down	MEIS2; EPHA2; P2RY1; SOX2;	GO:0070848~response to growth factor	4	14	28.5714285714286	0.0113404620093883	0.0915384800024673	1	1	0.999999717377144	0.999999717377143	0.84130440508344
down	AIF1; CSPG4; ARHGEF26; AIF1L;	GO:0097178~ruffle assembly	4	14	28.5714285714286	0.0113404620093883	0.0915384800024673	1	1	0.999999717377144	0.999999717377143	0.84130440508344
down	PRC1; TPPP; KIF20A; PLK1; NCKAP5; NAV1;	GO:0001578~microtubule bundle formation	6	32	18.75	0.0114848080313033	0.0922976178282108	1	1	0.999999717377144	0.999999717377143	0.848281427171268
down	PLXNB1; PLXNA2; FARP2; MET; SEMA6D; SEMA3F;	GO:0071526~semaphorin-plexin signaling pathway	6	32	18.75	0.0114848080313033	0.0922976178282108	1	1	0.999999717377144	0.999999717377143	0.848281427171268
down	TERT; EGFR; AIF1; ANXA1; CCND1; CDC45;	GO:1900087~positive regulation of G1/S transition of mitotic cell cycle	6	32	18.75	0.0114848080313033	0.0922976178282108	1	1	0.999999717377144	0.999999717377143	0.848281427171268
up	S100A4; S100A12; CARD16;	GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling	3	183	1.63934426229508	0.0118052206099489	0.0534707574371731	1	1	0.609259234757353	0.764540252498336	0.364065332438801
down	BMP7; DLL4; LRP6;	GO:0003344~pericardium morphogenesis	3	7	42.8571428571429	0.0118985908430524	0.0923860967433057	1	1	0.999999717377144	0.999999717377143	0.849094611976438
down	MYO1E; PM20D1; CPS1;	GO:0006807~nitrogen compound metabolic process	3	7	42.8571428571429	0.0118985908430524	0.0923860967433057	1	1	0.999999717377144	0.999999717377143	0.849094611976438
down	ARL1; FMO1; FMO2;	GO:0009404~toxin metabolic process	3	7	42.8571428571429	0.0118985908430524	0.0923860967433057	1	1	0.999999717377144	0.999999717377143	0.849094611976438
down	CRYAB; HSPA1B; CLNK;	GO:0010941~regulation of cell death	3	7	42.8571428571429	0.0118985908430524	0.0923860967433057	1	1	0.999999717377144	0.999999717377143	0.849094611976438
down	LRP6; FRZB; WNT10A;	GO:0014033~neural crest cell differentiation	3	7	42.8571428571429	0.0118985908430524	0.0923860967433057	1	1	0.999999717377144	0.999999717377143	0.849094611976438
down	ERBB3; GPC1; ADGRG6;	GO:0014037~Schwann cell differentiation	3	7	42.8571428571429	0.0118985908430524	0.0923860967433057	1	1	0.999999717377144	0.999999717377143	0.849094611976438
down	GATA1; TAL1; CDKN2B;	GO:0030219~megakaryocyte differentiation	3	7	42.8571428571429	0.0118985908430524	0.0923860967433057	1	1	0.999999717377144	0.999999717377143	0.849094611976438
down	ALOX15B; PRLR; CD24;	GO:0030856~regulation of epithelial cell differentiation	3	7	42.8571428571429	0.0118985908430524	0.0923860967433057	1	1	0.999999717377144	0.999999717377143	0.849094611976438
down	E2F8; CHMP4C; AURKB;	GO:0032466~negative regulation of cytokinesis	3	7	42.8571428571429	0.0118985908430524	0.0923860967433057	1	1	0.999999717377144	0.999999717377143	0.849094611976438
down	BPI; IL10; TLR9;	GO:0032717~negative regulation of interleukin-8 production	3	7	42.8571428571429	0.0118985908430524	0.0923860967433057	1	1	0.999999717377144	0.999999717377143	0.849094611976438
down	IGSF3; FGFR2; SOX9;	GO:0032808~lacrimal gland development	3	7	42.8571428571429	0.0118985908430524	0.0923860967433057	1	1	0.999999717377144	0.999999717377143	0.849094611976438
down	BMP4; APCDD1; WNT10A;	GO:0042487~regulation of odontogenesis of dentin-containing tooth	3	7	42.8571428571429	0.0118985908430524	0.0923860967433057	1	1	0.999999717377144	0.999999717377143	0.849094611976438
down	FCGR2B; FCRL3; CD300A;	GO:0050859~negative regulation of B cell receptor signaling pathway	3	7	42.8571428571429	0.0118985908430524	0.0923860967433057	1	1	0.999999717377144	0.999999717377143	0.849094611976438
down	VIL1; DSTN; SCIN;	GO:0051014~actin filament severing	3	7	42.8571428571429	0.0118985908430524	0.0923860967433057	1	1	0.999999717377144	0.999999717377143	0.849094611976438
down	KIF4A; AURKB; RACGAP1;	GO:0051256~mitotic spindle midzone assembly	3	7	42.8571428571429	0.0118985908430524	0.0923860967433057	1	1	0.999999717377144	0.999999717377143	0.849094611976438
down	NEK2; SPAG5; RACGAP1;	GO:0051988~regulation of attachment of spindle microtubules to kinetochore	3	7	42.8571428571429	0.0118985908430524	0.0923860967433057	1	1	0.999999717377144	0.999999717377143	0.849094611976438
down	FOXP2; USP46; SHANK1;	GO:0060013~righting reflex	3	7	42.8571428571429	0.0118985908430524	0.0923860967433057	1	1	0.999999717377144	0.999999717377143	0.849094611976438
down	CYP7B1; RARG; FOXA1;	GO:0060740~prostate gland epithelium morphogenesis	3	7	42.8571428571429	0.0118985908430524	0.0923860967433057	1	1	0.999999717377144	0.999999717377143	0.849094611976438
down	BMP4; EFNA1; PTCRA;	GO:0070244~negative regulation of thymocyte apoptotic process	3	7	42.8571428571429	0.0118985908430524	0.0923860967433057	1	1	0.999999717377144	0.999999717377143	0.849094611976438
down	CAPN1; ADGRV1; LGMN;	GO:0097264~self proteolysis	3	7	42.8571428571429	0.0118985908430524	0.0923860967433057	1	1	0.999999717377144	0.999999717377143	0.849094611976438
down	NUPR1; MMP8; IL18;	GO:0150078~positive regulation of neuroinflammatory response	3	7	42.8571428571429	0.0118985908430524	0.0923860967433057	1	1	0.999999717377144	0.999999717377143	0.849094611976438
down	ANXA8; SPINK5; ANXA8L1;	GO:1900004~negative regulation of serine-type endopeptidase activity	3	7	42.8571428571429	0.0118985908430524	0.0923860967433057	1	1	0.999999717377144	0.999999717377143	0.849094611976438
down	DMD; CACNB2; CACNB3;	GO:1901385~regulation of voltage-gated calcium channel activity	3	7	42.8571428571429	0.0118985908430524	0.0923860967433057	1	1	0.999999717377144	0.999999717377143	0.849094611976438
down	CFH; CD59; IL10;	GO:1903659~regulation of complement-dependent cytotoxicity	3	7	42.8571428571429	0.0118985908430524	0.0923860967433057	1	1	0.999999717377144	0.999999717377143	0.849094611976438
down	BHLHE40; CDK1; TOP2A; PPARG; MAPK10; PRKAA2; EZH2; PROX1; PPARGC1A;	GO:0042752~regulation of circadian rhythm	9	65	13.8461538461538	0.0122837735707525	0.0948159712785526	1	1	0.999999717377144	0.999999717377143	0.871426904912132
down	GLI3; VEGFA; CX3CL1; SMO; DCT;	GO:0002052~positive regulation of neuroblast proliferation	5	23	21.7391304347826	0.0122976573102428	0.0948159712785526	1	1	0.999999717377144	0.999999717377143	0.871426904912132
down	OBSL1; CDC25C; CAV2; NEK2; PKMYT1;	GO:0007088~regulation of mitotic nuclear division	5	23	21.7391304347826	0.0122976573102428	0.0948159712785526	1	1	0.999999717377144	0.999999717377143	0.871426904912132
down	ENTPD5; EGFR; CEACAM1; PTPN13; CEP55;	GO:0014066~regulation of phosphatidylinositol 3-kinase signaling	5	23	21.7391304347826	0.0122976573102428	0.0948159712785526	1	1	0.999999717377144	0.999999717377143	0.871426904912132
down	IL2RA; IGFBP2; CD24; IL18; HHLA2;	GO:0042104~positive regulation of activated T cell proliferation	5	23	21.7391304347826	0.0122976573102428	0.0948159712785526	1	1	0.999999717377144	0.999999717377143	0.871426904912132
down	WNT10B; RAPGEF3; CRHBP; IGFBP5; CPS1; KCNQ1; STC1; HCN3;	GO:0071320~cellular response to cAMP	8	54	14.8148148148148	0.0126721586667793	0.0974304936600838	1	1	0.999999717377144	0.999999717377143	0.895456244231642
down	DDX11L8; TK1; CRMP1; SLC29A2; PRPSAP1; REXO2;	GO:0006139~nucleobase-containing compound metabolic process	6	33	18.1818181818182	0.0130049023649016	0.0994333159983101	1	1	0.999999717377144	0.999999717377143	0.913863620623558
down	TBX3; TFAP2A; MSX1; CRABP2; OSR1; TP63;	GO:0035115~embryonic forelimb morphogenesis	6	33	18.1818181818182	0.0130049023649016	0.0994333159983101	1	1	0.999999717377144	0.999999717377143	0.913863620623558
down	EYA2; BAG3; KITLG; ERBB3; BCL2L10; BOK;	GO:0097192~extrinsic apoptotic signaling pathway in absence of ligand	6	33	18.1818181818182	0.0130049023649016	0.0994333159983101	1	1	0.999999717377144	0.999999717377143	0.913863620623558
up	CXCL11; TNFSF13; S100A6; S100A11; SNX27; PI4KB; PYCARD;	GO:0007165~signal transduction	7	989	0.70778564206269	0.0134798921525514	0.0565932662272406	1	1	0.634959996521311	0.764540252498336	0.385325498839748
down	BMP4; JAG1; HEYL; ROBO1;	GO:0003184~pulmonary valve morphogenesis	4	15	26.6666666666667	0.0137984345564939	0.101222452073476	1	1	0.999999717377144	0.999999717377143	0.930307066716283
down	RAD51; RECQL5; RECQL4; MCM4;	GO:0006268~DNA unwinding involved in DNA replication	4	15	26.6666666666667	0.0137984345564939	0.101222452073476	1	1	0.999999717377144	0.999999717377143	0.930307066716283
down	DLL1; LAMB2; ROR1; LAMC3;	GO:0014002~astrocyte development	4	15	26.6666666666667	0.0137984345564939	0.101222452073476	1	1	0.999999717377144	0.999999717377143	0.930307066716283
down	DBH; CRHBP; USP46; UNC79;	GO:0048149~behavioral response to ethanol	4	15	26.6666666666667	0.0137984345564939	0.101222452073476	1	1	0.999999717377144	0.999999717377143	0.930307066716283
down	MEIS1; TP73; GJA1; CXADR;	GO:0060044~negative regulation of cardiac muscle cell proliferation	4	15	26.6666666666667	0.0137984345564939	0.101222452073476	1	1	0.999999717377144	0.999999717377143	0.930307066716283
down	TGFB3; BMP4; RBPMS; NODAL;	GO:0060391~positive regulation of SMAD protein signal transduction	4	15	26.6666666666667	0.0137984345564939	0.101222452073476	1	1	0.999999717377144	0.999999717377143	0.930307066716283
down	TUSC3; NIPAL1; ZDHHC13; NIPAL2;	GO:1903830~magnesium ion transmembrane transport	4	15	26.6666666666667	0.0137984345564939	0.101222452073476	1	1	0.999999717377144	0.999999717377143	0.930307066716283
down	PTN; FGFR2; FGFR3; LOX; LGR4; ASPN; SLC24A3;	GO:0030282~bone mineralization	7	44	15.9090909090909	0.0139088022397311	0.101222452073476	1	1	0.999999717377144	0.999999717377143	0.930307066716283
down	PF4; IL10; CXCR5; CNR2; CX3CL1;	GO:0030595~leukocyte chemotaxis	5	24	20.8333333333333	0.0142533163604612	0.101222452073476	1	1	0.999999717377144	0.999999717377143	0.930307066716283
down	CYP2E1; HPGD; ALOX12; EPHX2; ELOVL6;	GO:0042759~long-chain fatty acid biosynthetic process	5	24	20.8333333333333	0.0142533163604612	0.101222452073476	1	1	0.999999717377144	0.999999717377143	0.930307066716283
down	CD24; ID1; ROR1; NTRK1; NTRK2;	GO:0043408~regulation of MAPK cascade	5	24	20.8333333333333	0.0142533163604612	0.101222452073476	1	1	0.999999717377144	0.999999717377143	0.930307066716283
down	WNT10B; KEL; CAV2; DNER; SMO;	GO:0048741~skeletal muscle fiber development	5	24	20.8333333333333	0.0142533163604612	0.101222452073476	1	1	0.999999717377144	0.999999717377143	0.930307066716283
down	FFAR3; LDLR; LPL; CCNB1; NME2;	GO:0071398~cellular response to fatty acid	5	24	20.8333333333333	0.0142533163604612	0.101222452073476	1	1	0.999999717377144	0.999999717377143	0.930307066716283
down	SOX9; SMO; TBX18; TBX3; TBX2; TBX21;	GO:0001708~cell fate specification	6	34	17.6470588235294	0.0146603621043832	0.102940425235496	1	1	0.999999717377144	0.999999717377143	0.946096474503961
down	ADCY6; ADCY5; AVPR2; CYP4F2; AQP3; MYO5B;	GO:0003091~renal water homeostasis	6	34	17.6470588235294	0.0146603621043832	0.102940425235496	1	1	0.999999717377144	0.999999717377143	0.946096474503961
down	SASH1; DKK1; ARHGEF5; TLR9; VANGL2; FZD4;	GO:0043507~positive regulation of JUN kinase activity	6	34	17.6470588235294	0.0146603621043832	0.102940425235496	1	1	0.999999717377144	0.999999717377143	0.946096474503961
down	TULP1; DLL1; SOX9; CLCN2; LAMB2; SOX8; LAMC3; PDE6A;	GO:0060041~retina development in camera-type eye	8	56	14.2857142857143	0.0151877817101195	0.10613446012726	1	1	0.999999717377144	0.999999717377143	0.975451950194165
down	CCL2; CCNB1; IGFBP5; KLF5; IL18; PLA2G4F; P2RY13;	GO:0071407~cellular response to organic cyclic compound	7	45	15.5555555555556	0.0153886859077452	0.10613446012726	1	1	0.999999717377144	0.999999717377143	0.975451950194165
down	RECQL4; SMARCA1; RAD54L;	GO:0000733~DNA strand renaturation	3	8	37.5	0.0157514721024471	0.10613446012726	1	1	0.999999717377144	0.999999717377143	0.975451950194165
down	FUT1; FUT2; ANGPT1;	GO:0001936~regulation of endothelial cell proliferation	3	8	37.5	0.0157514721024471	0.10613446012726	1	1	0.999999717377144	0.999999717377143	0.975451950194165
down	IL10; CD24; TLR9;	GO:0002237~response to molecule of bacterial origin	3	8	37.5	0.0157514721024471	0.10613446012726	1	1	0.999999717377144	0.999999717377143	0.975451950194165
down	FGFR2; FGFR3; ECM1;	GO:0003416~endochondral bone growth	3	8	37.5	0.0157514721024471	0.10613446012726	1	1	0.999999717377144	0.999999717377143	0.975451950194165
down	TNNI1; MYBPH; MYBPC3;	GO:0006942~regulation of striated muscle contraction	3	8	37.5	0.0157514721024471	0.10613446012726	1	1	0.999999717377144	0.999999717377143	0.975451950194165
down	SPINK5; OVOL1; OVOL2;	GO:0009913~epidermal cell differentiation	3	8	37.5	0.0157514721024471	0.10613446012726	1	1	0.999999717377144	0.999999717377143	0.975451950194165
down	ADRA2A; P2RY1; P2RY12;	GO:0010700~negative regulation of norepinephrine secretion	3	8	37.5	0.0157514721024471	0.10613446012726	1	1	0.999999717377144	0.999999717377143	0.975451950194165
down	YAP1; PRKD1; OVOL2;	GO:0010837~regulation of keratinocyte proliferation	3	8	37.5	0.0157514721024471	0.10613446012726	1	1	0.999999717377144	0.999999717377143	0.975451950194165
down	GJB6; GJA1; GJB2;	GO:0016264~gap junction assembly	3	8	37.5	0.0157514721024471	0.10613446012726	1	1	0.999999717377144	0.999999717377143	0.975451950194165
down	TPPP; GPC1; PMP22;	GO:0032288~myelin assembly	3	8	37.5	0.0157514721024471	0.10613446012726	1	1	0.999999717377144	0.999999717377143	0.975451950194165
down	IL18RAP; IL18; LILRA2;	GO:0032635~interleukin-6 production	3	8	37.5	0.0157514721024471	0.10613446012726	1	1	0.999999717377144	0.999999717377143	0.975451950194165
down	PLPP3; TJP2; XG;	GO:0034109~homotypic cell-cell adhesion	3	8	37.5	0.0157514721024471	0.10613446012726	1	1	0.999999717377144	0.999999717377143	0.975451950194165
down	CTNND1; MET; CDH1;	GO:0035635~entry of bacterium into host cell	3	8	37.5	0.0157514721024471	0.10613446012726	1	1	0.999999717377144	0.999999717377143	0.975451950194165
down	PLEKHG5; VEGFA; RAB13;	GO:0035767~endothelial cell chemotaxis	3	8	37.5	0.0157514721024471	0.10613446012726	1	1	0.999999717377144	0.999999717377143	0.975451950194165
down	CFAP69; GJB4; SHANK1;	GO:0042048~olfactory behavior	3	8	37.5	0.0157514721024471	0.10613446012726	1	1	0.999999717377144	0.999999717377143	0.975451950194165
down	EGFR; NHLH2; TYRO3;	GO:0042698~ovulation cycle	3	8	37.5	0.0157514721024471	0.10613446012726	1	1	0.999999717377144	0.999999717377143	0.975451950194165
down	NGFR; SOX2; TP63;	GO:0043281~regulation of cysteine-type endopeptidase activity involved in apoptotic process	3	8	37.5	0.0157514721024471	0.10613446012726	1	1	0.999999717377144	0.999999717377143	0.975451950194165
down	APOE; PC; CAV2;	GO:0044794~positive regulation by host of viral process	3	8	37.5	0.0157514721024471	0.10613446012726	1	1	0.999999717377144	0.999999717377143	0.975451950194165
down	TLR9; TLR8; TLR7;	GO:0045359~positive regulation of interferon-beta biosynthetic process	3	8	37.5	0.0157514721024471	0.10613446012726	1	1	0.999999717377144	0.999999717377143	0.975451950194165
down	DLG2; MAGI3; TJP2;	GO:0046710~GDP metabolic process	3	8	37.5	0.0157514721024471	0.10613446012726	1	1	0.999999717377144	0.999999717377143	0.975451950194165
down	SCNN1A; SCNN1B; TRPV4;	GO:0050891~multicellular organismal water homeostasis	3	8	37.5	0.0157514721024471	0.10613446012726	1	1	0.999999717377144	0.999999717377143	0.975451950194165
down	DLL1; LRP5; PROX1;	GO:0060042~retina morphogenesis in camera-type eye	3	8	37.5	0.0157514721024471	0.10613446012726	1	1	0.999999717377144	0.999999717377143	0.975451950194165
down	TERT; PTN; HES1;	GO:0060253~negative regulation of glial cell proliferation	3	8	37.5	0.0157514721024471	0.10613446012726	1	1	0.999999717377144	0.999999717377143	0.975451950194165
down	MSX1; WNT4; WNT7B;	GO:0061180~mammary gland epithelium development	3	8	37.5	0.0157514721024471	0.10613446012726	1	1	0.999999717377144	0.999999717377143	0.975451950194165
down	BMP4; HES1; ADGRF5;	GO:0061626~pharyngeal arch artery morphogenesis	3	8	37.5	0.0157514721024471	0.10613446012726	1	1	0.999999717377144	0.999999717377143	0.975451950194165
down	RAB3B; PLD1; RAPGEF4;	GO:0098693~regulation of synaptic vesicle cycle	3	8	37.5	0.0157514721024471	0.10613446012726	1	1	0.999999717377144	0.999999717377143	0.975451950194165
down	WNT5A; FZD4; GRIP1;	GO:0150012~positive regulation of neuron projection arborization	3	8	37.5	0.0157514721024471	0.10613446012726	1	1	0.999999717377144	0.999999717377143	0.975451950194165
down	FOXE1; CEP55; TP63;	GO:1904888~cranial skeletal system development	3	8	37.5	0.0157514721024471	0.10613446012726	1	1	0.999999717377144	0.999999717377143	0.975451950194165
down	DMD; CNKSR3; WNK4;	GO:2000651~positive regulation of sodium ion transmembrane transporter activity	3	8	37.5	0.0157514721024471	0.10613446012726	1	1	0.999999717377144	0.999999717377143	0.975451950194165
up	VAMP5; KRTDAP; ODF3; TDRKH; SPDEF;	GO:0030154~cell differentiation	5	572	0.874125874125874	0.0157759444935939	0.0593518201724509	1	1	0.678206470643355	0.764540252498336	0.404107612788543
down	IL2RA; IL5RA; IL20RB; IL36A; IL1RN;	GO:0002437~inflammatory response to antigenic stimulus	5	25	20	0.0164071392187342	0.109130853988348	1	1	0.999999717377144	0.999999717377143	1
down	PIGZ; PIGO; TMEM246; PIGW; CWH43;	GO:0006506~GPI anchor biosynthetic process	5	25	20	0.0164071392187342	0.109130853988348	1	1	0.999999717377144	0.999999717377143	1
down	CYP2E1; CYP2A6; CYP4F2; FMO1; FMO2;	GO:0017144~drug metabolic process	5	25	20	0.0164071392187342	0.109130853988348	1	1	0.999999717377144	0.999999717377143	1
down	CD40LG; TIGIT; IL20RB; TSLP; TLR9;	GO:0032733~positive regulation of interleukin-10 production	5	25	20	0.0164071392187342	0.109130853988348	1	1	0.999999717377144	0.999999717377143	1
down	CYP2A6; CYP4B1; NOS1; CYP2J2; CYP2E1;	GO:0042738~exogenous drug catabolic process	5	25	20	0.0164071392187342	0.109130853988348	1	1	0.999999717377144	0.999999717377143	1
down	TERT; MT-CYB; CDK1; KIT; HAAO;	GO:0046686~response to cadmium ion	5	25	20	0.0164071392187342	0.109130853988348	1	1	0.999999717377144	0.999999717377143	1
down	TNNI1; FGFR2; MYBPC3; PROX1; PKP2;	GO:0055010~ventricular cardiac muscle tissue morphogenesis	5	25	20	0.0164071392187342	0.109130853988348	1	1	0.999999717377144	0.999999717377143	1
down	CDK1; CCNB1; FGFR2; YAP1; TBX2;	GO:0060045~positive regulation of cardiac muscle cell proliferation	5	25	20	0.0164071392187342	0.109130853988348	1	1	0.999999717377144	0.999999717377143	1
down	HRH2; RAB25; DACT2; GRHL2;	GO:0003382~epithelial cell morphogenesis	4	16	25	0.0165696223352094	0.109130853988348	1	1	0.999999717377144	0.999999717377143	1
down	MT1X; MT1E; MT1H; MT1G;	GO:0010273~detoxification of copper ion	4	16	25	0.0165696223352094	0.109130853988348	1	1	0.999999717377144	0.999999717377143	1
down	PI15; CSTA; CSTB; ECM1;	GO:0010466~negative regulation of peptidase activity	4	16	25	0.0165696223352094	0.109130853988348	1	1	0.999999717377144	0.999999717377143	1
down	CCL21; WNT5A; CCR2; XCL2;	GO:0010820~positive regulation of T cell chemotaxis	4	16	25	0.0165696223352094	0.109130853988348	1	1	0.999999717377144	0.999999717377143	1
down	GREM1; GATA1; SOX9; ECM1;	GO:0030502~negative regulation of bone mineralization	4	16	25	0.0165696223352094	0.109130853988348	1	1	0.999999717377144	0.999999717377143	1
down	VIL1; IL10; BCAR1; LGMN;	GO:0035729~cellular response to hepatocyte growth factor stimulus	4	16	25	0.0165696223352094	0.109130853988348	1	1	0.999999717377144	0.999999717377143	1
down	DLL1; FOXA1; EYA1; ISL2;	GO:0048665~neuron fate specification	4	16	25	0.0165696223352094	0.109130853988348	1	1	0.999999717377144	0.999999717377143	1
down	GJA1; WNT4; CD109; WFDC1;	GO:0061045~negative regulation of wound healing	4	16	25	0.0165696223352094	0.109130853988348	1	1	0.999999717377144	0.999999717377143	1
down	ADCY5; EFNA5; CDK16; LRP5;	GO:0061178~regulation of insulin secretion involved in cellular response to glucose stimulus	4	16	25	0.0165696223352094	0.109130853988348	1	1	0.999999717377144	0.999999717377143	1
down	ADCY6; PPARG; PRKAA2; SFRP1;	GO:0071380~cellular response to prostaglandin E stimulus	4	16	25	0.0165696223352094	0.109130853988348	1	1	0.999999717377144	0.999999717377143	1
down	MT-CYB; EGFR; SDC1; CCND1; SLC6A1; AQP3; S100A16; TRPV6;	GO:0051592~response to calcium ion	8	57	14.0350877192982	0.0165728236029534	0.109130853988348	1	1	0.999999717377144	0.999999717377143	1
down	FOXP2; WDR62; SLC2A1; MDK; NTRK2; SMO; GNG12; LRP6; TACC2;	GO:0021987~cerebral cortex development	9	69	13.0434782608696	0.0169553677381613	0.111260019281328	1	1	0.999999717377144	0.999999717377143	1
down	KALRN; PRL; VEGFA; PRLR; CCND1; XDH; DDR1;	GO:0007595~lactation	7	46	15.2173913043478	0.0169770056669056	0.111260019281328	1	1	0.999999717377144	0.999999717377143	1
down	VEGFD; MET; BMP4; VEGFA; CX3CL1; SEMA5A; ANGPT1;	GO:0050918~positive chemotaxis	7	46	15.2173913043478	0.0169770056669056	0.111260019281328	1	1	0.999999717377144	0.999999717377143	1
down	ATP1B1; DMD; KCNQ1; SCN5A; MYBPC3; PPP1R13L; TNNI1;	GO:0060048~cardiac muscle contraction	7	46	15.2173913043478	0.0169770056669056	0.111260019281328	1	1	0.999999717377144	0.999999717377143	1
down	LPL; PPARG; HSPA2; LRP11; ACOT11; PPARGC1A;	GO:0009409~response to cold	6	36	16.6666666666667	0.0183989331110849	0.120007259213889	1	1	0.999999717377144	0.999999717377143	1
down	FLRT2; NRP2; EFNA5; FLRT3; SEMA3F; SEMA6D;	GO:0050919~negative chemotaxis	6	36	16.6666666666667	0.0183989331110849	0.120007259213889	1	1	0.999999717377144	0.999999717377143	1
down	LRP5; LRP6; GJA1; BMP7; GNAI1; HHEX; ANXA1;	GO:0043434~response to peptide hormone	7	47	14.8936170212766	0.018677520549761	0.121398638158655	1	1	0.999999717377144	0.999999717377143	1
down	PLCH2; INPP1; PLCB4; INPP5J; PPIP5K1; ITPKC; IPPK;	GO:0043647~inositol phosphate metabolic process	7	47	14.8936170212766	0.018677520549761	0.121398638158655	1	1	0.999999717377144	0.999999717377143	1
down	GJB3; GJB5; TRIP10; KREMEN1; GJA3;	GO:0007154~cell communication	5	26	19.2307692307692	0.018766619631792	0.121398638158655	1	1	0.999999717377144	0.999999717377143	1
down	IFNG; CD40LG; IRF8; SCIMP; TLR9;	GO:0032735~positive regulation of interleukin-12 production	5	26	19.2307692307692	0.018766619631792	0.121398638158655	1	1	0.999999717377144	0.999999717377143	1
down	BAG3; TM7SF3; HSPB8; HSPA2; HSPA1B;	GO:0034620~cellular response to unfolded protein	5	26	19.2307692307692	0.018766619631792	0.121398638158655	1	1	0.999999717377144	0.999999717377143	1
down	ADCY6; ADCY5; GJB2; CPS1; GLP1R;	GO:0071377~cellular response to glucagon stimulus	5	26	19.2307692307692	0.018766619631792	0.121398638158655	1	1	0.999999717377144	0.999999717377143	1
down	RGS4; CACNB3; BAIAP2; SHANK1; SHANK2;	GO:2000463~positive regulation of excitatory postsynaptic potential	5	26	19.2307692307692	0.018766619631792	0.121398638158655	1	1	0.999999717377144	0.999999717377143	1
down	DLL1; LEFTY1; GAS8; PCSK6; FOXJ1; DISP1; PITX2; DNAI2;	GO:0007368~determination of left/right symmetry	8	59	13.5593220338983	0.0196117622524793	0.124106687490102	1	1	0.999999717377144	0.999999717377143	1
down	TRPM2; TK1; SHMT1; ALDH9A1; CBR4; TRPV5; UPB1; PFKP;	GO:0051289~protein homotetramerization	8	59	13.5593220338983	0.0196117622524793	0.124106687490102	1	1	0.999999717377144	0.999999717377143	1
down	TF; BMP4; BMP7; ATOH8; NODAL; TGFB3; LEFTY1; BMP3;	GO:0060395~SMAD protein signal transduction	8	59	13.5593220338983	0.0196117622524793	0.124106687490102	1	1	0.999999717377144	0.999999717377143	1
down	FCGR2B; P2RY1; PCSK9; MUC4;	GO:0010469~regulation of signaling receptor activity	4	17	23.5294117647059	0.0196649168321801	0.124106687490102	1	1	0.999999717377144	0.999999717377143	1
down	ALOX15B; PF4; LPL; IL18;	GO:0010744~positive regulation of macrophage derived foam cell differentiation	4	17	23.5294117647059	0.0196649168321801	0.124106687490102	1	1	0.999999717377144	0.999999717377143	1
down	APOE; CETP; PLTP; LIPG;	GO:0034375~high-density lipoprotein particle remodeling	4	17	23.5294117647059	0.0196649168321801	0.124106687490102	1	1	0.999999717377144	0.999999717377143	1
down	CD109; AQP3; GRHL1; SERPINB13;	GO:0045616~regulation of keratinocyte differentiation	4	17	23.5294117647059	0.0196649168321801	0.124106687490102	1	1	0.999999717377144	0.999999717377143	1
down	EGFR; IFNG; C1QA; SMO;	GO:0048143~astrocyte activation	4	17	23.5294117647059	0.0196649168321801	0.124106687490102	1	1	0.999999717377144	0.999999717377143	1
down	GATA1; SLC11A2; NCKAP1L; ADGRF5;	GO:0048821~erythrocyte development	4	17	23.5294117647059	0.0196649168321801	0.124106687490102	1	1	0.999999717377144	0.999999717377143	1
down	THY1; CCL2; CCR2; SIRPG;	GO:0050870~positive regulation of T cell activation	4	17	23.5294117647059	0.0196649168321801	0.124106687490102	1	1	0.999999717377144	0.999999717377143	1
down	CCL21; AIF1; P2RY12; CCL26;	GO:0050921~positive regulation of chemotaxis	4	17	23.5294117647059	0.0196649168321801	0.124106687490102	1	1	0.999999717377144	0.999999717377143	1
down	STXBP1; SORCS2; PLK2; SHANK2;	GO:0060292~long-term synaptic depression	4	17	23.5294117647059	0.0196649168321801	0.124106687490102	1	1	0.999999717377144	0.999999717377143	1
down	BMP4; MDK; WNT5A; SOX9;	GO:0061036~positive regulation of cartilage development	4	17	23.5294117647059	0.0196649168321801	0.124106687490102	1	1	0.999999717377144	0.999999717377143	1
down	LDLR; CD9; PPARG; SREBF2;	GO:0071404~cellular response to low-density lipoprotein particle stimulus	4	17	23.5294117647059	0.0196649168321801	0.124106687490102	1	1	0.999999717377144	0.999999717377143	1
down	SNAI2; CEACAM6; PTK2; NTRK2;	GO:2000811~negative regulation of anoikis	4	17	23.5294117647059	0.0196649168321801	0.124106687490102	1	1	0.999999717377144	0.999999717377143	1
down	GRHL2; HEYL; DLL4;	GO:0003208~cardiac ventricle morphogenesis	3	9	33.3333333333333	0.0202222885883054	0.124106687490102	1	1	0.999999717377144	0.999999717377143	1
down	SFN; KDF1; EXPH5;	GO:0003334~keratinocyte development	3	9	33.3333333333333	0.0202222885883054	0.124106687490102	1	1	0.999999717377144	0.999999717377143	1
down	HAAO; IDO2; AADAT;	GO:0006569~tryptophan catabolic process	3	9	33.3333333333333	0.0202222885883054	0.124106687490102	1	1	0.999999717377144	0.999999717377143	1
down	CYP2J2; CYP4F2; CYP4F22;	GO:0006690~icosanoid metabolic process	3	9	33.3333333333333	0.0202222885883054	0.124106687490102	1	1	0.999999717377144	0.999999717377143	1
down	VWF; AVPR2; P2RY12;	GO:0007599~hemostasis	3	9	33.3333333333333	0.0202222885883054	0.124106687490102	1	1	0.999999717377144	0.999999717377143	1
down	NME2; AK4; AK7;	GO:0009142~nucleoside triphosphate biosynthetic process	3	9	33.3333333333333	0.0202222885883054	0.124106687490102	1	1	0.999999717377144	0.999999717377143	1
down	PLK1; CDC6; UBE2C;	GO:0030071~regulation of mitotic metaphase/anaphase transition	3	9	33.3333333333333	0.0202222885883054	0.124106687490102	1	1	0.999999717377144	0.999999717377143	1
down	VIL1; DSTN; SEMA5A;	GO:0030836~positive regulation of actin filament depolymerization	3	9	33.3333333333333	0.0202222885883054	0.124106687490102	1	1	0.999999717377144	0.999999717377143	1
down	CSF3; SPI1; CEBPE;	GO:0030851~granulocyte differentiation	3	9	33.3333333333333	0.0202222885883054	0.124106687490102	1	1	0.999999717377144	0.999999717377143	1
down	COBL; YAP1; SOX9;	GO:0030903~notochord development	3	9	33.3333333333333	0.0202222885883054	0.124106687490102	1	1	0.999999717377144	0.999999717377143	1
down	WWTR1; HEYL; VANGL2;	GO:0032835~glomerulus development	3	9	33.3333333333333	0.0202222885883054	0.124106687490102	1	1	0.999999717377144	0.999999717377143	1
down	PLXNB1; GREM1; SFRP1;	GO:0033689~negative regulation of osteoblast proliferation	3	9	33.3333333333333	0.0202222885883054	0.124106687490102	1	1	0.999999717377144	0.999999717377143	1
down	APOE; LPL; CETP;	GO:0034372~very-low-density lipoprotein particle remodeling	3	9	33.3333333333333	0.0202222885883054	0.124106687490102	1	1	0.999999717377144	0.999999717377143	1
down	WWC1; DLG5; AJUBA;	GO:0035331~negative regulation of hippo signaling	3	9	33.3333333333333	0.0202222885883054	0.124106687490102	1	1	0.999999717377144	0.999999717377143	1
down	LRP5; NODAL; MIXL1;	GO:0042074~cell migration involved in gastrulation	3	9	33.3333333333333	0.0202222885883054	0.124106687490102	1	1	0.999999717377144	0.999999717377143	1
down	BPI; FCGR2B; ADGRF5;	GO:0043031~negative regulation of macrophage activation	3	9	33.3333333333333	0.0202222885883054	0.124106687490102	1	1	0.999999717377144	0.999999717377143	1
down	VEGFA; ADGRF5; EPAS1;	GO:0043129~surfactant homeostasis	3	9	33.3333333333333	0.0202222885883054	0.124106687490102	1	1	0.999999717377144	0.999999717377143	1
down	AKR1C2; AKR1C1; CBR4;	GO:0044597~daunorubicin metabolic process	3	9	33.3333333333333	0.0202222885883054	0.124106687490102	1	1	0.999999717377144	0.999999717377143	1
down	AKR1C2; AKR1C1; CBR4;	GO:0044598~doxorubicin metabolic process	3	9	33.3333333333333	0.0202222885883054	0.124106687490102	1	1	0.999999717377144	0.999999717377143	1
down	SLC6A4; PTK2; WWC1;	GO:0046621~negative regulation of organ growth	3	9	33.3333333333333	0.0202222885883054	0.124106687490102	1	1	0.999999717377144	0.999999717377143	1
down	RARB; RARG; EFEMP1;	GO:0048048~embryonic eye morphogenesis	3	9	33.3333333333333	0.0202222885883054	0.124106687490102	1	1	0.999999717377144	0.999999717377143	1
down	TULP3; GLI3; TGFB3;	GO:0048702~embryonic neurocranium morphogenesis	3	9	33.3333333333333	0.0202222885883054	0.124106687490102	1	1	0.999999717377144	0.999999717377143	1
down	IGHD; ORM1; ORM2;	GO:0050716~positive regulation of interleukin-1 secretion	3	9	33.3333333333333	0.0202222885883054	0.124106687490102	1	1	0.999999717377144	0.999999717377143	1
down	DLL1; EFHC1; KIF18B;	GO:0051302~regulation of cell division	3	9	33.3333333333333	0.0202222885883054	0.124106687490102	1	1	0.999999717377144	0.999999717377143	1
down	BUB1; AURKB; KIF2C;	GO:0051983~regulation of chromosome segregation	3	9	33.3333333333333	0.0202222885883054	0.124106687490102	1	1	0.999999717377144	0.999999717377143	1
down	GCNT3; WWTR1; VANGL2;	GO:0060993~kidney morphogenesis	3	9	33.3333333333333	0.0202222885883054	0.124106687490102	1	1	0.999999717377144	0.999999717377143	1
down	LAMB4; LAMB2; LAMB3;	GO:0070831~basement membrane assembly	3	9	33.3333333333333	0.0202222885883054	0.124106687490102	1	1	0.999999717377144	0.999999717377143	1
down	GJA1; KCNQ1; SCN5A;	GO:0086014~atrial cardiac muscle cell action potential	3	9	33.3333333333333	0.0202222885883054	0.124106687490102	1	1	0.999999717377144	0.999999717377143	1
down	HPN; PTN; MDK;	GO:2000347~positive regulation of hepatocyte proliferation	3	9	33.3333333333333	0.0202222885883054	0.124106687490102	1	1	0.999999717377144	0.999999717377143	1
down	GREM1; EFNB2; MYOCD;	GO:2000727~positive regulation of cardiac muscle cell differentiation	3	9	33.3333333333333	0.0202222885883054	0.124106687490102	1	1	0.999999717377144	0.999999717377143	1
down	CLIC3; ANO1; WNK4; TTYH1; NMUR1; CLCN2;	GO:0006821~chloride transport	6	37	16.2162162162162	0.0204921994844172	0.125346146721129	1	1	0.999999717377144	0.999999717377143	1
down	CHL1; KALRN; SNCG; CSTB; OPRD1; SEZ6L; SLITRK6;	GO:0008344~adult locomotory behavior	7	48	14.5833333333333	0.0204938602851302	0.125346146721129	1	1	0.999999717377144	0.999999717377143	1
down	RHOD; ERBB2; VEGFA; MDK; FUT7; ANGPT1; TNFSF18;	GO:0045785~positive regulation of cell adhesion	7	48	14.5833333333333	0.0204938602851302	0.125346146721129	1	1	0.999999717377144	0.999999717377143	1
up	CTSV; TSPAN8; ODF3; TDRKH;	GO:0007283~spermatogenesis	4	407	0.982800982800983	0.0205975175770765	0.0634153874494234	1	1	0.72636215375331	0.764540252498336	0.431775146268253
down	LRP6; THY1; HSPB1; CEACAM1; EPHA1; SFN; DEPTOR; DBNDD2; WWTR1;	GO:0006469~negative regulation of protein kinase activity	9	72	12.5	0.0212254082263035	0.125346146721129	1	1	0.999999717377144	0.999999717377143	1
down	NTRK1; MS4A1; VCAM1; IL10; CD40LG; FLT3; HHEX; BLNK; KIT;	GO:0030183~B cell differentiation	9	72	12.5	0.0212254082263035	0.125346146721129	1	1	0.999999717377144	0.999999717377143	1
down	IRF6; MID1; IFNG; HLA-DQA2; HLA-DQB2; VCAM1; IRF8; IRF4; FCGR1B;	GO:0060333~interferon-gamma-mediated signaling pathway	9	72	12.5	0.0212254082263035	0.125346146721129	1	1	0.999999717377144	0.999999717377143	1
down	DLL1; GREM1; LRP4; GLI3; TP63;	GO:0009954~proximal/distal pattern formation	5	27	18.5185185185185	0.0213386283212684	0.125346146721129	1	1	0.999999717377144	0.999999717377143	1
down	BMP4; CDH1; MSX1; SOX2; PITX1;	GO:0021983~pituitary gland development	5	27	18.5185185185185	0.0213386283212684	0.125346146721129	1	1	0.999999717377144	0.999999717377143	1
down	CCL2; CPS1; POSTN; SFRP1; DLL4;	GO:0044344~cellular response to fibroblast growth factor stimulus	5	27	18.5185185185185	0.0213386283212684	0.125346146721129	1	1	0.999999717377144	0.999999717377143	1
down	IFNG; IL10; CLEC6A; CLEC9A; CADM1;	GO:0050715~positive regulation of cytokine secretion	5	27	18.5185185185185	0.0213386283212684	0.125346146721129	1	1	0.999999717377144	0.999999717377143	1
down	GJB6; NTRK1; AIF1; CYFIP1; S100A13;	GO:0051602~response to electrical stimulus	5	27	18.5185185185185	0.0213386283212684	0.125346146721129	1	1	0.999999717377144	0.999999717377143	1
down	CDK1; NGFR; PLK1; CARD10; GTSE1;	GO:1900182~positive regulation of protein localization to nucleus	5	27	18.5185185185185	0.0213386283212684	0.125346146721129	1	1	0.999999717377144	0.999999717377143	1
up	CXCL11; S100A9; GJB1;	GO:0007267~cell-cell signaling	3	230	1.30434782608696	0.0213851620108917	0.0654437488044155	1	1	0.731406335376596	0.764540252498336	0.445585611771363
down	MYO1C; PARD3; ZDHHC15; ZDHHC11B; RTP5; ZDHHC9; ZDHHC19;	GO:0006612~protein targeting to membrane	7	49	14.2857142857143	0.0224295130630151	0.125346146721129	1	1	0.999999717377144	0.999999717377143	1
down	ORM1; BPI; IL10; CX3CL1; ARG2; SLAMF1; CLEC4A;	GO:0032720~negative regulation of tumor necrosis factor production	7	49	14.2857142857143	0.0224295130630151	0.125346146721129	1	1	0.999999717377144	0.999999717377143	1
down	FLRT2; LEFTY1; VEGFA; PTK2; MYBPC3; DLC1;	GO:0003007~heart morphogenesis	6	38	15.7894736842105	0.0227411002842529	0.125346146721129	1	1	0.999999717377144	0.999999717377143	1
down	MAP3K6; TF; CD40LG; WNT5A; WNT7B; MAP3K9;	GO:0007257~activation of JUN kinase activity	6	38	15.7894736842105	0.0227411002842529	0.125346146721129	1	1	0.999999717377144	0.999999717377143	1
down	CIT; GIPC1; CXCR5; AURKB; CDC6; RACGAP1;	GO:0032467~positive regulation of cytokinesis	6	38	15.7894736842105	0.0227411002842529	0.125346146721129	1	1	0.999999717377144	0.999999717377143	1
down	BIRC5; TOP2A; NEK2; SKA3; CENPN; SPAG5; CDT1; NEK11; TTK;	GO:0007059~chromosome segregation	9	73	12.3287671232877	0.0228064637450355	0.125346146721129	1	1	0.999999717377144	0.999999717377143	1
down	MELTF; SLC11A2; TTYH1; SFXN1;	GO:0006826~iron ion transport	4	18	22.2222222222222	0.0230934104782472	0.125346146721129	1	1	0.999999717377144	0.999999717377143	1
down	ATP1B1; C7; TMPRSS3; ATP12A;	GO:0006883~cellular sodium ion homeostasis	4	18	22.2222222222222	0.0230934104782472	0.125346146721129	1	1	0.999999717377144	0.999999717377143	1
down	PPEF2; SPRY2; SPRED2; PARD3;	GO:0010801~negative regulation of peptidyl-threonine phosphorylation	4	18	22.2222222222222	0.0230934104782472	0.125346146721129	1	1	0.999999717377144	0.999999717377143	1
down	POU3F1; NTRK2; ADGRG6; PARD3;	GO:0022011~myelination in peripheral nervous system	4	18	22.2222222222222	0.0230934104782472	0.125346146721129	1	1	0.999999717377144	0.999999717377143	1
down	TUBB4B; IL18; RAET1E; ULBP2;	GO:0042267~natural killer cell mediated cytotoxicity	4	18	22.2222222222222	0.0230934104782472	0.125346146721129	1	1	0.999999717377144	0.999999717377143	1
down	PDLIM1; ITGB5; TNFAIP1; SORBS1;	GO:0043149~stress fiber assembly	4	18	22.2222222222222	0.0230934104782472	0.125346146721129	1	1	0.999999717377144	0.999999717377143	1
down	FGD1; FGD5; TTYH1; ARHGEF4;	GO:0046847~filopodium assembly	4	18	22.2222222222222	0.0230934104782472	0.125346146721129	1	1	0.999999717377144	0.999999717377143	1
down	GLI3; FGFR2; RBPMS2; OVOL2;	GO:0048557~embryonic digestive tract morphogenesis	4	18	22.2222222222222	0.0230934104782472	0.125346146721129	1	1	0.999999717377144	0.999999717377143	1
down	GPX3; HBA1; DUOX1; HBZ; HBD;	GO:0042744~hydrogen peroxide catabolic process	5	28	17.8571428571429	0.0241293860832608	0.130483566196808	1	1	0.999999717377144	0.999999717377143	1
down	TRPM2; CCR5; CACNB3; BSPRY; CACNG6; TRPV6; NMUR1; TRPV4; TRPV5;	GO:0006816~calcium ion transport	9	74	12.1621621621622	0.0244698670780388	0.132065312024121	1	1	0.999999717377144	0.999999717377143	1
down	DOC2B; DHCR24; DUOXA1; PHYHIP; CCDC120; WNK4; CCDC68; PARD3; PARD3B;	GO:0008104~protein localization	9	74	12.1621621621622	0.0244698670780388	0.132065312024121	1	1	0.999999717377144	0.999999717377143	1
down	AVPR2; RXFP2; ADRA1D; GNA15; GNAI1; ADRA2A; CYSLTR2; GNA11;	GO:0007188~adenylate cyclase-modulating G protein-coupled receptor signaling pathway	8	62	12.9032258064516	0.024883367409229	0.132853741653747	1	1	0.999999717377144	0.999999717377143	1
down	DLL1; IFNG; OSM; IGFBP2; HMGA2; IGSF11; KCTD11; NDN;	GO:0040008~regulation of growth	8	62	12.9032258064516	0.024883367409229	0.132853741653747	1	1	0.999999717377144	0.999999717377143	1
down	ANXA8; ALS2CL; LAPTM4B; SNX33; HOOK2; ANXA8L1;	GO:0007032~endosome organization	6	39	15.3846153846154	0.0251500012670823	0.132853741653747	1	1	0.999999717377144	0.999999717377143	1
down	GREM1; DKK1; BMP7; PRRX1; SALL4; LRP6;	GO:0030326~embryonic limb morphogenesis	6	39	15.3846153846154	0.0251500012670823	0.132853741653747	1	1	0.999999717377144	0.999999717377143	1
down	APOE; BMP4; BMP7; CD300A; SPRY1; SPRY2;	GO:0043407~negative regulation of MAP kinase activity	6	39	15.3846153846154	0.0251500012670823	0.132853741653747	1	1	0.999999717377144	0.999999717377143	1
down	CDC45; CDC6; CDT1;	GO:0000076~DNA replication checkpoint	3	10	30	0.025315817437744	0.132853741653747	1	1	0.999999717377144	0.999999717377143	1
down	BMP4; FGFR2; VANGL2;	GO:0003149~membranous septum morphogenesis	3	10	30	0.025315817437744	0.132853741653747	1	1	0.999999717377144	0.999999717377143	1
down	NTN1; CTTN; P2RY12;	GO:0006930~substrate-dependent cell migration, cell extension	3	10	30	0.025315817437744	0.132853741653747	1	1	0.999999717377144	0.999999717377143	1
down	TFAP2A; MUC1; HHEX;	GO:0010944~negative regulation of transcription by competitive promoter binding	3	10	30	0.025315817437744	0.132853741653747	1	1	0.999999717377144	0.999999717377143	1
down	STXBP1; UNC13B; ZDHHC15;	GO:0016188~synaptic vesicle maturation	3	10	30	0.025315817437744	0.132853741653747	1	1	0.999999717377144	0.999999717377143	1
down	BMP4; FOXA1; SMO;	GO:0021904~dorsal/ventral neural tube patterning	3	10	30	0.025315817437744	0.132853741653747	1	1	0.999999717377144	0.999999717377143	1
down	LDLR; AKR1C1; NPC1L1;	GO:0030299~intestinal cholesterol absorption	3	10	30	0.025315817437744	0.132853741653747	1	1	0.999999717377144	0.999999717377143	1
down	ADORA2B; RCVRN; NOS1;	GO:0031284~positive regulation of guanylate cyclase activity	3	10	30	0.025315817437744	0.132853741653747	1	1	0.999999717377144	0.999999717377143	1
down	IL18RAP; AVPR2; LILRB1;	GO:0032609~interferon-gamma production	3	10	30	0.025315817437744	0.132853741653747	1	1	0.999999717377144	0.999999717377143	1
down	CCDC120; CCDC68; NINL;	GO:0034454~microtubule anchoring at centrosome	3	10	30	0.025315817437744	0.132853741653747	1	1	0.999999717377144	0.999999717377143	1
down	FGFR3; STC1; HMGA2;	GO:0035988~chondrocyte proliferation	3	10	30	0.025315817437744	0.132853741653747	1	1	0.999999717377144	0.999999717377143	1
down	CEACAM1; CDH13; RHBDF1;	GO:0042058~regulation of epidermal growth factor receptor signaling pathway	3	10	30	0.025315817437744	0.132853741653747	1	1	0.999999717377144	0.999999717377143	1
down	IL27; CD209; TNFSF18;	GO:0042129~regulation of T cell proliferation	3	10	30	0.025315817437744	0.132853741653747	1	1	0.999999717377144	0.999999717377143	1
down	FCRL3; TLR9; SLAMF8;	GO:0045577~regulation of B cell differentiation	3	10	30	0.025315817437744	0.132853741653747	1	1	0.999999717377144	0.999999717377143	1
down	DLG2; MAGI3; TJP2;	GO:0046037~GMP metabolic process	3	10	30	0.025315817437744	0.132853741653747	1	1	0.999999717377144	0.999999717377143	1
down	EGFR; REEP1; RTP5;	GO:0051205~protein insertion into membrane	3	10	30	0.025315817437744	0.132853741653747	1	1	0.999999717377144	0.999999717377143	1
down	DCN; ALOX12; KDR;	GO:0051901~positive regulation of mitochondrial depolarization	3	10	30	0.025315817437744	0.132853741653747	1	1	0.999999717377144	0.999999717377143	1
down	BMP4; BMP7; OSR1;	GO:0060272~embryonic skeletal joint morphogenesis	3	10	30	0.025315817437744	0.132853741653747	1	1	0.999999717377144	0.999999717377143	1
down	SLC1A3; SLC1A1; CXADR;	GO:0070633~transepithelial transport	3	10	30	0.025315817437744	0.132853741653747	1	1	0.999999717377144	0.999999717377143	1
down	BMP4; WNT7B; DLG5;	GO:0072205~metanephric collecting duct development	3	10	30	0.025315817437744	0.132853741653747	1	1	0.999999717377144	0.999999717377143	1
down	HSPA1B; DNAJB1; HSPA2;	GO:0090084~negative regulation of inclusion body assembly	3	10	30	0.025315817437744	0.132853741653747	1	1	0.999999717377144	0.999999717377143	1
down	SPRY2; DCN; XDH;	GO:1900747~negative regulation of vascular endothelial growth factor signaling pathway	3	10	30	0.025315817437744	0.132853741653747	1	1	0.999999717377144	0.999999717377143	1
down	OSR1; DLG2; DLG3; LRRC1;	GO:0009790~embryo development	4	19	21.0526315789474	0.0268624149261022	0.139113447006766	1	1	0.999999717377144	0.999999717377143	1
down	MYO1E; MYH14; MYO6; WIPF3;	GO:0030048~actin filament-based movement	4	19	21.0526315789474	0.0268624149261022	0.139113447006766	1	1	0.999999717377144	0.999999717377143	1
down	VWF; ANGPT1; TTYH1; FAT2;	GO:0031589~cell-substrate adhesion	4	19	21.0526315789474	0.0268624149261022	0.139113447006766	1	1	0.999999717377144	0.999999717377143	1
down	TPPP; S100B; PARD3; ZNF488;	GO:0031643~positive regulation of myelination	4	19	21.0526315789474	0.0268624149261022	0.139113447006766	1	1	0.999999717377144	0.999999717377143	1
down	EPHA2; WNT5A; TP63; VANGL2;	GO:0036342~post-anal tail morphogenesis	4	19	21.0526315789474	0.0268624149261022	0.139113447006766	1	1	0.999999717377144	0.999999717377143	1
down	APOE; NOS1; BDKRB2; CPS1;	GO:0042311~vasodilation	4	19	21.0526315789474	0.0268624149261022	0.139113447006766	1	1	0.999999717377144	0.999999717377143	1
down	IL2RA; MDK; PIK3R6; IL1RL2;	GO:0045582~positive regulation of T cell differentiation	4	19	21.0526315789474	0.0268624149261022	0.139113447006766	1	1	0.999999717377144	0.999999717377143	1
down	LAMA5; CDK1; LAMA1; RACGAP1;	GO:0045995~regulation of embryonic development	4	19	21.0526315789474	0.0268624149261022	0.139113447006766	1	1	0.999999717377144	0.999999717377143	1
down	SNCG; CHRNB4; SYT12; SNCAIP;	GO:0046928~regulation of neurotransmitter secretion	4	19	21.0526315789474	0.0268624149261022	0.139113447006766	1	1	0.999999717377144	0.999999717377143	1
down	BMP4; OLIG2; ZNF521; NOTCH3;	GO:0048663~neuron fate commitment	4	19	21.0526315789474	0.0268624149261022	0.139113447006766	1	1	0.999999717377144	0.999999717377143	1
down	UNC13B; GABRB3; SULF1; SLITRK6;	GO:0060384~innervation	4	19	21.0526315789474	0.0268624149261022	0.139113447006766	1	1	0.999999717377144	0.999999717377143	1
down	ADCY6; NPR1; P2RY2; P2RY1;	GO:0097746~regulation of blood vessel diameter	4	19	21.0526315789474	0.0268624149261022	0.139113447006766	1	1	0.999999717377144	0.999999717377143	1
down	RHOD; TRPM2; RAPGEF3; MDK;	GO:2000249~regulation of actin cytoskeleton reorganization	4	19	21.0526315789474	0.0268624149261022	0.139113447006766	1	1	0.999999717377144	0.999999717377143	1
down	VEGFA; EDNRA; KDR; DLL4; NRARP;	GO:0001569~branching involved in blood vessel morphogenesis	5	29	17.2413793103448	0.0271444427820795	0.139263893304145	1	1	0.999999717377144	0.999999717377143	1
down	SPRY1; GLI3; BMP7; IRX3; EYA1;	GO:0001656~metanephros development	5	29	17.2413793103448	0.0271444427820795	0.139263893304145	1	1	0.999999717377144	0.999999717377143	1
down	B4GALT2; PRELP; FMOD; CHST6; B3GNT3;	GO:0018146~keratan sulfate biosynthetic process	5	29	17.2413793103448	0.0271444427820795	0.139263893304145	1	1	0.999999717377144	0.999999717377143	1
down	P2RX1; MYH14; GPR88; SCN5A; SCN7A;	GO:0019228~neuronal action potential	5	29	17.2413793103448	0.0271444427820795	0.139263893304145	1	1	0.999999717377144	0.999999717377143	1
down	NR2F2; CDKN2B; PLK1; HHEX; MYOCD;	GO:0045736~negative regulation of cyclin-dependent protein serine/threonine kinase activity	5	29	17.2413793103448	0.0271444427820795	0.139263893304145	1	1	0.999999717377144	0.999999717377143	1
down	EGFR; HRAS; CDK1; TNFAIP1; CDT1;	GO:0045740~positive regulation of DNA replication	5	29	17.2413793103448	0.0271444427820795	0.139263893304145	1	1	0.999999717377144	0.999999717377143	1
down	PRL; KIT; IL10; HES1; GHR;	GO:0046427~positive regulation of receptor signaling pathway via JAK-STAT	5	29	17.2413793103448	0.0271444427820795	0.139263893304145	1	1	0.999999717377144	0.999999717377143	1
down	THY1; CD19; BDKRB1; CX3CL1; F2RL3;	GO:0051281~positive regulation of release of sequestered calcium ion into cytosol	5	29	17.2413793103448	0.0271444427820795	0.139263893304145	1	1	0.999999717377144	0.999999717377143	1
down	NRG2; EGFR; ERBB2; ERBB3; BTC;	GO:2000145~regulation of cell motility	5	29	17.2413793103448	0.0271444427820795	0.139263893304145	1	1	0.999999717377144	0.999999717377143	1
down	CAPN1; CRHBP; DLG2; DLG3; PPARGC1A;	GO:2000310~regulation of NMDA receptor activity	5	29	17.2413793103448	0.0271444427820795	0.139263893304145	1	1	0.999999717377144	0.999999717377143	1
down	PRLR; FBLN1; STC1; EMP2; DDR1; FUT7;	GO:0007566~embryo implantation	6	40	15	0.0277229532960084	0.141967309669327	1	1	0.999999717377144	0.999999717377143	1
down	CIT; TNFRSF21; NGFR; ERBB3; TP63; BOK;	GO:0051402~neuron apoptotic process	6	40	15	0.0277229532960084	0.141967309669327	1	1	0.999999717377144	0.999999717377143	1
down	SCNN1B; SLC12A3; SCN7A; SCN5A; SLC10A6; SLC4A11; SLC5A11; SLC38A4; SLC13A4;	GO:0006814~sodium ion transport	9	77	11.6883116883117	0.029973953390535	0.15306735938302	1	1	0.999999717377144	0.999999717377143	1
down	TRIP13; RAD54B; RAD51; MND1; RAD54L;	GO:0007131~reciprocal meiotic recombination	5	30	16.6666666666667	0.0303886619325264	0.153251179737739	1	1	0.999999717377144	0.999999717377143	1
down	PIR; PRSS3; AKR1C2; AKR1C1; PPARGC1A;	GO:0007586~digestion	5	30	16.6666666666667	0.0303886619325264	0.153251179737739	1	1	0.999999717377144	0.999999717377143	1
down	LGI3; RAPGEF4; PCLO; RAB13; RAB3B;	GO:0017157~regulation of exocytosis	5	30	16.6666666666667	0.0303886619325264	0.153251179737739	1	1	0.999999717377144	0.999999717377143	1
down	PCDH17; SPTBN2; RNF180; SHANK2; SHANK1;	GO:0030534~adult behavior	5	30	16.6666666666667	0.0303886619325264	0.153251179737739	1	1	0.999999717377144	0.999999717377143	1
down	THY1; PTN; LRRC1; DLG3; DLG2;	GO:0043113~receptor clustering	5	30	16.6666666666667	0.0303886619325264	0.153251179737739	1	1	0.999999717377144	0.999999717377143	1
down	PTN; MDK; TRIP13; HORMAD1; PAQR5;	GO:0048477~oogenesis	5	30	16.6666666666667	0.0303886619325264	0.153251179737739	1	1	0.999999717377144	0.999999717377143	1
down	KIT; MSX1; HMGA2; OSR1; SOX21;	GO:0048863~stem cell differentiation	5	30	16.6666666666667	0.0303886619325264	0.153251179737739	1	1	0.999999717377144	0.999999717377143	1
down	LRP5; OXCT1; SOX8; AACS; PPARGC1A;	GO:0060612~adipose tissue development	5	30	16.6666666666667	0.0303886619325264	0.153251179737739	1	1	0.999999717377144	0.999999717377143	1
down	PLD2; PLD1; PLA2G4D; GPD1L; LIPH; PLA2G2D;	GO:0006654~phosphatidic acid biosynthetic process	6	41	14.6341463414634	0.0304636786624051	0.153251179737739	1	1	0.999999717377144	0.999999717377143	1
down	NTRK1; NGFR; GJA1; VCAM1; FCGR2B; LGMN;	GO:1904646~cellular response to amyloid-beta	6	41	14.6341463414634	0.0304636786624051	0.153251179737739	1	1	0.999999717377144	0.999999717377143	1
down	NGFR; PPARGC1A; HK3; HK1;	GO:0001678~cellular glucose homeostasis	4	20	20	0.0309774955544111	0.153251179737739	1	1	0.999999717377144	0.999999717377143	1
down	VEGFA; OPRD1; PRKD1; ADGRF1;	GO:0032793~positive regulation of CREB transcription factor activity	4	20	20	0.0309774955544111	0.153251179737739	1	1	0.999999717377144	0.999999717377143	1
down	MSX1; PRRX1; OSR1; EYA1;	GO:0042474~middle ear morphogenesis	4	20	20	0.0309774955544111	0.153251179737739	1	1	0.999999717377144	0.999999717377143	1
down	CRHBP; TMED10; STEAP2; TMEM79;	GO:0045055~regulated exocytosis	4	20	20	0.0309774955544111	0.153251179737739	1	1	0.999999717377144	0.999999717377143	1
down	RAPGEF3; BAG3; SFN; GTSE1;	GO:0046827~positive regulation of protein export from nucleus	4	20	20	0.0309774955544111	0.153251179737739	1	1	0.999999717377144	0.999999717377143	1
down	KCNQ1; SNTA1; SCN5A; KCNE1B;	GO:0060307~regulation of ventricular cardiac muscle cell membrane repolarization	4	20	20	0.0309774955544111	0.153251179737739	1	1	0.999999717377144	0.999999717377143	1
down	DDR1; POSTN; PAK6; FLRT3;	GO:1990138~neuron projection extension	4	20	20	0.0309774955544111	0.153251179737739	1	1	0.999999717377144	0.999999717377143	1
down	BMP4; BMP7; OSR1;	GO:0001823~mesonephros development	3	11	27.2727272727273	0.0310308637683926	0.153251179737739	1	1	0.999999717377144	0.999999717377143	1
down	NR2F2; NODAL; STOX2;	GO:0001893~maternal placenta development	3	11	27.2727272727273	0.0310308637683926	0.153251179737739	1	1	0.999999717377144	0.999999717377143	1
down	SOX9; HMGA2; SFRP1;	GO:0010564~regulation of cell cycle process	3	11	27.2727272727273	0.0310308637683926	0.153251179737739	1	1	0.999999717377144	0.999999717377143	1
down	ERO1A; EGLN3; P4HA2;	GO:0018401~peptidyl-proline hydroxylation to 4-hydroxy-L-proline	3	11	27.2727272727273	0.0310308637683926	0.153251179737739	1	1	0.999999717377144	0.999999717377143	1
down	ITPKC; IPPK; PPIP5K1;	GO:0032958~inositol phosphate biosynthetic process	3	11	27.2727272727273	0.0310308637683926	0.153251179737739	1	1	0.999999717377144	0.999999717377143	1
down	CRHBP; DLG2; PPARGC1A;	GO:0035865~cellular response to potassium ion	3	11	27.2727272727273	0.0310308637683926	0.153251179737739	1	1	0.999999717377144	0.999999717377143	1
down	NOS1; SLC6A4; ALDH9A1;	GO:0042136~neurotransmitter biosynthetic process	3	11	27.2727272727273	0.0310308637683926	0.153251179737739	1	1	0.999999717377144	0.999999717377143	1
down	IRF6; CDH13; SDR16C5;	GO:0043616~keratinocyte proliferation	3	11	27.2727272727273	0.0310308637683926	0.153251179737739	1	1	0.999999717377144	0.999999717377143	1
down	VIL1; LMOD1; SCIN;	GO:0045010~actin nucleation	3	11	27.2727272727273	0.0310308637683926	0.153251179737739	1	1	0.999999717377144	0.999999717377143	1
down	PTN; JAG1; KDR;	GO:0045446~endothelial cell differentiation	3	11	27.2727272727273	0.0310308637683926	0.153251179737739	1	1	0.999999717377144	0.999999717377143	1
down	PLXNA2; FGFR2; SOX9;	GO:0060174~limb bud formation	3	11	27.2727272727273	0.0310308637683926	0.153251179737739	1	1	0.999999717377144	0.999999717377143	1
down	TRPM2; TRPV6; TRPV5;	GO:0098703~calcium ion import across plasma membrane	3	11	27.2727272727273	0.0310308637683926	0.153251179737739	1	1	0.999999717377144	0.999999717377143	1
down	CTNND1; EFNB2; DLG3;	GO:0099072~regulation of postsynaptic membrane neurotransmitter receptor levels	3	11	27.2727272727273	0.0310308637683926	0.153251179737739	1	1	0.999999717377144	0.999999717377143	1
down	WNT5A; FOXA1; TJP1;	GO:2000049~positive regulation of cell-cell adhesion mediated by cadherin	3	11	27.2727272727273	0.0310308637683926	0.153251179737739	1	1	0.999999717377144	0.999999717377143	1
down	ANXA1; CCL2; SSTR3; CNR2; OPRD1; LPAR3; HRH1; HRH2;	GO:0007187~G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger	8	65	12.3076923076923	0.0310717848144952	0.153251179737739	1	1	0.999999717377144	0.999999717377143	1
down	BHLHE40; NGFR; CIART; NPAS2; LGR4; PPARGC1A; PER3; ID1;	GO:0032922~circadian regulation of gene expression	8	65	12.3076923076923	0.0310717848144952	0.153251179737739	1	1	0.999999717377144	0.999999717377143	1
down	GCNT3; GALNT18; GALNT9; B3GALT5; B3GALNT1; B3GNT9; B3GNT3;	GO:0006493~protein O-linked glycosylation	7	53	13.2075471698113	0.0314294415112575	0.153251179737739	1	1	0.999999717377144	0.999999717377143	1
down	EGFR; IFNG; VIL1; EPHA2; EPHA3; ARHGEF16; SORBS1;	GO:1903078~positive regulation of protein localization to plasma membrane	7	53	13.2075471698113	0.0314294415112575	0.153251179737739	1	1	0.999999717377144	0.999999717377143	1
down	ANXA1; WNT5A; CCR2; SLC7A2; NLRP6; DUOXA1; MGLL; LRRC19; IL1RL2;	GO:0050727~regulation of inflammatory response	9	78	11.5384615384615	0.0319862026183467	0.153251179737739	1	1	0.999999717377144	0.999999717377143	1
down	CLDN4; TGFB3; PTN; GJB2; YAP1; DSG2;	GO:0032570~response to progesterone	6	42	14.2857142857143	0.0333755593737513	0.153251179737739	1	1	0.999999717377144	0.999999717377143	1
down	DKK1; ADH7; CLEC12B; PCSK9; PPARGC1A; DKK3;	GO:2000272~negative regulation of signaling receptor activity	6	42	14.2857142857143	0.0333755593737513	0.153251179737739	1	1	0.999999717377144	0.999999717377143	1
down	IFNG; GHR; CCL2; PRLR; CCR2;	GO:0007259~receptor signaling pathway via JAK-STAT	5	31	16.1290322580645	0.0338662105412773	0.154332358468321	1	1	0.999999717377144	0.999999717377143	1
down	GIPC1; S100A2; PRSS3; CDH13; PTK2;	GO:0043542~endothelial cell migration	5	31	16.1290322580645	0.0338662105412773	0.154332358468321	1	1	0.999999717377144	0.999999717377143	1
down	EGFR; CCNB1; CCND1; PROX1; CDC6;	GO:0045737~positive regulation of cyclin-dependent protein serine/threonine kinase activity	5	31	16.1290322580645	0.0338662105412773	0.154332358468321	1	1	0.999999717377144	0.999999717377143	1
up	MMP3; SAA1; RORC;	GO:0019221~cytokine-mediated signaling pathway	3	278	1.07913669064748	0.0344867873077995	0.0797174885305328	1	1	0.764540252498336	0.764540252498336	0.54277095283633
down	NCKAP1L; SPNS2; TNFRSF13B; GAPT;	GO:0001782~B cell homeostasis	4	21	19.047619047619	0.0354425194960215	0.159796125983291	1	1	0.999999717377144	0.999999717377143	1
down	YAP1; SOX9; TP53INP2; WWTR1;	GO:0001894~tissue homeostasis	4	21	19.047619047619	0.0354425194960215	0.159796125983291	1	1	0.999999717377144	0.999999717377143	1
down	SCEL; CAMSAP3; STOX2; RAI2;	GO:0009792~embryo development ending in birth or egg hatching	4	21	19.047619047619	0.0354425194960215	0.159796125983291	1	1	0.999999717377144	0.999999717377143	1
down	SNAI2; EDNRA; SOX9; SOX8;	GO:0014032~neural crest cell development	4	21	19.047619047619	0.0354425194960215	0.159796125983291	1	1	0.999999717377144	0.999999717377143	1
down	GLI3; KIT; OCA2; MREG;	GO:0030318~melanocyte differentiation	4	21	19.047619047619	0.0354425194960215	0.159796125983291	1	1	0.999999717377144	0.999999717377143	1
down	PLA2G4F; PLA2G4D; OSBPL10; PLA2G2D;	GO:0036150~phosphatidylserine acyl-chain remodeling	4	21	19.047619047619	0.0354425194960215	0.159796125983291	1	1	0.999999717377144	0.999999717377143	1
down	TYROBP; IFNG; HSPB1; CCR2;	GO:0042535~positive regulation of tumor necrosis factor biosynthetic process	4	21	19.047619047619	0.0354425194960215	0.159796125983291	1	1	0.999999717377144	0.999999717377143	1
down	APOE; FCGR2B; TREML2; TREML4;	GO:0045088~regulation of innate immune response	4	21	19.047619047619	0.0354425194960215	0.159796125983291	1	1	0.999999717377144	0.999999717377143	1
down	IL18RAP; RAET1E; NECTIN2; CADM1;	GO:0045954~positive regulation of natural killer cell mediated cytotoxicity	4	21	19.047619047619	0.0354425194960215	0.159796125983291	1	1	0.999999717377144	0.999999717377143	1
down	IL10; ETV5; WNT5A; IGSF9;	GO:0050807~regulation of synapse organization	4	21	19.047619047619	0.0354425194960215	0.159796125983291	1	1	0.999999717377144	0.999999717377143	1
down	TERT; APOE; FCER2; NPR3;	GO:0051000~positive regulation of nitric-oxide synthase activity	4	21	19.047619047619	0.0354425194960215	0.159796125983291	1	1	0.999999717377144	0.999999717377143	1
down	HS6ST1; HES1; NSDHL; OVOL2;	GO:0060716~labyrinthine layer blood vessel development	4	21	19.047619047619	0.0354425194960215	0.159796125983291	1	1	0.999999717377144	0.999999717377143	1
down	LRP5; LRP6; HSPB1; SFN;	GO:0071901~negative regulation of protein serine/threonine kinase activity	4	21	19.047619047619	0.0354425194960215	0.159796125983291	1	1	0.999999717377144	0.999999717377143	1
down	PANO1; TERT; GIPC1; LMNA; TF; LSS; PRKD1; RNF128; ADGRV1;	GO:0031647~regulation of protein stability	9	80	11.25	0.0362875270079795	0.163453793727657	1	1	0.999999717377144	0.999999717377143	1
down	MYO1C; RHOD; GIPC1; RASSF9; FUT10; AP1M2;	GO:0006605~protein targeting	6	43	13.953488372093	0.0364616273746707	0.163453793727657	1	1	0.999999717377144	0.999999717377143	1
down	RGS12; TULP3; RGS11; RGS4; GNG4; HOMER2;	GO:0008277~regulation of G protein-coupled receptor signaling pathway	6	43	13.953488372093	0.0364616273746707	0.163453793727657	1	1	0.999999717377144	0.999999717377143	1
down	MMP8; COL15A1; COL19A1; ADAMTS14; MMP28; MMP19;	GO:0030574~collagen catabolic process	6	43	13.953488372093	0.0364616273746707	0.163453793727657	1	1	0.999999717377144	0.999999717377143	1
down	MT-CYB; WNT1; CDK1; CCNA2; FLT3; PPARG;	GO:0031100~animal organ regeneration	6	43	13.953488372093	0.0364616273746707	0.163453793727657	1	1	0.999999717377144	0.999999717377143	1
down	HSPB1; GATA1; METAP1; STXBP1; TYRO3; P2RY12;	GO:0070527~platelet aggregation	6	43	13.953488372093	0.0364616273746707	0.163453793727657	1	1	0.999999717377144	0.999999717377143	1
down	ATP1B1; KCNJ5; ATP12A; SLC12A3; SLC12A8; SLC12A1;	GO:1990573~potassium ion import across plasma membrane	6	43	13.953488372093	0.0364616273746707	0.163453793727657	1	1	0.999999717377144	0.999999717377143	1
down	THY1; DDR1; EMP2;	GO:0001952~regulation of cell-matrix adhesion	3	12	25	0.0373610501976953	0.16349171807497	1	1	0.999999717377144	0.999999717377143	1
down	SLC9A4; SHROOM3; TP63;	GO:0002064~epithelial cell development	3	12	25	0.0373610501976953	0.16349171807497	1	1	0.999999717377144	0.999999717377143	1
down	AK4; SLC25A23; COX7A1;	GO:0002082~regulation of oxidative phosphorylation	3	12	25	0.0373610501976953	0.16349171807497	1	1	0.999999717377144	0.999999717377143	1
down	EDN2; PTN; MDK;	GO:0002690~positive regulation of leukocyte chemotaxis	3	12	25	0.0373610501976953	0.16349171807497	1	1	0.999999717377144	0.999999717377143	1
down	HK1; HK3; PFKP;	GO:0006002~fructose 6-phosphate metabolic process	3	12	25	0.0373610501976953	0.16349171807497	1	1	0.999999717377144	0.999999717377143	1
down	SLC26A4; ATP12A; RHCG;	GO:0006885~regulation of pH	3	12	25	0.0373610501976953	0.16349171807497	1	1	0.999999717377144	0.999999717377143	1
down	ADRA2A; CHRNB4; CNN1;	GO:0006940~regulation of smooth muscle contraction	3	12	25	0.0373610501976953	0.16349171807497	1	1	0.999999717377144	0.999999717377143	1
down	CDK1; CCNB1; PLK1;	GO:0007077~mitotic nuclear envelope disassembly	3	12	25	0.0373610501976953	0.16349171807497	1	1	0.999999717377144	0.999999717377143	1
down	IL10; SLAMF1; TIGIT;	GO:0032695~negative regulation of interleukin-12 production	3	12	25	0.0373610501976953	0.16349171807497	1	1	0.999999717377144	0.999999717377143	1
down	COLEC12; SCARA3; SCIMP;	GO:0034138~toll-like receptor 3 signaling pathway	3	12	25	0.0373610501976953	0.16349171807497	1	1	0.999999717377144	0.999999717377143	1
down	BAIAP2; SHANK1; PCLO;	GO:0035418~protein localization to synapse	3	12	25	0.0373610501976953	0.16349171807497	1	1	0.999999717377144	0.999999717377143	1
down	DIO2; CHST8; DUOX1;	GO:0042446~hormone biosynthetic process	3	12	25	0.0373610501976953	0.16349171807497	1	1	0.999999717377144	0.999999717377143	1
down	KALRN; DBH; AVPR1A;	GO:0042711~maternal behavior	3	12	25	0.0373610501976953	0.16349171807497	1	1	0.999999717377144	0.999999717377143	1
down	MSX1; PLA2R1; SPRED2;	GO:0043517~positive regulation of DNA damage response, signal transduction by p53 class mediator	3	12	25	0.0373610501976953	0.16349171807497	1	1	0.999999717377144	0.999999717377143	1
down	SNAI2; FGFR2; PTK2;	GO:0045667~regulation of osteoblast differentiation	3	12	25	0.0373610501976953	0.16349171807497	1	1	0.999999717377144	0.999999717377143	1
down	BMP4; PTN; WNT5A;	GO:0045778~positive regulation of ossification	3	12	25	0.0373610501976953	0.16349171807497	1	1	0.999999717377144	0.999999717377143	1
down	EDN2; HRH1; NMUR1;	GO:0048016~inositol phosphate-mediated signaling	3	12	25	0.0373610501976953	0.16349171807497	1	1	0.999999717377144	0.999999717377143	1
down	EDNRA; SOX8; PHACTR4;	GO:0048484~enteric nervous system development	3	12	25	0.0373610501976953	0.16349171807497	1	1	0.999999717377144	0.999999717377143	1
down	VEGFA; MYH11; CXADR;	GO:0048739~cardiac muscle fiber development	3	12	25	0.0373610501976953	0.16349171807497	1	1	0.999999717377144	0.999999717377143	1
down	VEGFA; KDR; CDH13;	GO:0050927~positive regulation of positive chemotaxis	3	12	25	0.0373610501976953	0.16349171807497	1	1	0.999999717377144	0.999999717377143	1
down	NFIA; SEZ6L; SHANK1;	GO:0060074~synapse maturation	3	12	25	0.0373610501976953	0.16349171807497	1	1	0.999999717377144	0.999999717377143	1
down	C3; PPARG; NCKAP1L;	GO:0060100~positive regulation of phagocytosis, engulfment	3	12	25	0.0373610501976953	0.16349171807497	1	1	0.999999717377144	0.999999717377143	1
down	NFIB; VEGFA; SMO;	GO:0071679~commissural neuron axon guidance	3	12	25	0.0373610501976953	0.16349171807497	1	1	0.999999717377144	0.999999717377143	1
down	ALOX15B; LPL; AIF1;	GO:0090197~positive regulation of chemokine secretion	3	12	25	0.0373610501976953	0.16349171807497	1	1	0.999999717377144	0.999999717377143	1
down	KCNE1B; KCNJ5; KCNQ1;	GO:0098915~membrane repolarization during ventricular cardiac muscle cell action potential	3	12	25	0.0373610501976953	0.16349171807497	1	1	0.999999717377144	0.999999717377143	1
down	TYROBP; APOE; PTN;	GO:1900272~negative regulation of long-term synaptic potentiation	3	12	25	0.0373610501976953	0.16349171807497	1	1	0.999999717377144	0.999999717377143	1
down	SEMA3F; PLXNA2; PLXNB1;	GO:1902287~semaphorin-plexin signaling pathway involved in axon guidance	3	12	25	0.0373610501976953	0.16349171807497	1	1	0.999999717377144	0.999999717377143	1
down	UBE2C; PLK1; CDC20;	GO:1904668~positive regulation of ubiquitin protein ligase activity	3	12	25	0.0373610501976953	0.16349171807497	1	1	0.999999717377144	0.999999717377143	1
down	PLXNB1; GABRB3; WNT5A;	GO:1904862~inhibitory synapse assembly	3	12	25	0.0373610501976953	0.16349171807497	1	1	0.999999717377144	0.999999717377143	1
down	SPINT2; TACSTD2; FBLN1;	GO:2000146~negative regulation of cell motility	3	12	25	0.0373610501976953	0.16349171807497	1	1	0.999999717377144	0.999999717377143	1
down	DBH; CCR2; JAG1; EPAS1; DLL4;	GO:0001974~blood vessel remodeling	5	32	15.625	0.0375805538673398	0.163931021426074	1	1	0.999999717377144	0.999999717377143	1
down	DNAJB1; ERO1A; HSPA2; DNAJB13; HSPA1B;	GO:0051085~chaperone cofactor-dependent protein refolding	5	32	15.625	0.0375805538673398	0.163931021426074	1	1	0.999999717377144	0.999999717377143	1
down	TPPP; EPHA3; EFNA5; PRKAA2; CAMSAP3;	GO:0070507~regulation of microtubule cytoskeleton organization	5	32	15.625	0.0375805538673398	0.163931021426074	1	1	0.999999717377144	0.999999717377143	1
down	CCNA2; GABRB3; HES1; TIFAB; SLITRK6;	GO:0090102~cochlea development	5	32	15.625	0.0375805538673398	0.163931021426074	1	1	0.999999717377144	0.999999717377143	1
down	RARB; BMP4; ETV5; NBL1; FOXA1; IRX3; DUOXA1; SH3GL3; HEYL;	GO:0045666~positive regulation of neuron differentiation	9	81	11.1111111111111	0.0385798194260989	0.168023659763192	1	1	0.999999717377144	0.999999717377143	1
down	HSPB1; LOX; PTK2; RAD51; TLR8; TLR7;	GO:0001932~regulation of protein phosphorylation	6	44	13.6363636363636	0.0397245566644823	0.172735927676126	1	1	0.999999717377144	0.999999717377143	1
down	RBFOX2; ADCY5; SLC1A3; TIFAB; GPR88; SHANK1;	GO:0050885~neuromuscular process controlling balance	6	44	13.6363636363636	0.0397245566644823	0.172735927676126	1	1	0.999999717377144	0.999999717377143	1
down	TRPM2; EDN2; NMU; PPARGC1A;	GO:0001659~temperature homeostasis	4	22	18.1818181818182	0.0402597147879012	0.174374295757196	1	1	0.999999717377144	0.999999717377143	1
down	ZDHHC19; ZDHHC9; ZDHHC11B; ZDHHC15;	GO:0018230~peptidyl-L-cysteine S-palmitoylation	4	22	18.1818181818182	0.0402597147879012	0.174374295757196	1	1	0.999999717377144	0.999999717377143	1
down	TBX3; TGFB3; SOX9; PRL;	GO:0030879~mammary gland development	4	22	18.1818181818182	0.0402597147879012	0.174374295757196	1	1	0.999999717377144	0.999999717377143	1
down	GSTA4; GSTT2B; MGST2; GSTO2;	GO:1901687~glutathione derivative biosynthetic process	4	22	18.1818181818182	0.0402597147879012	0.174374295757196	1	1	0.999999717377144	0.999999717377143	1
down	MDK; NES; PROX1; DLL4;	GO:2000179~positive regulation of neural precursor cell proliferation	4	22	18.1818181818182	0.0402597147879012	0.174374295757196	1	1	0.999999717377144	0.999999717377143	1
down	MELTF; CEACAM1; IGFBP4; IGFBP5; BCAR1; DDR1; NET1; WFDC1;	GO:0001558~regulation of cell growth	8	69	11.5942028985507	0.0408530270595628	0.176804963807306	1	1	0.999999717377144	0.999999717377143	1
down	APOE; CYP2E1; LPL; CETP; PCSK9;	GO:0006641~triglyceride metabolic process	5	33	15.1515151515152	0.0415344547515859	0.178636221793225	1	1	0.999999717377144	0.999999717377143	1
down	IL1RN; FAM3B; RAPGEF4; PCLO; ANXA1;	GO:0030073~insulin secretion	5	33	15.1515151515152	0.0415344547515859	0.178636221793225	1	1	0.999999717377144	0.999999717377143	1
down	ENPP3; ENTPD5; ATP1B1; HSPA1B; AK4;	GO:0046034~ATP metabolic process	5	33	15.1515151515152	0.0415344547515859	0.178636221793225	1	1	0.999999717377144	0.999999717377143	1
down	NGFR; NTRK2; ROBO1; PLXNA2; PLXNB1;	GO:0050772~positive regulation of axonogenesis	5	33	15.1515151515152	0.0415344547515859	0.178636221793225	1	1	0.999999717377144	0.999999717377143	1
down	NTRK1; NPR3; GPR143; NCS1; PLCB4; PLCH2; PIK3C2G;	GO:0048015~phosphatidylinositol-mediated signaling	7	57	12.280701754386	0.0425734860433319	0.178636221793225	1	1	0.999999717377144	0.999999717377143	1
down	GREM1; ANXA2; LOX; FMOD; ADAMTS14; LOXL4;	GO:0030199~collagen fibril organization	6	45	13.3333333333333	0.0431666572544874	0.178636221793225	1	1	0.999999717377144	0.999999717377143	1
down	RASSF9; ANXA8; RAB13; SNX33; CHMP4C; TINAGL1; MYO5B; ZFYVE9; ANXA8L1;	GO:0016197~endosomal transport	9	83	10.8433734939759	0.0434550558065523	0.178636221793225	1	1	0.999999717377144	0.999999717377143	1
down	TOM1L1; SCG5; NGFR; CLTB; TMED10; CTTN; TOM1L2; EXPH5; SYTL5; SNX33; SORCS2; COPZ2; MYO6; RAB25; TBC1D3E; RAB38; RAB3B; GRTP1; ARL4D; STX19; RAB7B; ARL1; RAB13; USP6NL; RAB39A;	GO:0006886~intracellular protein transport	25	317	7.88643533123028	0.0434796437919953	0.178636221793225	1	1	0.999999717377144	0.999999717377143	1
down	APOE; APOD; PPARGC1A;	GO:0000302~response to reactive oxygen species	3	13	23.0769230769231	0.0442955317977602	0.178636221793225	1	1	0.999999717377144	0.999999717377143	1
down	IL10; CLEC4A; NDRG2;	GO:0001818~negative regulation of cytokine production	3	13	23.0769230769231	0.0442955317977602	0.178636221793225	1	1	0.999999717377144	0.999999717377143	1
down	BMP4; JAG1; PPP1R13L;	GO:0003215~cardiac right ventricle morphogenesis	3	13	23.0769230769231	0.0442955317977602	0.178636221793225	1	1	0.999999717377144	0.999999717377143	1
down	MIPEP; CPXM1; CPXM2;	GO:0006518~peptide metabolic process	3	13	23.0769230769231	0.0442955317977602	0.178636221793225	1	1	0.999999717377144	0.999999717377143	1
down	C3; CFH; C7;	GO:0006957~complement activation, alternative pathway	3	13	23.0769230769231	0.0442955317977602	0.178636221793225	1	1	0.999999717377144	0.999999717377143	1
down	C3; LPL; HILPDA;	GO:0010884~positive regulation of lipid storage	3	13	23.0769230769231	0.0442955317977602	0.178636221793225	1	1	0.999999717377144	0.999999717377143	1
down	TUSC3; NIPAL1; NIPAL2;	GO:0015693~magnesium ion transport	3	13	23.0769230769231	0.0442955317977602	0.178636221793225	1	1	0.999999717377144	0.999999717377143	1
down	CD19; FCGR2B; TLR8;	GO:0016064~immunoglobulin mediated immune response	3	13	23.0769230769231	0.0442955317977602	0.178636221793225	1	1	0.999999717377144	0.999999717377143	1
down	CDK1; CCNA2; NEK11;	GO:0016572~histone phosphorylation	3	13	23.0769230769231	0.0442955317977602	0.178636221793225	1	1	0.999999717377144	0.999999717377143	1
down	EPN2; HHEX; MMRN2;	GO:0030948~negative regulation of vascular endothelial growth factor receptor signaling pathway	3	13	23.0769230769231	0.0442955317977602	0.178636221793225	1	1	0.999999717377144	0.999999717377143	1
down	VIL1; ID1; CX3CL1;	GO:0032233~positive regulation of actin filament bundle assembly	3	13	23.0769230769231	0.0442955317977602	0.178636221793225	1	1	0.999999717377144	0.999999717377143	1
down	EFNA1; EPHA2; PTK2;	GO:0033628~regulation of cell adhesion mediated by integrin	3	13	23.0769230769231	0.0442955317977602	0.178636221793225	1	1	0.999999717377144	0.999999717377143	1
down	DDAH1; CEACAM1; ANGPT1;	GO:0043116~negative regulation of vascular permeability	3	13	23.0769230769231	0.0442955317977602	0.178636221793225	1	1	0.999999717377144	0.999999717377143	1
down	CCR2; SPINK5; TBX21;	GO:0045580~regulation of T cell differentiation	3	13	23.0769230769231	0.0442955317977602	0.178636221793225	1	1	0.999999717377144	0.999999717377143	1
down	AK4; AK7; AK3;	GO:0046940~nucleoside monophosphate phosphorylation	3	13	23.0769230769231	0.0442955317977602	0.178636221793225	1	1	0.999999717377144	0.999999717377143	1
down	SPICE1; KIF2C; FAM83D;	GO:0051310~metaphase plate congression	3	13	23.0769230769231	0.0442955317977602	0.178636221793225	1	1	0.999999717377144	0.999999717377143	1
down	BMP4; ID1; WNT7B;	GO:0060425~lung morphogenesis	3	13	23.0769230769231	0.0442955317977602	0.178636221793225	1	1	0.999999717377144	0.999999717377143	1
down	EGFR; TFAP2A; GRHL3;	GO:0061029~eyelid development in camera-type eye	3	13	23.0769230769231	0.0442955317977602	0.178636221793225	1	1	0.999999717377144	0.999999717377143	1
down	FLRT2; SPINT2; CAV2;	GO:0071711~basement membrane organization	3	13	23.0769230769231	0.0442955317977602	0.178636221793225	1	1	0.999999717377144	0.999999717377143	1
down	HES1; PARD3; FRMD4A;	GO:0090162~establishment of epithelial cell polarity	3	13	23.0769230769231	0.0442955317977602	0.178636221793225	1	1	0.999999717377144	0.999999717377143	1
down	KIT; GATA1; PPARGC1A;	GO:0097067~cellular response to thyroid hormone stimulus	3	13	23.0769230769231	0.0442955317977602	0.178636221793225	1	1	0.999999717377144	0.999999717377143	1
down	DLG3; LRRC1; DLG2;	GO:0097120~receptor localization to synapse	3	13	23.0769230769231	0.0442955317977602	0.178636221793225	1	1	0.999999717377144	0.999999717377143	1
down	USP6NL; EHD3; CAMSAP3;	GO:1903358~regulation of Golgi organization	3	13	23.0769230769231	0.0442955317977602	0.178636221793225	1	1	0.999999717377144	0.999999717377143	1
down	PIR; TRIP13; PTPN14;	GO:1903506~regulation of nucleic acid-templated transcription	3	13	23.0769230769231	0.0442955317977602	0.178636221793225	1	1	0.999999717377144	0.999999717377143	1
down	HMGA2; ARG2; PAWR;	GO:2000774~positive regulation of cellular senescence	3	13	23.0769230769231	0.0442955317977602	0.178636221793225	1	1	0.999999717377144	0.999999717377143	1
down	CDC45; RRM2; CDC6; CDT1;	GO:0000083~regulation of transcription involved in G1/S transition of mitotic cell cycle	4	23	17.3913043478261	0.0454297385123551	0.178636221793225	1	1	0.999999717377144	0.999999717377143	1
down	TSPAN12; TFAP2A; SDK1; FJX1;	GO:0010842~retina layer formation	4	23	17.3913043478261	0.0454297385123551	0.178636221793225	1	1	0.999999717377144	0.999999717377143	1
down	LPL; CPS1; PNPLA4; MGLL;	GO:0019433~triglyceride catabolic process	4	23	17.3913043478261	0.0454297385123551	0.178636221793225	1	1	0.999999717377144	0.999999717377143	1
down	KALRN; KANK1; EPS8L1; EPS8L2;	GO:0035023~regulation of Rho protein signal transduction	4	23	17.3913043478261	0.0454297385123551	0.178636221793225	1	1	0.999999717377144	0.999999717377143	1
down	NCS1; VSNL1; EXPH5; CADPS;	GO:0045921~positive regulation of exocytosis	4	23	17.3913043478261	0.0454297385123551	0.178636221793225	1	1	0.999999717377144	0.999999717377143	1
down	APOE; DLG5; SHANK1; SHANK2;	GO:0060999~positive regulation of dendritic spine development	4	23	17.3913043478261	0.0454297385123551	0.178636221793225	1	1	0.999999717377144	0.999999717377143	1
down	ANXA1; SSTR3; FLT3; STC1;	GO:0071385~cellular response to glucocorticoid stimulus	4	23	17.3913043478261	0.0454297385123551	0.178636221793225	1	1	0.999999717377144	0.999999717377143	1
down	TBX3; HRAS; CDKN2B; TBX2;	GO:0090398~cellular senescence	4	23	17.3913043478261	0.0454297385123551	0.178636221793225	1	1	0.999999717377144	0.999999717377143	1
up	AKR1B15; AKR1B10; CYP1A1; SELENBP1;	GO:0055114~oxidation-reduction process	4	526	0.760456273764259	0.0456240208139742	0.0923386556713103	1	1	0.764540252498336	0.764540252498336	0.62870445426974
down	BMP3; BMP7; WNT5A; SOX9; PRRX1; PITX1; SULF1;	GO:0051216~cartilage development	7	58	12.0689655172414	0.0457114970274703	0.17904944827433	1	1	0.999999717377144	0.999999717377143	1
down	ETV5; STXBP1; CHRNB4; RIMBP3B; CHRNG;	GO:0007274~neuromuscular synaptic transmission	5	34	14.7058823529412	0.0457299771614365	0.17904944827433	1	1	0.999999717377144	0.999999717377143	1
down	RBFOX2; LRP4; SLC11A2; VLDLR; CELSR2;	GO:0048813~dendrite morphogenesis	5	34	14.7058823529412	0.0457299771614365	0.17904944827433	1	1	0.999999717377144	0.999999717377143	1
down	GREM1; NEK2; GRHL2; PARM1; AURKB;	GO:0051973~positive regulation of telomerase activity	5	34	14.7058823529412	0.0457299771614365	0.17904944827433	1	1	0.999999717377144	0.999999717377143	1
down	TBX3; HES1; PROX1; HEYL; ROBO1;	GO:0060412~ventricular septum morphogenesis	5	34	14.7058823529412	0.0457299771614365	0.17904944827433	1	1	0.999999717377144	0.999999717377143	1
down	NOL3; LMNA; BMP4; YAP1; CTTN;	GO:2001237~negative regulation of extrinsic apoptotic signaling pathway	5	34	14.7058823529412	0.0457299771614365	0.17904944827433	1	1	0.999999717377144	0.999999717377143	1
down	TBX3; VEGFA; TBX2; HES1; EYA1; HEYL;	GO:0003151~outflow tract morphogenesis	6	46	13.0434782608696	0.0467898709084622	0.182809254330081	1	1	0.999999717377144	0.999999717377143	1
down	ADRA2A; GHR; IGFBP2; AIF1; AVPR2; AVPR1A;	GO:0032870~cellular response to hormone stimulus	6	46	13.0434782608696	0.0467898709084622	0.182809254330081	1	1	0.999999717377144	0.999999717377143	1
down	WNT10B; WNT1; WNT5A; JAG1; RUNX1T1; WWTR1;	GO:0045599~negative regulation of fat cell differentiation	6	46	13.0434782608696	0.0467898709084622	0.182809254330081	1	1	0.999999717377144	0.999999717377143	1
down	EDN2; AVPR1A; CCR5; P2RY12; NMUR1; CCR2; CALML6; CXCR5; CXCR1;	GO:0019722~calcium-mediated signaling	9	85	10.5882352941176	0.0487266073759185	0.189971652694356	1	1	0.999999717377144	0.999999717377143	1
down	DMD; GJA1; WNT5A; DUOXA1; AJUBA; FRMD6; GAS8;	GO:0034613~cellular protein localization	7	59	11.864406779661	0.0489937793949121	0.190878100190369	1	1	0.999999717377144	0.999999717377143	1
down	CRYAB; NGFR; VIL1; VEGFA; SFN; NAIP; DHCR24; BIRC5;	GO:0043154~negative regulation of cysteine-type endopeptidase activity involved in apoptotic process	8	72	11.1111111111111	0.0494004682115808	0.192326433878891	1	1	0.999999717377144	0.999999717377143	1
